‫תשע"א‬/'‫ח‬
5/2011
‫רשומות‬
ISRAEL STATE RECORDS
‫כ"ז באייר התשע"א‬
May 31 ,2011
‫יומן הפטנטים והמדגמים‬
PATENTS AND DESIGNS JOURNAL
Page/‫עמוד‬
Patents
Applications filed
Applications accepted
Patents renewed
Patents renewed for 20 years
Country codes
Indices of applications accepted
Designs
Designs registered
Designs canceled
1
4
101
256
256
285
278
261
276
‫פטנטים‬
‫בקשות שהוגשו‬
‫בקשות שקובלו‬
‫פטנטים שחודשו‬
‫פטנטים שחודשו לעשרים שנה‬
‫קודים למדינות‬
‫מפתחות לבקשות שהתקבלו‬
‫מדגמים‬
‫מדגמים שנרשמו‬
‫מדגמים שבוטלו‬
May 31, 2011-‫כ"ז באייר התשע"א‬
‫ידיעות כלליות‬
:‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬
.‫ ירושלים‬,‫ מלחה‬5 ‫ בנין‬,‫ גנים טכנולוגיים ירושלים‬,‫רשם הפטנטים והמדגמים‬
‫אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הרשות בבנק הדואר‬
‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה‬.0-24145-2 '‫מס‬
.‫האגרה שולמה‬
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of
the Authority, No. 0-24145-2. The receipt of the Postal Bank must be presented to the
office together with the application for the action for which the fee has been paid.
Copyright by the State of Israel. No Extracts may be published except with the
permission of the Patent Office.
2
‫זכות היוצרים בתקצירים אלה שמורה למדינת‬
‫ אין להעתיק מתקצירים אלה אלא‬,‫ישראל‬
.‫ברשות לשכת הפטנטים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
PATENTS
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new applications complying with the provisions of rule
32(a) of the Patent Regulations, 5728-1968:
Particulars of the applications are given in
the following order:
Number and date of application and the first
four symbols of the International Classification.
Title of invention (as proposed by applicant)
Applicant
Priority right:
Convention countryNumber and date of
Foreign application
International Application Number
International Publication Number
3
‫פטנטים‬
-‫ תשכ"ז‬,‫ לחוק הפטנטים‬16 ‫הודעה לפי סעיף‬
1967
‫להלן רשימת בקשות חדשות הממלאות אחר‬
‫(א) לתקנות‬32 ‫הדרישות שנקבעו בתקנה‬
:1968-‫ תשכ"ח‬,‫הפטנטים‬
:‫פרטי הבקשות מובאים לפי סדר זה‬
‫מספר הבקשה – ותאריך הגשתה וארבעה‬
‫הסמנים הראשונים של הסיווג הבינלאומי‬
)‫שם האמצאה (כפי שהוצע ע"י המבקש‬
‫המבקש‬
– ‫מדינת האיגוד‬
:‫דין קדימה‬
‫תאריך ומספר‬
‫בקשת החוץ‬
‫מספר בקשה בינלאומית‬
‫מספר פרסום בינלאומי‬
May 31, 2011-‫כ"ז באייר התשע"א‬
02/05/2010
205479
‫מנעל הניתן לקיפול‬
‫מור טליה שלום‬
A FOLDABLE FOOTWEAR
MOR TALIA SHALOM
09/12/2010
209861
MULTI-BAND, REDUCED-VOLUME
RADIATION DETECTORS AND
METHODS OF FORMATION
RAYTHEON COMPANY
US
12/640586
17/12/2009
12/12/2010
209934
UHF RADAR SYSTEM TO
IMPLEMENT A PROCESS FOR
REMOVING A TANGLE OF
VEGETATION
THALES
FR
0906003
11/12/2009
11/06/2009
209943
CONDUCTIVE INKS AND PASTES
NANOMAS TECHNOLOGIES INC,
US
61/061076
12/06/2008
PCT/US/2009/047120
WO/2009/152388
4
B23C )2010.01(
H01L )2010.01(
‫ רבי תדרים ושיטה‬,‫גלאי קרינה מוקטנים‬
‫לייצורם‬
G01S )2010.01(
‫ ליישום תהליך של‬UHF ‫מערכת מכ"מ‬
‫הסרת סבך של צמחיה‬
B22F )2010.01(
‫דיו ומשחה בעלי מוליכות‬
May 31, 2011-‫כ"ז באייר התשע"א‬
13/12/2010
209958
ONE WAY AND ROUND TRIP
DELAYS USING TELEPHONY INBAND TONES
IXIA
US
12/684635
08/01/2010
15/12/2010
‫השהיות חד–כיווניות והשהיות הלוך וחוזר‬
‫תוך שימוש בצלילים תוך–פסיים‬
210023
METHOD FOR DIAGNOSING SPINAL
MUSCULAR ATROPHY
KAOHSIUNG MEDICAL UNIVERSITY
15/12/2010
210025
5
F03D )2010.01(
‫מנגנון מתנדנד לטורבינת רוח רב להבית‬
210208
SYSTEMS, DEVICES, AND METHODS
FOR IMPROVING ACCURACY OF
BIOSENSORS USING FILL TIME
LIFESCAN, INC.
US
12/649594
30/12/2009
A61B )2010.01(
‫שיטה לאבחון ניוון שרירים שידרתי‬
TEETER MECHANISM FOR A
MULTIPLE-BLADED WIND TURBINE
HAMILTON SUNDSTRAND
CORPORATION
US
12/639027
16/12/2009
23/12/2010
G09B )2010.01(
C12M )2010.01(
‫ התקנים ושיטות לשיפור הדיוק‬,‫מערכות‬
‫של חיישנים ביולוגים ע"י שימוש בזמן מילוי‬
May 31, 2011-‫כ"ז באייר התשע"א‬
US
02/09/2009
12/971777
17/12/2010
211341
C07D )2010.01(
2-OXO-1,2-DIHYDRO-QUIYDROQUINOLINE MODULATORS OF
IMMUNE FUNCTION
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
61/093943
03/09/2008
PCT/US/2009/055692
WO/2010/028015
22/08/2009
–2 ‫מווסתי פעילות חיסונית על בסיס‬
‫ דיהידרו קינולין‬1,2–‫אוקסו‬
‫טבע תעשיות פרמצבטיות בע"מ‬
211343
SINGLE UNIT ORAL DOSE
PHARMACEUTICAL COMPOSITION
COMPRISING LEVODOPA, CARBIDOPA
AND ENTACAPONE OR SALTS THEREOF
WOCKHARDT RESEARCH CENTRE
IN
1779/MUM/2008 22/08/2008
PCT/IB/2009/053699
WO/2010/020970
22/08/2009
6
‫יחידת מינון להושטה פומית של תכשיר‬
‫ קרבידופה‬,‫רוקחי המכיל לבדופה‬
‫ואנטאקפון או מלחיהם‬
211344
AN EXTENDED RELEASE
PHARMACEUTICAL COMPOSITION OF
ENTACAPONE OR SALTS THEREOF
WOCKHARDT RESEARCH CENTRE
IN
1777/MUM/2008 22/08/2008
IN
MUM/2008/1778 22/08/2008
PCT/IB/2009/053698
WO/2010/020969
A61K )2010.01(
A61K )2010.01(
‫תכשיר רוקחי לשחרור מושהה של‬
‫אנטקופן או מלחיו‬
May 31, 2011-‫כ"ז באייר התשע"א‬
27/08/2009
211346
ADIPONECTIN FOR TREATING
PULMONARY DISEASE
OTSUKA PHARMACEUTICAL CO.,
LTD.
2008JP
27/08/2008
217721
PCT/JP/2009/065380
WO/2010/024460
28/08/2009
‫אדיפונקטין לטיפול במחלת ריאות‬
211347
BUTYRYLCHOLINESTERASE
LIGANDS AS DIAGNOSTIC TOOLS
AND TREATMENT FOR DESEASES
OF THE NERVOUS SYSTEM
TREVENTIS CORPORATION
US
61/092861
29/08/2008
PCT/US/2009/055365
WO/2010/025368
04/09/2009
01/09/2009
7
A61K )2010.01(
–‫–דימתילאמינומתיל‬6 ‫שילוב רוקחי המכיל‬
–3,1–‫–מתוקסי–פניל)–ציקלוהקסאן‬3(–1
NSAID–‫דיאול ו‬
211349
MULTISPECIFIC ANTIBODIES
GENENTECH, INC.
US
61/190856
03/09/2008
A61K )2010.01(
‫ליגנדים בוטירילקולינאסטראז ככלים‬
‫לאבחון וטיפול עבור מחלות של מערכת‬
‫העצבים‬
211348
PHARMACEUTICAL COMBINATION
COMPRISING 6DIMETHYLAMINOMETHYL-1-(3METHOXY-PHENYL)CYCLOHEXANE-1,3-DIOL AND AN
NSAID
GRUNENTHAL GMBH
EP
08015687.0 05/09/2008
PCT/EP/2009/006439
WO/2010/025934
A61K )2010.01(
C07K )2010.01(
‫נוגדנים רב–ספציפיים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
PCT/US/2009/055625
WO/2010/027981
14/08/2009
211350
‫התקן תקשורת‬
A COMMUNICATION DEVICE
THE SORTING OFFICE LIMITED
GB
0815467.6
22/08/2008
PCT/GB/2009/001996
WO/2010/020761
21/08/2009
211351
SELF CONTAINED IN-GROUND
PEOTHERMAL GENERATOR
NIKOLA LAKIC
US
12/197073
22/08/2008
PCT/US/2009/054656
WO/2010/022354
METHOD FOR PURIFYING
ELEMENTARY BORON
H.C. STARCK GMBH
DE
102008045858.9
PCT/EP/2009/061154
WO/2010/026111
31/08/2009
C01B )2010.01(
‫שיטה לטיהור בורון יסודי‬
05/09/2008
211353
POLYMORPHS OF ACYL
SULFONAMIDES
F. HOFFMANN-LA ROCHE AG
US
61/095364
09/09/2008
PCT/EP/2009/061185
WO/2010/028968
8
F24J )2010.01(
‫מחולל גיאותרמי הכלול בתוך הקרקע‬
211352
28/08/2009
H04L )2010.01(
C07C )2010.01(
‫פולימורפים של אציל סולפונאמידים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
11/09/2009
211354
TETHER-BASED ORTHOPEDIC JOINT
DEVICE DELIVERY METHODS
ARTICULINX, INC.
US
12/210099
12/09/2008
12/212587
17/09/2008
US
61/171408
21/04/2009
US
61/171409
21/04/2009
US
61/171410
21/04/2009
US
61/171412
21/04/2009
US
PCT/US/2009/056724
WO/2010/030933
24/08/2009
211355
A MANEUVERABLE BRISTLE
TOOTHBRUSH
HADASIT MEDICAL RESEARCH
SERVICES AND DEVELOPMENT LTD.
US
61/091386
24/08/2008
PCT/IL/2009/000819
WO/2010/023660
21/08/2009
211356
METAMATERIALS FOR SURFACES
AND WAVEGUIDES
DUKE UNIVERSITY
US
61/091337
22/08/2008
PCT/US/2009/004772
WO/2010/021736
09/03/2010
9
211358
A61F )2010.01(
‫התקן אורטופדי למפרק המבוסס על‬
‫רצועה ושיטות להכנסתו‬
A46B )2010.01(
‫מברשת שיניים בעלת זיפים ניתנים‬
‫לתמרון‬
‫הדסית שרותי מחקר רפואי ופתוח בע"מ‬
H01P )2010.01(
‫מטא–חומרים לפני–שטח ולמוליכי גלים‬
B65D )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
MICROWAVE COOKING
CONTAINERS WITH SHIELDING
BEMIS COMPANY, INC.
US
12/714131
26/02/2010
PCT/US/2010/026652
WO/2010/104849
17/09/2009
211359
USING SIGNAL MONITORING TO
RESOLVE ACCESS POINT
IDENTIFIER AMBIGUITY
QUALCOMM INCORPORATED
US
61/098203
18/09/2008
61/158536
09/03/2009
US
12/560634
16/09/2009
US
PCT/US/2009/057358
WO/2010/033729
18/09/2009
211360
NETWORK AND MOBILE DEVICE
INTIATED QUALITY OF SERVICE
QUALCOMM INCORPORATED
US
61/098647
19/09/2008
12/561570
17/09/2009
US
PCT/US/2009/057584
WO/2010/033872
04/09/2009
211361
METHOD FOR INHIBITING SCALE
FORMATION AND DEPOSITION IN
MEMBRANE SYSTEMS VIA THE USE
OF AN AA-AMPS COPOLYMER
NALCO COMPANY
US
12/204488
04/09/2008
PCT/US/2009/055964
WO/2010/028196
10
‫מיכלים עם מגן לבישול בתנור מיקרוגל‬
H04W )2010.01(
‫שימוש בפיקוח על אותות ליישוב ערפול‬
‫מזהה נקודת גישה‬
H04W )2010.01(
‫איכוד שירות מותחל על ידי רשת והתקן‬
‫נייד‬
C02F )2010.01(
‫שיטה למניעת יצירת והנחת אבנית‬
‫במערכות ממברניות על ידי שימוש‬
AMPS–AA ‫בקופולימר‬
May 31, 2011-‫כ"ז באייר התשע"א‬
27/10/2009
211362
REFLECTIVE TRIPLET OPTICAL
FORM WITH EXTERNAL REAR
APERTURE STOP FOR COLD
SHIELDING
RAYTHEON COMPANY
US
12/264887
04/11/2008
PCT/US/2009/062263
WO/2010/053758
27/08/2009
211388
DNA REPLICON SYSTEM FOR HIGHLEVEL RAPID PRODUCTION OF
VACCINES AND MONOCLONAL
ANTIBODY THERAPEUTICS IN
PLANTS
THE ARIZONA BOARD OF REGENTS
FOR AND ON BEHAIF OF ARIZONA
STATE UNIVERSITY
US
61/092318
27/08/2008
PCT/US/2009/055237
WO/2010/025285
17/09/2009
211390
COMPRESSED TISSUE PRODUCT
KIMBERLY-CLARK WORLDWIDE,
INC.
US
12/286563
30/09/2008
PCT/IB/2009/054082
WO/2010/038164
26/08/2009
11
211391
G02B )2010.01(
‫צורה אופטית שלישיה משקפת עם עצר‬
‫פתח אחורי חיצוני למיגון קר‬
A01H )2010.01(
‫ עבור ייצור‬DNA ‫מערכת לרפליקון של‬
‫מהיר ברמה גבוהה של חיסונים וטיפולי‬
‫נוגדנים חד–שבטיים בצמחים‬
A47K )2010.01(
‫מוצר טישו דחוס‬
C07D )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
COMPOUNDS THAT MODULATE
INTRACELLULAR CALCIUM
CALCIMEDICA,INC.
US
61/092364
27/08/2008
61/142846
06/01/2009
US
61/143739
09/01/2009
US
61/157274
04/03/2009
US
61/158702
09/03/2009
US
61/158710
09/03/2009
US
PCT/US/2009/055090
WO/2010/027875
10/08/2009
211392
FILTER WITH ADJUSTABLE
POROSITY
FILTOFLEX LTD
US
61/136351
29/08/2008
PCT/IL/2009/000777
WO/2010/023656
19/10/2005
211393
ANTIBODY FORMULATIONS
GENENTECH, INC.
US
20/10/2004
PCT/US/2005/037471
WO/2006/044908
28/08/2009
211394
PREVENTION, TREATMENT AND
DIAGNOSIS OF P.GINGIVALIS
INFECTION
ORAL HEALTH AUSTRALIA PTY LTD
AU
2008904476 29/08/2008
2008905483
23/10/2008
AU
61/151132
09/02/2009
US
2009903052
30/06/2009
AU
12
‫תרכובות המאפננות סידן תוך–תאי‬
B01D )2010.01(
‫פילטר עם נקבוביות ניתנת להתאמה‬
‫פילטופלקס בע"מ‬
A61K )2010.01(
‫הרכבי נוגדנים‬
C07K )2010.01(
‫ טיפול ואבחון של זיהום בחניכיים‬,‫מניעה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
PCT/AU/2009/001112
WO/2010/022463
04/09/2009
211395
PHARMACEUTICAL COMBINATION
COMPRISING 6DIMETHYLAMINOMETHYL-1-(3METHOXY-PHENYL)CYCLOHEXANE-1,3 DIOL AND
PARACETAMOL
GRUNENTHAL GMBH
EP
08015621.9 05/09/2008
PCT/EP/2009/006422
WO/2010/025930
28/09/2009
‫–דימתיל אמינו‬6 ‫תצריף רוקחות המכיל‬
–‫–מתוקסי–פניל)–ציקלוהקסאן‬3(–1–‫מתיל‬
‫–דיאול ופאראצטמול‬3,1
211396
211400
SUBSTITUTED AMINOINDANES AND
ANALOGS THEREOF, AND THE
PHARMACEUTICAL USE THEREOF
SANOFI AVENTIS
EP
08290826.0 02/09/2008
PCT/EP/2009/006135
WO/2010/025856
26/08/2009
13
C25B )2010.01(
‫איבר קטודי ולוח ביפולרי עבור תאים‬
‫היפוכלוריטים‬
CATHODE MEMBER AND BIPOLAR
PLATE FOR HYPOCHLORITE CELLS
INDUSTRIE DE NORA S.P.A
US
61/101246
30/09/2008
PCT/EP/2009/062509
WO/2010/037706
25/08/2009
A61K )2010.01(
C07D )2010.01(
,‫אמינואינדאנים מותמרים ואנלוגים שלהם‬
‫ושימושים פרמצבטיים בהם‬
211401
F24J )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
SOLAR TROUGH FRAME, PART AND
METHOD
WERNER EXTRUSION SOLUTIONS
LLC
US
61/190573
29/08/2008
PCT/US/2009/004852
WO/2010/024891
22/10/2009
‫ חלק ושיטה‬,‫מסגרת תעלה סולארית‬
211403
PROCESS FOR THE PREPARATION
OF CENTRE-FILLED CHOCOLATE
PRODUCTS
CADBURY HOLDINGS LIMITED
GB
0819683.4
27/10/2008
PCT/GB/2009/002516
WO/2010/049671
30/10/2009
‫שיטה להכנת מוצרי שוקולד ממולאים‬
‫באמצע‬
211404
CENTREFILLED CONFECTIONERY
COMPOSITION
CADBURY HOLDINGS LIMITED
GB
0820103.0
31/10/2008
PCT/GB/2009/002586
WO/2010/049701
25/08/2009
14
A23G )2010.01(
‫תכשיר קונדיטוריה ממולאת באמצע‬
211405
T-CELL RECEPTOR ANTIBODIES
AND METHODS OF USE THEREOF
MACROGENICS, INC.
US
61/092005
26/08/2008
PCT/US/2009/054911
WO/2010/027797
A23G )2010.01(
C07K )2010.01(
‫ ושיטות שימושיהם‬T ‫נוגדנים לקולטן תאי‬
May 31, 2011-‫כ"ז באייר התשע"א‬
16/09/2009
211406
‫בנזאמידים מותמרים כליגנדים לקולטן‬
‫קאנאבינויד‬
SUBSTITUTED BENZAMIDES AS
CANNABINOID RECEPTOR LIGANDS
ABBOTT LABORATORIES
US
61/097378
16/09/2008
61/224200
09/07/2009
US
PCT/US/2009/057088
WO/2010/033543
28/08/2009
211407
CONTROLLED-RELEASED PEPTIDE
FORMULATIONS
GENZYME CORPORATION
US
61/093258
29/08/2008
PCT/US/2009/055461
WO/2010/025435
10/09/2009
08/09/2009
15
A61K )2010.01(
‫מעכבי פרוטאז סרין מקרוציקלי של צהבת‬
C
211409
INSPECTION METHOD FOR
LITHOGRAPHY
ASML NETHERLANDS B.V
US
61/097374
16/09/2008
PCT/EP/2009/006518
WO/2010/031510
A61K )2010.01(
‫פורמולציות פפטיד לשחרור מבוקר‬
211408
MACROCYCLIC HEPATITIS C SERINE
PROTEASE INHIBITORS
ENANTA PHARMACEUTICALS, INC.
US
61/191725
11/09/2008
61/209689
10/03/2009
US
PCT/US/2009/005082
WO/2010/030359
C07D )2010.01(
G03F )2010.01(
‫שיטת צפייה לליטוגרפיה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
22/09/2009
211410
METHOD FOR PREPARING
NEBIVOLOL
ZACH SYSTEM
FR
0856415
24/09/2008
PCT/FR/2009/051775
WO/2010/034927
28/08/2009
‫שיטה להכנת נביוולול‬
211411
HETEROARYLS AMIDE
DERIVATIVES AND THEIR USE AS
GLUCOKINASE ACTIVATORS
PFIZER INC.
US
61/096056
11/09/2008
61/232578
10/08/2009
US
PCT/IB/2009/053773
WO/2010/029461
15/09/2009
02/06/2009
16
C07D )2010.01(
–6,2–‫–ציס‬N–[6 ‫מלחים של‬
–2–]‫–יל‬3–‫–יל)פירידינ‬4–‫דימתילמורפולין‬
–]‫–ביפניל‬1,1[)‫–(טריפלואורומתוקסי‬4–‫מתיל‬
‫–קרבוקסאמיד‬3
211413
MODULAR BOTTLE CLOSURE
HAREL SHWARTS
IL
193662
25/08/2008
C07D )2010.01(
‫תולדות אמיד הטרוארילים ושימושם‬
‫כמשפעלי גלוקוקינאז‬
211412
SALTS OF N-[6-CIS-2,6DIMETHYLMORPHOLIN4YL)PYRIDINE-3YL]-2-METHYL-4(TRIFLUOROMETHOXY)[1,1BIPHENYL]-3-CARBOXAMIDE
NOVARTIS AG
US
61/097580
17/09/2008
PCT/US/2009/056918
WO/2010/033481
C07D )2010.01(
B65D )2010.01(
‫סוגר בקבוק מודולארי‬
‫הראל שוורץ‬
May 31, 2011-‫כ"ז באייר התשע"א‬
PCT/IL/2009/000552
WO/2010/023652
03/09/2009
211416
METHOD FOR DELIVERING A
PHARMACEUTICAL COMPOSITION
TO PATIENT IN NEED THEREOF
POZEN INC.
US
61/095584
09/09/2008
PCT/GB/2009/051108
WO/2010/029335
27/08/2009
‫שיטה למתן תכשיר רפואי לחולה זקוק‬
211417
PYRIDINE DERIVATIVES AS VEGFR-2
RECEPTOR AND PROTEIN TYROSINE
KINASE INHIBITORS
LEO PHARMA A/S
US
61/092213
27/08/2008
DK
PA200801449 17/10/2008
PCT/DK/2009/000190
WO/2010/022725
28/08/2008
A61K )2010.01(
211418
OPERATING SUPPORT FOR
SURGEONS
PRIMARY PURPOSE, LLC
C07D )2010.01(
–2 ‫נגזרות של פירידין כמעכבי רצפטור‬
‫ –וחלבון טירוזין קינאז‬VEGFR
A61B )2010.01(
‫תומך למנתחים בניתוחים‬
PCT/US/2008/074669
WO/2010/024813
25/08/2009
PESTICIDAL COMPOSITIONS
DOW AGROSCIENCES LLC
17
211419
A01N )2010.01(
‫תכשירים להדברת מזיקים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
US
61/092077
PCT/US/2009/054876
WO/2010/027779
24/08/2009
27/08/2008
211420
METHOD FOR PRODUCING THRUST
(EMBODIMENTS) AND APPARATUS
FOR TRAVEL IN A FLUID MEDIUM
(EMBODIMENTS)
"KB BRIZ" JOINT-STOCK COMPANY
RU
2008134763 25/08/2008
PCT/RU/2009/000426
WO/2010/024726
31/08/2009
211421
TRANSGENIC PLANTS WITH
ENHANCED GROWTH
CHARACTERISTICS
UNIVERSITY OF MAINE SYSTEM
BOARD OF TRUSTEES
US
61/190520
29/08/2008
PCT/US/2009/055557
WO/2010/025466
04/09/2009
211424
METHOD FOR DIAGNOSTIC MARKER
DEVELOPMENT
KEYGENE N.V.
US
61/096054
11/09/2008
PCT/NL/2009/000172
WO/2010/030171
28/08/2009
18
211425
B64C )2010.01(
‫שיטה לייצור דחף (התגלמויות) והתקן‬
)‫לתנועה בנוזל (התגלמויות‬
C12N )2010.01(
‫צמחים טרנסגניים בעלי תכונות גידול‬
‫משופרות‬
C12N )2010.01(
‫שיטה לפיתוח סמן אבחון‬
A61K )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
‫תכשירים ושיטות לטיפול במחלת‬
‫עמילואיד‬
COMPOSITIONS AND METHODS OF
TREATING AMYLOID DISEASE
TREVENTIS CORPORATION
US
61/092845
29/08/2008
PCT/US/2009/055377
WO/2010/025375
31/08/2009
211426
LIQUID HEATING APPARATUS AND
LIQUID HEATING METHOD
KURITA WATER INDUSTRIES LTD
2008JP
01/09/2008
223396
PCT/JP/2009/004260
WO/2010/023959
31/08/2009
03/09/2009
G06K )2010.01(
‫שיטה לקביעת פסאודו זהות על בסיס‬
‫תכונות של פרטים מדוייקים ומכשיר קשור‬
211428
COMPOUNDS, COMPOSITIONS AND
METHODS OF USING SAME FOR
MODULATING URIC ACID LEVELS
ARDEA BIOSCIENCES, INC.
US
61/094388
04/09/2008
61/180110
20/05/2009
US
PCT/US/2009/055947
WO/2010/028189
19
‫מערכת לחימום נוזל ושיטה לחימום נוזל‬
211427
METHOD OF DETERMINING A
PSEUDO-INDENTITY ON THE BASIS
OF CHARACTERISTICS OF MINUTIAE
AND ASSOCIATED DEVICE
MORPHO
FR
0855853
01/09/2008
PCT/FR/2009/051645
WO/2010/023415
F24H )2010.01(
C07D )2010.01(
‫תרכובות תכשירים ושיטות לשימוש בהם‬
‫לאפנון רמות חומצת שתן‬
May 31, 2011-‫כ"ז באייר התשע"א‬
03/09/2009
211429
COMPOUNDS, COMPOSITIONS AND
METHODS OF USING SAME FOR
MODULATING URIC ACID LEVELS
ARDEA BIOSCIENCES, INC.
US
61/094388
04/09/2008
12/324764
26/11/2008
US
61/180110
20/05/2009
US
PCT/US/2009/055948
WO/2010/028190
05/10/2009
‫ תכשירים ושיטות לשימוש בהם‬,‫תרכובות‬
‫לאפנון רמות חומצת שתן‬
211430
CARBAZOLE COMPOUNDS AND
THERAPEUTIC USES OF THE
COMPOUNDS
INCURON, LLC
US
61/102913
06/10/2008
PCT/US/2009/059558
WO/2010/042445
19/08/2009
28/08/2009
ARTICLE FORMED FROM
ELECTROSPINNING A DISPERSION
20
C07D )2010.01(
‫תרכובות קרבאזול ושימושים טיפוליים‬
‫בתרכובות‬
211431
FIBERS INCLUDING
NANOPARTICLES AND A METHOD
OF PRODUCING THE
NANOPARTICLES
DOW CORNING CORPORATION
US
61/190542
29/08/2008
PCT/US/2009/054306
WO/2010/025067
C07D )2010.01(
C01B )2010.01(
‫סיבים הכוללים ננוחלקיקים ושיטה לייצור‬
‫הננוחלקיקים‬
211432
D01D )2010.01(
‫פריט המיוצר מאלקטרוספינינג של‬
‫דיספרסיה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
DOW CORNING CORPORATION
US
61/092979
29/08/2008
PCT/US/2009/055386
WO/2010/025381
28/08/2009
211433
PROCESSES AND SYSTEMS FOR
ACHIEVING AND ASSISTING IN
IMPROVED NUTRITION BASED ON
FOOD ENERGY DATA AND
RELATIVE HEALTHFULNESS DATA
WEIGHT WATCHERS
INTERNATIONAL, INC.
US
61/092981
29/08/2008
PCT/US/2009/055445
WO/2010/025422
27/08/2009
‫תהליכים ומערכות להשגה וסיוע בתזונה‬
‫משופרת המבוססים על נתוני אנרגית מזון‬
‫ונתוני בריאות יחסיים‬
211434
211435
PRODUCTION OF SQUALENE FROM
HYPER-PRODUCING YEASTS
NOVARTIS AG
US
61/190486
28/08/2008
PCT/IB/2009/006825
WO/2010/023551
21
G01V )2010.01(
‫הדמייה המבוססת על קרינה קוסמית‬
‫המיוצרת ע"י חלקיקים טעונים‬
IMAGING BASED ON COSMIC-RAY
PRODUCED CHARGED PARTICLES
LOS ALAMOS NATIONAL SECURITY,
LLC
US
61/092372
27/08/2008
61/145091
15/01/2009
US
PCT/US/2009/055253
WO/2010/025300
28/08/2009
G06F )2010.01(
C12P )2010.01(
‫ייצור של סקוולן משמרים מייצרים בכמות‬
‫רבה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
26/08/2009
211436
HOUSING FOR A DUAL RELEASE
TWIN BUCKLE ASSEMBLY
CONAX FLORIDA CORPORATION
US
61/091886
26/08/2008
61/093485
02/09/2008
US
12/546890
25/08/2009
US
PCT/US/2009/055042
WO/2010/025182
26/08/2009
‫אכסון עבור הרכב אבזם תואם עם שחרור‬
‫דואלי‬
211437
TWIN BUCKLE ASSEMBLY WITH
DUAL RELEASE POSITIONS
CONAX FLORIDA CORPORATION
US
61/091876
26/08/2008
12/546914
25/08/2009
US
PCT/US/2009/055036
WO/2010/027853
23/07/2009
211438
SPHERICAL MIRROR MOUNT
RAYTHEON COMPANY
US
12/236256
23/09/2008
PCT/US/2009/051531
WO/2010/036447
28/08/2009
211439
OPTIMIZED FLAVORED POLYMERIC
COMPOSITIONS
A. SCHULMAN, INC.
US
61/190511
29/08/2008
08253299.5
09/10/2008
EP
22
A44B )2010.01(
A44B )2010.01(
‫הרכב אבזם תואם עם עמדות שחרור‬
‫דואליות‬
G02B )2010.01(
‫כן מראה כדורי‬
A61K )2010.01(
‫תכשירים פולימריים מיועלים בעלי טעם‬
May 31, 2011-‫כ"ז באייר התשע"א‬
PCT/US/2009/004927
WO/2010/024941
11/09/2009
211440
SPIRO-TETRACYCLIC RING
COMPOUNDS AS BETASECRETASE
MODULATORS AND METHODS OF
USE
AMGEN INC.
US
61/096082
11/09/2008
PCT/US/2009/056748
WO/2010/030954
25/08/2009
211441
ENDOLYSIN VARIANTS,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
KATHOLIEKE UNIVERSITEIT
LEUVEN K.U. LEUVEN R&D
GB
0815484.1
26/08/2008
PCT/EP/2009/060947
WO/2010/023207
29/08/2008
211442
FIBRE MONITORING IN OPTICAL
NETWORKS
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL)
C07D )2010.01(
‫תרכובות טבעת ספירו–טטראציקלית‬
‫כמאפנני בטא–סקרטאז ושיטות שימוש‬
C12N )2010.01(
‫ תכשירים המכילים‬,‫וריאנטי אנדוליזין‬
‫אותם ושימושים בהם‬
H04B )2010.01(
‫ניטור סיבים במערכות אופטיות‬
PCT/EP/2008/061399
WO/2010/022787
04/09/2009
23
211445
A61K )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
‫טיפול בסקלרודרמה‬
TREATMENT OF SCLERODERMA
UNIVERSITAT ZURICH
PROREKTORAT MNW
EP
08015597.1 04/09/2008
PCT/EP/2009/061454
WO/2010/026213
28/08/2009
211446
A61F )2010.01(
‫מחבר מכני ביומימטי‬
A BIOMIMETIC MECHANICAL JOINT
RAYTHEON SARCOS LLC
US
61/092699
28/08/2008
PCT/US/2009/055429
WO/2010/025409
05/08/2009
211447
FUSED PYRROLIDINOCYCLOPROPANE DERIVATIVES AS
SELECTIVE 11-BETAHYDROXYSTEROID
DEHYDROGENASE TYPE 1
INHIBITORS
MERCK PATENT GMBH
EP
08290822.9 01/09/2008
PCT/EP/2009/005654
WO/2010/022850
27/08/2009
‫נגזרות מאוחות של פירולידינו–ציקלופרופן‬
–‫–בטא‬11 ‫כמעכבים סלקטיביים של‬
1 ‫הידרוקסיסטרואיד–דיהידרוגנאז סוג‬
211448
USE OF ENHANCERS, POSSIBLY
ASSOCIATED TO RIBOFLAVIN, AS WELL
AS CORRESPONDING OPHTHLMIC
COMPOSITIONS FOR CORNEAL CROSSLINKING IN THE TREATMENT OF THE
KERATOCONUS OR OF OTHER
CORNEAL ECTASIC DISORDERS
SOOFT ITALIA SPA
IT
RM2008A000472 28/08/2008
24
C07D )2010.01(
A61K )2010.01(
‫שימוש במגבירים שיכולים להיות‬
‫קשורים לריבופלבין ותכשירים לעיניים‬
‫הכוללים אותם להצלבה בקרנית‬
‫לטיפול בקראטוקונוס או בהפרעות‬
‫קרניות אקטאסיות אחרות‬
May 31, 2011-‫כ"ז באייר התשע"א‬
PCT/IT/2009/000392
WO/2010/023705
28/02/2011
211449
‫מתקן אסלה רב מושבי‬
‫ענת מזרחי‬
MULTIPLE TOILET SEAT FIXTURE
ANAT MIZRACHI
06/09/2009
211450
IN-BAND OPTICAL SIGNAL TO
NOISE RATIO MONITORING
TECHNIQUE
ECI TELECOM LTD.
28/02/2011
EXTRA-THIN, SINGLE-USE SINK
STRAINER THAT SELF - ADHERES
UPON CONTACT WITH WATER
25
A61L )2010.01(
‫הרכבים דביקים חדשים הניתנים לפירוק‬
‫ביולוגי‬
NOVEL BIODEGRADABLE
ADHESIVE COMPOSITIONS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD
US
61/094329
04/09/2008
PCT/IL/2009/000865
WO/2010/026590
28/02/2011
A47K )2010.01(
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ‬
211451
G02B )2010.01(
‫ לפיקוח על היחס בין‬BAND–IN ‫טכנולוגית‬
‫אות אופטי לרעש‬
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
211452
B08B )2010.01(
‫ דק במיוחד ובעל‬,‫מסנן חד–פעמי לכיור‬
‫תכונת היצמדות עצמית הנגרמת במגע‬
‫עם מים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
‫שרון יחיה‬
SHARON YCHIE
28/02/2011
211453
A TILE ATTACHING DEVICE AND
METHOD THEREFOR
MOSHE SHAUL
28/02/2011
‫מתקן להצמדת אריחים ושיטה עבורו‬
‫משה שאול‬
211454
211455
RECORDING MATERIAL SUPPLY
SYSTEM, CIRCUIT BOARD,
STRUCTURE, AND INK CARTRIDGE
FOR RECORDING MATERIAL
CONSUMPTION DEVICE
SEIKO EPSON CORPORATION
2009JP
15/05/2009
118175
PCT/JP/2010/003271
WO/2010/131480
02/09/2008
26
B65D )2010.01(
‫מזוודה מתרחבת‬
‫שרגא יעקובוביץ‬
AN EXTENDABLE SUITCASE
SHRAGA JAKOBOVITS
14/05/2010
E04B )2010.01(
B41J )2010.01(
,‫ לוח מעגל‬,‫מערכת המספקת רישום חומר‬
‫מבנה ומחסנית דיו עבור התקן צורך‬
‫לרישום חומר‬
211456
C12N )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
INSECT-DERIVED PROMOTERS FOR
FOREIGN PROTEINS EXPRESSION IN
INSECT CELLS
ALTERNATIVE GENE EXPRESSION,
S.L. (ALGENEX)
‫מקדמים הנגזרים מחרקים עבור ביטוי‬
‫חלבונים זרים בתאי חרקים‬
PCT/EP/2008/061580
WO/2010/025764
01/09/2009
211457
OVERPRESSURE AND HEELING
DETECTOR FOR A SHOCK
ABSORBER OR THE LIKE
MESSIER-DOWTY SA
FR
08/05010
12/09/2008
PCT/FR/2009/001049
WO/2010/029224
11/09/2009
20/08/2009
A61K )2010.01(
‫פוליפפטידים של הלבלב וצורות הקשורות‬
‫להן לשימוש בטיפול באי–סדרים של המעי‬
211460
MULTI-ROLLER REGISTERED
REPEAT DEFECT DETECTION OF A
WEB PROCESS LINE
3M INNOVATIVE PROPERTIES
COMPANY
US
12/207582
10/09/2008
PCT/US/2009/054463
WO/2010/030483
27
‫גלאי לחץ יתר ונטייה עבור בולם זעזועים‬
‫או משהו דומה‬
211459
PANCREATIC POLYPEPTIDE AND
VARIANTS THEREOF FOR USE IN
THE TREATMENT OF INTESTINAL
DISORDERS
7TM PHARMA A/S
US
0817067.2
18/09/2008
PCT/EP/2009/006604
WO/2010/031521
F16F )2010.01(
B65H )2010.01(
‫זיהוי פגם חוזר בקו יצור רשום מרובה‬
‫גלילים ברשת‬
May 31, 2011-‫כ"ז באייר התשע"א‬
211461
25/08/2009
VALVE METAL AND VALVE METAL
OXIDE AGGLOMERATE POWDERS AND
METHOD FOR THE PRODUCTION
THEREOF
H.C. STARCK GMBH
DE
102008048614.0 23/09/2008
PCT/EP/2009/060912
WO/2010/034577
25/09/2009
28/02/2011
‫ אבחון ומעקב של זאבת‬,‫שיטות לטיפול‬
B23C )2010.01(
‫כלי בעל ציר מסתובב‬
04/09/2008
211464
SUSTAINED-RELEASE DONEPEZIL
FORMULATION
DEXCEL PHARMA TECHNOLOGIES
LTD.
US
61309013
01/03/2010
28
C12Q )2010.01(
211463
20/08/2009
ROTATING SHAFT TOOL
KOMET GROUP GMBH
DE
102008045675.6
PCT/EP/2009/060782
WO/2010/026055
METAL ‫אבקות של צברים של‬
‫ ותחמוצותיהן ושיטה לייצורן‬VALVE
211462
METHODS FOR TREATING,
DIAGNOSING, AND MONITORING
LUPUS
GENENTECH, INC.
US
61/100659
26/09/2008
PCT/US/2009/058478
WO/2010/036960
H01G )2010.01(
A61K )2010.01(
‫פורמולציה לשחרור מושהה של דונפזיל‬
‫דקסל פארמה טכנולוגיות בע"מ‬
May 31, 2011-‫כ"ז באייר התשע"א‬
28/08/2009
211469
VTOL VEHICLE WITH COAXIALLY
TILTED OR TILTABLE ROTORS
URBAN AERONAUTICS LTD.
US
61/136381
02/09/2008
PCT/IB/2009/053768
WO/2010/026517
29/06/2010
211470
COLOR POWDER FOR COATING
TECOLOR LTD
US
12/512578
30/07/2009
PCT/IL/2010/000520
WO/2011/013114
16/09/2008
211471
B64C )2010.01(
‫כלי טיסה להמראה ונחיתה אנכית עם‬
‫רוטורים מוטים בצורה חד צירית או‬
‫רוטורים שניתן להטות‬
‫אורבן איירונוטיקס בע"מ‬
C09D )2010.01(
‫אבקת צבע לציפוי‬
‫טאוקולור בע"מ‬
G01N )2010.01(
‫פס בדיקה קומבינטורי‬
COMBINATORY TESTING STRIP
ACTHERM INC
PCT/CN/2008/001613
WO/2010/031201
09/08/2005
211473
PERMUTATION DATA TRANSFORM
TO ENHANCE SECURITY
CMLA, LLC
US
10/918717
12/08/2004
10/918103
12/08/2004
US
29
H04K )2010.01(
‫פרמוטציות של העברת מידע להגברת‬
‫בטיחות‬
May 31, 2011-‫כ"ז באייר התשע"א‬
10/918718
US
PCT/US/2005/028316
WO/2006/023334
09/08/2005
12/08/2004
211474
PERMUTATION DATA TRANSFORM
TO ENHANCE SECURITY
CMLA, LLC
US
10/918717
12/08/2004
10/918103
12/08/2004
US
10/918718
12/08/2004
US
PCT/US/2005/028316
WO/2006/023334
09/08/2005
211475
PERMUTATION DATA TRANSFORM
TO ENHANCE SECURITY
CMLA, LLC
US
10/918717
12/08/2004
10/918103
12/08/2004
US
10/918718
12/08/2004
US
PCT/US/2005/028316
WO/2006/023334
09/08/2005
211476
PERMUTATION DATA TRANSFORM
TO ENHANCE SECURITY
CMLA, LLC
US
10/918717
12/08/2004
10/918103
12/08/2004
US
10/918718
12/08/2004
US
PCT/US/2005/028316
WO/2006/023334
30
H04K )2010.01(
‫פרמוטציות של העברת מידע להגברת‬
‫בטיחות‬
H04K )2010.01(
‫פרמוציות של העברת מידע להגברת‬
‫בטיחות‬
H04K )2010.01(
‫פרמוטציות של העברת מידע להגברת‬
‫בטיחות‬
May 31, 2011-‫כ"ז באייר התשע"א‬
05/02/2010
211477
RESOLUTION ON DEMAND
RAYTHEON COMPANY
US
12/536434
05/08/2009
PCT/US/2010/023403
WO/2011/016874
26/08/2009
211478
INTEGRATED BIOLOGICAL
WASTEWATER TREATMENT AND
CLARIFICATION
AQWISE-WISE WATER
TECHNOLOGIES LTD.
US
61/191023
03/09/2008
PCT/IL/2009/000825
WO/2010/026564
16/09/2009
211479
AMIDE COMPOUNDS USEFUL IN
THERAPY
PFIZER LIMITED
US
61/097902
18/09/2008
PCT/IB/2009/054038
WO/2010/032200
02/09/2009
211480
ENZYMES AND METHODS FOR
DEGRADING S-TRIAZINES AND
DIAZINES
COMMONWEALTH SCIENTIFIC AND
INDUSTRIAL RESEARCH
ORGANISATION
US
61/094044
03/09/2008
31
G01J )2010.01(
‫רזולוציה לפי דרישה‬
C02F )2010.01(
‫טיפול והבהרה של שפכים ביולוגיים‬
‫אקוויז טכנולוגיות מים חכמות בע"מ‬
C07D )2010.01(
‫תרכובות אמיד היעילות בתרפיה‬
C12N )2010.01(
‫–טריאזינים‬S ‫אנזימים ושיטות לפירוק‬
‫ודיאזינים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
PCT/AU/2009/001136
WO/2010/025499
23/01/2001
211482
ORALLY CONSUMABLE SOLID
FILMS ADAPTED TO DISSOLVE IN
THE MOUTH, COMPRISING AT
LEAST ONE WATER SOLUBLE
POLYMER, AND AN ADSORPTION
COMPLEX, AND METHODS FOR
THEIR PREPARATION
WARNER-LAMBERT COMPANY LLC
US
09/535005
23/03/2000
PCT/US/2001/002192
WO/2001/070194
07/07/2010
‫פילמים מוצקים אכילים המותאמים‬
‫ המכילים לפחות פולימר‬,‫להתמוסס בפה‬
‫ ושיטות‬,‫מסיס במים וקומפלקס ספיחה‬
‫להכנתם‬
211483
IMAGE PROCESSING DEVICE, IMAGE
PROCESSING METHOD, AND
PROGRAM
SONY CORPORATION
P2009JP
07/07/2009
160954
PCT/JP/2010/061513
WO/2011/004832
17/09/2009
32
H04N )2010.01(
‫ שיטה לעיבוד‬,‫מכשיר לעיבוד תמונה‬
‫ ותוכנה‬,‫תמונה‬
211484
INDUCTIVELY RECEIVING
ELECTRIC ENERGY FOR A VEHICLE
BOMBARDIER TRANSPORTATION
GMBH
GB
0817310.6
19/09/2008
PCT/EP/2009/006930
WO/2010/031595
A61K )2010.01(
B60L )2010.01(
‫קבלת אנרגיה חשמלית אינדוקטיבית לכלי‬
‫רכב‬
May 31, 2011-‫כ"ז באייר התשע"א‬
27/08/2009
211485
DEVICE AND METHOD FOR
GENERATING ELECTRICITY
LANDA LABORATORIES LTD
US
61/136317
28/08/2008
0816418.8
08/09/2008
GB
PCT/IL/2009/000831
WO/2010/023669
06/08/2009
28/08/2009
‫התקן ושיטה לייצור חשמל‬
‫לנדא לבורטוריס בע"מ‬
211486
METHOD FOR DETECTING CHANGES
IN A VACUUM STATE IN A
DETECTOR OF A THERMAL CAMERA
OPGAL OPTRONIC INDUSTRIES LTD.
US
61/092440
28/08/2008
PCT/IL/2009/000768
WO/2010/023654
211487
211489
PROMOTERS EXHIBITING
ENDOTHELIAL CELL SPECIFICITY
AND METHODS OF USING SAME FOR
REGULATION OF ANGIOGENESIS
VASCULAR BIOGENICS LTD.
US
10/988487
14/11/2004
PCT/US/2005/001195
33
G01L )2010.01(
‫שיטה לגילוי שינויים במצב הוואקום בגלאי‬
‫של מצלמה תרמית‬
IMMUNOMODULATING ACTIVITIES
NOVOGEN RESEARCH PTY LTD.
AU
2008904483 29/08/2008
PCT/AU/2009/001117
WO/2010/022467
14/11/2005
H02N )2010.01(
‫אופגל תעשיות אופטרוניות בע"מ‬
A61K )2010.01(
‫תכשירים אימונומודולטוריים‬
A61K )2010.01(
‫פרומוטרים עם ספציפיות לתאי אנדותל‬
‫ושיטות לשימוש בהם לבקרת אנגיוגנזה‬
‫וסקולר ביוג'ניק בע"מ‬
May 31, 2011-‫כ"ז באייר התשע"א‬
WO/2006/051545
01/03/2011
211490
‫הבאה מוקדמת של חבילות מידע‬
‫ אל) בע"מ‬.‫ אס‬.‫ איי‬. ‫מרבל ישראל ( אמ‬
PRE-FETCHING OF DATA PACKETS
MARVELL ISRAEL(M.I.S.L.) LTD.
US
61/309804
02/03/2010
211491
18/06/2005
4-(BENZIMIDAZOLYLMETHYLAMINO)BENZAMIDINES
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
04014917.1
25/06/2004
PCT/EP/2005/006586
WO/2006/000353
04/09/2009
211492
STABLE CELL CLONE EXPRESSING
A PRION
LFB-BIOTECHNOLOGIES
FR
0855985
05/09/2008
PCT/FR/2009/051673
WO/2010/026346
11/08/2009
211494
ASSESSING EXPRESSION OF
ENDOGENOUS AND EXOGENOUS
GENES
PROMEGA CORPORATION
US
61/096536
12/09/2008
PCT/US/2009/053436
34
G06F )2010.01(
C07D )2010.01(
–)‫ –(בנזאימידאזולילמתילאמינו‬4
‫בנזאמידינים‬
G01N )2010.01(
‫שיבוט תא יציב המבטא פריון‬
C12Q )2010.01(
‫ביטוי האומד גנים אנדוגנים ואקסוגנים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
WO/2010/030461
10/09/2009
211495
A61K )2010.01(
‫תכשיר רוקחות חדש לטיפול בכאב שנגרם‬
‫ע"י גירוי של קולטנים תחושתיים במערכת‬
‫העצבים‬
NOVEL PHARMACEUTICAL
COMPOSITION FOR TREATING
NOCICEPTIVE PAIN
ASTELLAS PHARMA INC.
2008JP
11/09/2008
234069
PCT/JP/2009/065791
WO/2010/029958
10/09/2009
211496
NOVEL SALT OF MORPHOLINE
DERIVATIVE
ASTELLAS PHARMA INC.
2008JP
11/09/2008
234066
PCT/JP/2009/065792
WO/2010/029959
28/10/2009
‫מלח חדש של נגזרת מורפולין‬
211497
PROCESS FOR PREPARING NEBIVOLOL
ZACH SYSTEM S.P.A.
IT
MI2008A001924 31/10/2008
PCT/EP/2009/064230
WO/2010/049455
20/11/2009
VECTOR COMPRISING MULTIPLE
HOMOLOGOUS NUCLEOTIDE
SEQUENCES
BAVARIAN NORDIC A/S
35
C07D )2010.01(
211498
C07D )2010.01(
‫תהליך להכנת נביוולול‬
C12N )2010.01(
‫וקטור המכיל מספר רב של רצפי‬
‫נוקליאוטיד הומולוגים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
US
61/116672
PCT/EP/2009/008275
WO/2010/057650
21/11/2008
211499
07/10/2009
METHOD FOR REDUCING THE PULP
CONTENT OF FRUIT JUICES
CONTAINING PULP
GEA MECHANICAL EQUIPMENT GMBH
DE
102008051499.3 13/10/2008
PCT/EP/2009/063028
WO/2010/043524
01/09/2009
211500
ADHERENT CELLS FROM PLACENTA
TISSUE AND USE THEREOF IN
THERAPY
PLURISTEM LTD
US
61/136377
02/09/2008
61/202049
23/01/2009
US
PCT/IL/2009/000845
WO/2010/026574
01/09/2009
211501
METHODS OF SELECTION OF CELLS
FOR TRANSPLANTATION
PLURISTEM LTD
US
61/136374
02/09/2008
PCT/IL/2009/000844
WO/2010/026573
09/09/2004
36
211502
A23L )2010.01(
‫שיטה להפחתת תוכן בשרי של פרי‬
‫במיצי פירות בשריים‬
A61K )2010.01(
‫תאים נצמדים מרקמת שליה ושימושם‬
‫בטיפול‬
‫פלוריסטם בע"מ‬
G01N )2010.01(
‫שיטות לבחירת תאים להשתלה‬
‫פלוריסטם בע"מ‬
A43B )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
ORTHOPEDIC INSOLES FOR
PROTECTING SKIN FROM
STRETCHING AND CRACKING IN
THE AREA OF THE FIVE
METATARSAL HEADS OF THE
FOREFOOT
BARAK YEHOSHUA
US
60/502943
16/09/2003
PCT/IL/2004/000822
WO/2005/025356
31/08/2009
211504
SACRIFICIAL ELECTRODE DESIGN
AND DELIVERY SPECIES SUITABLE
FOR PROLONGED IONTOPHORESIS
APPLICATION PERIODS
TRAVANTI PHARMA INC.
US
61/093464
02/09/2008
PCT/US/2009/004928
WO/2010/027444
03/09/2009
211505
IONTOPHORETIC DRUG DELIVERY
PACKAGING
TRAVANTI PHARMA INC.
US
61/094442
05/09/2008
PCT/US/2009/004969
WO/2010/027468
08/03/2007
211506
METHOD FOR UNIVERSAL
IMPROVEMENT OF VISION
SCIENTIFIC OPTICS, INC.
US
60/780153
08/03/2006
PCT/US/2007/063572
WO/2007/104013
37
‫מדרסים אורטופדים להגנה על העור‬
‫ עצמות‬5 ‫ממתיחה וסדקים באזור‬
‫המטטרסל של כף הרגל‬
‫יהושוע ברק‬
A61N )2010.01(
‫עיצוב ומיני מסירה של אלקטרודה‬
‫מוקרבת המתאימה לתקופות יישום‬
‫יונטופורסיס ממושכות‬
A61N )2010.01(
‫אריזה להעברת תרופה ינוטופורטית‬
A61F )2010.01(
‫שיטה לשיפור כללי בראייה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
03/09/2009
211507
A CHARGE TRANSFER ZERO LOSS
POWER AND SIGNAL
TRANSMISSION CABLE
PAUL LENWORTH MANTOCK
GB
0816106.9
04/09/2008
PCT/GB/2009/002122
WO/2010/026380
13/04/2003
02/03/2011
‫כבל להעברת מטען ואות עם אובדן כוח‬
‫אפס‬
211508
MODULATION OF STEM AND
PROGENITOR CELL
DIFFERENTIATION, ASSAYS, AND
USES THEREOF
CELGENE CORPORATION
US
60/372,348
12/04/2002
60/437,348
31/12/2002
US
60/437,350
31/12/2002
US
PCT/US/2003/011327
WO/2003/087392
211511
B63C )2010.01(
‫מחבר לנרגילה‬
‫עומר רעני‬
211517
FLUID TURBINE SYSTEMS
CALIFORNIA ENERGY & POWER
US
61/094386
04/09/2008
38
C12N )2009.01(
,‫מודולציה של התמיינות תאי גזע ותאי אב‬
‫בדיקות הרכב ושימושים שלהן‬
HOOKAH CONNECTOR
OMER RAANY
14/08/2009
H01B )2010.01(
F03D )2010.01(
‫מערכות טורבינת נוזל‬
May 31, 2011-‫כ"ז באייר התשע"א‬
12/268274
US
PCT/US/2009/053934
WO/2010/027635
10/11/2008
02/09/2009
211518
METHOD AND APPARATUS FOR
DEFECT DETECTION
TGT ENTERPRISES LTD
200806868SG
02/09/2008
6
PCT/CN/2009/073687
WO/2010/025667
11/09/2009
211519
PCSK9 ANTAGONISTS
RINAT NEUROSCIENCE CORP.
US
61/096716
12/09/2008
61/232161
07/08/2009
US
61/235643
20/08/2009
US
PCT/IB/2009/053990
WO/2010/029513
02/09/2009
211520
ESTIMATING A STATE OF AT LEAST
ONE TARGET
BAE SYSTEMS PLC
GB
0816040.0
03/09/2008
08275048.0
03/09/2008
EP
PCT/GB/2009/051103
WO/2010/026417
02/03/2011
POWERED SAFETY RAZOR
39
211521
G01N )2010.01(
‫שיטה ומערכת לגילוי פגמים‬
A61K )2010.01(
PCSK 9 ‫אנטגוניסטים‬
G05B )2010.01(
‫הערכת מצב של לפחות מטרה אחת‬
A46B )2010.01(
‫מכשיר גילוח עם מנוע חשמלי‬
May 31, 2011-‫כ"ז באייר התשע"א‬
‫גולדיאל בע"מ‬
GOLDYEL LTD
02/03/2011
211522
METHOD FOR PREVENTING
CREATION OF PUCKERING ALONG
STITCHES OF A GARMENT
BAGIR CO. (1961) LTD
09/09/2009
‫שיטה למניעת היווצרות של קמטים לאורך‬
‫תפרים של פריט לבוש‬
‫) בע"מ‬1961( ‫ בגיר‬.‫חב‬
211523
METHOD AND DEVICES TO
INCREASE CRANIOFACIAL BONE
DENSITY
NEW YORK UNIVERSITY
US
61/095434
09/09/2008
PCT/US/2009/056313
WO/2010/030630
16/07/2009
A61C )2010.01(
‫שיטה והתקנים להגברת צפיפות עצמות‬
‫הלסת–גולגולת‬
211524
SYSTEM AND METHOD FOR
DESPECKLING AN IMAGE
ILLUMINATED BY A COHERENT
LIGHT SOURCE
ELBIT SYSTEMS OF AMERICA, LLC
US
61/093626
02/09/2008
12/337111
17/12/2008
US
PCT/US/2009/050786
WO/2010/027563
40
D05B )2010.01(
G02B )2010.01(
‫מערכת ושיטה להצגה בחלקיקים של‬
‫דמות המוארת על–ידי מקור אור קוהרנטי‬
May 31, 2011-‫כ"ז באייר התשע"א‬
01/09/2009
211525
ADHERENT CELLS FROM PLACENTA
TISSUE AND USE THEREOF IN
THERAPY
PLURISTEM LTD
US
61/136375
02/09/2008
61/202050
23/01/2009
US
PCT/IL/2009/000846
WO/2010/026575
07/09/2007
07/09/2007
‫פלוריסטם בע"מ‬
A61K )2010.01(
‫תרכובות ושיטות עבור גורמים המסומנים‬
‫ תכשירים המכילים תרכובות אלו‬,F18 ‫עם‬
‫והשימוש בהם להדמיה מאובחנת‬
211527
COMPOUNDS AND METHODS FOR
18F LABELED AGENTS,
COMPOSITIONS COMPRISING SUCH
COMPOUNDS AND THEIR USE FOR
DIAGNOSTIC IMAGING
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
EP
06090166.7 08/09/2006
07090079.0
23/04/2007
EP
PCT/EP/2007/008042
WO/2008/028688
41
‫תאים נדבקים משילייה ושימושיהם‬
‫בטיפול קליני‬
211526
COMPOUNDS AND METHODS FOR
18F LABELED AGENTS,
COMPOSITIONS COMPRISING SUCH
COMPOUNDS AND THEIR USE FOR
DIAGNOSTIC IMAGING
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
EP
06090166.7 08/09/2006
07090079.0
23/04/2007
EP
PCT/EP/2007/008042
WO/2008/028688
C12N )2010.01(
A61K )2010.01(
‫תרכובות ושיטות עבור גורמים המסומנים‬
‫ תכשירים המכילים תרכובות אלו‬,F18 ‫עם‬
‫והשימוש בהם להדמיה מאובחנת‬
May 31, 2011-‫כ"ז באייר התשע"א‬
03/09/2009
211528
PACKET WITH A CLOSURE FOR ITS
OUTLET, E.G. FOR ARTICLES
STORAGE AND DISPENSING
TADBIK LTD
US
61/136426
04/09/2008
PCT/IL/2009/000858
WO/2010/026584
19/05/2004
‫ למשל עבור‬,‫חבילה עם סוגר ליציאה שלה‬
‫אחסון וחלוקת פריטים‬
‫תדביק בע"מ‬
211529
CARBOSTYRIL DERIVATIVES AND
MOOD STABILIZERS FOR TREATING
MOOD DISORDERS
OTSUKA PHARMACEUTICAL CO.,
LTD.
US
60/473378
23/05/2003
PCT/US/2004/013308
WO/2004/105682
26/04/2002
26/04/2002
211530
A61K )2010.01(
‫מערכת לשחרור מושהה של תרופה‬
‫מבוססת פולימר המכילה תוספים‬
‫משולבים‬
26/04/2001
17/09/2001
15/04/2002
211531
INJECTABLE POLYMER-BASED
SUSTAINED RELEASE COMPOSITION
PSIVIDA US, INC.
US
60/286343
26/04/2001
42
A61K )2010.01(
‫תולדות קרבוסטריליות ומייצבי מצב רוח‬
‫לטיפול בהפרעה במצב הרוח‬
POLYMER BASED SUSTAINED
RELEASE DRUG DELIVERY SYSTEM
CONTAINING CODRUGS
PSIVIDA US, INC.
US
60/286343
60/322428
US
60/372761
US
PCT/US/2002/013385
WO/2002/087586
B65D )2010.01(
A61K )2010.01(
‫מערכת לשחרור מושהה מבוססת פולימר‬
‫להזרקה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
60/322428
US
60/372761
US
PCT/US/2002/013385
WO/2002/087586
07/09/2009
17/09/2001
15/04/2002
211533
HEATING SYSTEM WITH OPTIMIZED
RECOVERY OF WASTE WATER HEAT
ALAIN MOURE
FR
0855980
05/09/2008
PCT/FR/2009/051679
WO/2010/026352
02/09/2009
‫מערכת הסקה עם השבה אופטימלית של‬
‫חום של מי שפכים‬
211534
SULFUR-LINKED COMPOUNDS FOR
TREATING OPHTHALMIC DISEASES
AND DISORDERS
ACUCELA INC
US
61/094841
05/09/2008
61/197065
22/10/2008
US
PCT/US/2009/055785
WO/2010/028088
03/03/2011
211535
A MODULAR REMOVABLE
EQUIPMENT FOR PLANT MULCHING
HOCHBERG MORDEHAI
04/09/2009
43
F24D )2010.01(
211536
C07C )2010.01(
‫תרכובות הקשורות לגופרית לטיפול‬
‫במחלות ואי–סדרים עיניים‬
C09K )2010.01(
‫מתקן מודולארי נייד לחיפוי צמחים‬
‫הוכברג מרדכי‬
H02H )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
METHOD AND APPARATUS FOR
PROTECTING POWER SYSTEMS
FROM EXTRAORDINARY
ELECTROMAGNETIC PULSES
ADVANCED FUSION SYSTEMS LLC
US
61/192591
19/09/2008
PCT/US/2009/056124
WO/2010/047890
211537
03/03/2011
SYSTEM AND METHOD FOR
PARTITIONING COOLED CARGO
AREAS IN A TRUCK
AVI SALOMON
16/11/2009
SOLID OIL POWDERS
NESTEC S.A.
EP
08169434.1
PCT/EP/2009/065229
WO/2010/057852
09/09/2009
F25B )2010.01(
‫מערכת ושיטה להפרדת אזורי קרור מטען‬
‫במשאית‬
‫אבי סלומון‬
211538
A23D )2010.01(
‫אבקות שמן מוצקות‬
19/11/2008
211539
SYSTEMS, DEVICES AND METHODS
FOR POWERING AND/OR
CONTROLLING DEVICES, FOR
INSTANCE TRANSDERMAL
DELIVERY DEVICES
TRANSCU LTD
US
61/095526
09/09/2008
PCT/US/2009/056353
WO/2010/030659
44
‫שיטה והתקן להגנת מערכות כוח‬
‫מפולסים אלקטרומגנטיים גבוהים מהרגיל‬
A61N )2010.01(
‫ התקנים ושיטות להפעלה או‬,‫מערכות‬
‫בקרה של מתקנים כמו מתקני העברה‬
‫דרך העור‬
May 31, 2011-‫כ"ז באייר התשע"א‬
18/09/2009
211540
OPTICAL METHOD FOR THE
DETECTION OF ALZHEIMER'S
DISEASE
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
61/098206
18/09/2008
PCT/US/2009/057569
WO/2010/033861
28/08/2009
211541
CO-CRYSTAL COMPOSITIONS,
METHODS OF PRODUCING THE
SAME AND USES THEREOF
VERTEX PHARMACEUTICALS
INCORPORATED
US
61/093942
03/09/2008
61/093972
03/09/2008
US
PCT/US/2009/055384
WO/2010/027921
22/09/2009
211543
CONFECTIONERY AND METHODS OF
PRODUCTION THEREOF
CAROLE JEAN ELLEMAN
GB
0817365.0
23/09/2008
PCT/GB/2009/002243
WO/2010/034975
01/09/2009
211544
DOG'S WASTE CATCHER
MOSHE HAZAN
US
61/093731
03/09/2008
45
A61K )2010.01(
‫שיטה אופטית לגילוי מחלת האלצהיימר‬
‫ידע חברה למחקר ופיתוח בע"מ‬
A61K )2010.01(
‫ שיטות להכנתם‬,‫תכשירים קו–גבישיים‬
‫ושימושים בהם‬
A23G )2010.01(
‫קונדטוריה ושיטות להכנתה‬
A01K )2010.01(
‫מכשיר ושיטה לאיסוף צואת כלבים‬
‫משה חזן‬
May 31, 2011-‫כ"ז באייר התשע"א‬
PCT/IL/2009/000837
WO/2010/026567
13/09/2009
211545
LEUCOJUM BULB EXTRACTS AND
USE THEREOF
I.B.R ISRAELI BIOTECHNOLOGY
RESEARCH LTD
US
61/095954
11/09/2008
PCT/IL/2009/000891
WO/2010/029554
06/09/2009
211546
NAPHTHOQUINONE DERIVATIVES
USEFUL FOR PREVENTION OF
AMYLOID DEPOSITS AND
TREATMENT OF DISEASES
INVOLVING AMYLOIDOGENESIS
RAMOT AT TEL-AVIV UNIVERSITY
LTD.
GB
0816269.5
05/09/2008
61/183089
02/06/2009
US
PCT/IL/2009/000867
WO/2010/026592
10/09/2009
211547
TRANSDERMAL DELIVERY OF
OLIGOSACCHARIDES
TRANSPHARMA MEDICAL LTD
US
61/095637
10/09/2008
PCT/IL/2009/000889
WO/2010/029552
46
A01N )2010.01(
‫ והשימוש‬LEUCOJUM ‫מיצויים מבדלי‬
‫בהם‬
'‫ ישראלי ביוטכנולוגי ריסרץ‬.‫אר‬.‫בי‬.‫איי‬
‫בע"מ‬
A61K )2010.01(
‫נגזרות נפתוקינון יעילות למניעה של‬
‫משקעי אמילויד ולטיפול במחלות‬
‫הקשורות באמילוידג'נסיס‬
‫אביב בע"מ‬-‫רמות ליד אוניברסיטת תל‬
A61F )2010.01(
‫הולכה דרך העור של אוליגוסכרידים‬
‫טראנספרמה מדיקל בע"מ‬
May 31, 2011-‫כ"ז באייר התשע"א‬
06/09/2009
211548
METHOD SYSTEM AND SOFTWARE
FOR PROVIDING IMAGE SENSOR
BASED HUMAN MACHINE
INTERFACING
EXTREME REALITY LTD
US
61/094078
04/09/2008
PCT/IL/2009/000862
WO/2010/026587
08/09/2009
‫שיטה מערכת ותוכנה ליצירת ממשק‬
‫אדם–מכונה‬
‫אקסטרים ריאליטי בע"מ‬
211549
211550
A METHOD AND A DEVICE FOR
FLYING SAFELY AT LOW ALTITUDE
IN AN AIRCRAFT
EUROCOPTER FRANCE
FR
FR1001024 15/03/2010
30/09/2009
47
B64C )2010.01(
‫שיטה ומכשיר לטיסה בטוחה בגובה נמוך‬
‫בכלי תעופה‬
211551
IMPROVED METHOD OF RNA
DISPLAY
ABBOTT LABORATORIES
US
61/101471
30/09/2008
PCT/US/2009/059057
WO/2010/039850
C07D )2010.01(
‫אמינוטריאזולופירידינים ושימושיהם‬
‫כמעכבי קינאזה‬
AMINOTRIAZOLOPYRIDINES AND
THEIR USE AS KINASE INHIBITORS
SIGNAL PHARMACEUTICALS, LLC
US
61/095217
08/09/2008
61/230479
31/07/2009
US
PCT/US/2009/005020
WO/2010/027500
03/03/2011
G06F )2010.01(
G01N )2010.01(
RNA ‫שיטה משופרת להצגת‬
May 31, 2011-‫כ"ז באייר התשע"א‬
30/09/2009
211552
IMPROVED ANTIBODY LIBRARIES
ABBOTT LABORATORIES
US
61/101483
30/09/2008
PCT/US/2009/059059
WO/2010/039852
04/09/2009
211553
ALGORITHM FOR DESIGNING
IRREVERSIBLE INHIBITORS
AVILA THERAPEUTICS, INC.
US
61/094782
05/09/2008
PCT/US/2009/056025
WO/2010/028236
28/08/2009
211554
EXTERNALLY ORIENTABLE LED
INGROUND LIGHT
LSI INDUSTRIES, INC.
US
61/095159
08/09/2008
12/245116
03/10/2008
US
PCT/US/2009/055326
WO/2010/027913
03/09/2009
211555
PROCESS FOR MAKING
BIVALIRUDIN
SCINOPHARM TAIWAN, LTD.
US
61/190928
03/09/2008
PCT/US/2009/055853
WO/2010/028122
48
C07H )2010.01(
‫ספריות משופרות של נוגדן‬
C12N )2010.01(
‫אלגוריתם לתכנון מעכבים בלתי הפיכים‬
F21S )2010.01(
‫אור לדי תוך קרקעי הניתן לכיוון חיצוני‬
A61K )2010.01(
‫תהליך לייצור ביולירודין‬
May 31, 2011-‫כ"ז באייר התשע"א‬
03/09/2009
211556
PROCESS FOR THE PREPARATION
OF PRAMLINTIDE
SCINOPHARM TAIWAN, LTD.
US
61/190928
03/09/2008
PCT/US/2009/055867
WO/2010/028131
03/09/2009
211557
METHODS AND SYSTEM FOR
MONITORING HYGIENE HABITS
HYGINEX INC.
US
61/136413
03/09/2008
PCT/IL/2009/000854
WO/2010/026581
04/09/2009
211558
TOUCH-SENSITIVE WIRELESS
DEVICE AND ON SCREEN DISPLAY
FOR REMOTELY CONTROLLING A
SYSTEM
SAVANT SYSTEMS LLC
US
61/094099
04/09/2008
PCT/US/2009/005001
WO/2010/027492
03/09/2009
211559
METHOD FOR TREATMENT OF
NATURAL RUBBER PRODUCTS
BUDEV B.V.
NL
1035901
05/09/2008
PCT/NL/2009/050528
WO/2010/027261
49
A61K )2010.01(
‫תהליך להכנת פרמלינטיד‬
G08B )2010.01(
‫שיטות ומערכות לבקרה הרגלי גהות‬
H04L )2010.01(
‫מתקן אלחוטי הרגיש למגע ותצוגה על‬
‫מסך לשליטה מרחוק במערכת‬
C08C )2010.01(
‫שיטות לטיפול במוצרים מגומי טבעי‬
May 31, 2011-‫כ"ז באייר התשע"א‬
03/03/2011
211560
KIT AND METHOD FOR COLLECTING
FLUID SAMPLES IN ORDER TO
PERFORM DRIED FLUID SPOT (DFS)
TESTS THEREON
ILEX MEDICAL LTD
ZA
2011/01080 10/02/2011
07/09/2008
211561
ANTI-EXTENDED TYPE I
GLYCOSPHINGOLIPID ANTIBODY
DERIVATIVES THEREOF AND USE
GLYCONEX INC.
G01N )2010.01(
‫ערכה ושיטה לאיסוף דגימות נוזל בצורך‬
‫) על‬DFS( ‫ביצוע מבחן אתר נוזל מיובש‬
‫הדגימות‬
‫אילקס מדיקל בע"מ‬
C08C )2010.01(
GLYCOSPHINGOLIPID I TYPE ‫אנטי‬
‫ ותוצריו ושימושיו‬EXTENDED
PCT/US/2008/075533
WO/2010/027364
04/09/2009
211562
TEMPORARY EMBOLIC
PROTECTION DEVICE AND MEDICAL
PROCEDURE FOR DELIVERY
THEREOF
JONSSON ANDERS
SE
0801901-0
04/09/2008
61/094283
04/09/2008
US
PCT/EP/2009/061509
WO/2010/026240
03/03/2011
50
211563
A61F )2010.01(
‫מכשיר זמני להגנה סחיפית והליך רפואי‬
‫להובלתו‬
B67D )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
‫מכשיר ביתי לטיהור מים ומגש טיפות‬
‫עבורו‬
WATER DISPENSER AND SPILL
COLLECTOR THEREFOR
ELECTRA CONSUMER PRODUCTS
(1951) LTD
20/07/2009
‫) בע"מ‬1951( ‫אלקטרה מוצרי צריכה‬
211564
METHOD FOR PREPARING 1METHYL CYCLOPROPENE AND
ADDING SAME TO PLANTS
ERUM BIOTECHNOLOGIES INC
10-2008KR
25/09/2008
0093959
PCT/KR/2009/004001
WO/2010/035947
15/09/2009
15/09/2009
C07D )2010.01(
‫–יל‬3–‫] פירידינ‬5,4[ ‫תולדות איזוקסאזולו‬
‫פיפראזין היעילות כמאפננים של רצפטורי‬
D3 ‫דופאמין‬
211566
2,3-SUBSTITUTED INDAZOLE OR
4,5,6,7-TETRAHYDRO-INDAZOLES AS
FXR MODULATORS AGAINST
DYSLIPIDEMIA AND RELATED
DISEASES
F. HOFFMANN-LA ROCHE AG
EP
08165145.7 25/09/2008
51
‫–מתיל ציקלופרופן‬1 ‫שיטה להכנת‬
‫והוספתו לצמחים‬
211565
ISOXAZOLO[4,5]PYRIDIN-3-YLPIPERAZIN DERIVATIVES USEFUL
AS MODULATORSOF DOPAMINE D3
RECEPTORS
F. HOFFMANN-LA ROCHE AG
EP
08164904.8 23/09/2008
PCT/EP/2009/061965
WO/2010/034656
C07F )2010.01(
C07D )2010.01(
–7,6,5,4 ‫ –מותמר או‬3,2 ‫אינדאזול‬
‫טטראהידרו–אינדאזולים כמאפננים של‬
‫ כנגד דיסליפידמיה ומחלות קשורות‬FXR
May 31, 2011-‫כ"ז באייר התשע"א‬
PCT/EP/2009/061912
WO/2010/034649
04/09/2009
211567
USE OF STEM CELLS TO PREVENT
NEURONAL DIEBACK
CASE WESTERN RESERVE
UNIVERSITY
US
61/094210
04/09/2008
PCT/US/2009/056046
WO/2010/028249
01/09/2009
211568
PHOTOVOLTAIC CELL APPARATUS
CLIVE, BARRY
GB
0816113.5
04/09/2008
PCT/GB/2009/051099
WO/2010/026415
13/10/2009
211569
NICOTINIC ACETYLCHOLINE
RECEPTOR LIGANDS AND THE USES
THEREOF
THE BOARD OF TRUSTEES OF THE
UNIVERSITY OF ILLINOIS
US
61/105167
14/10/2008
PCT/US/2009/060473
WO/2010/045212
02/09/2009
52
211570
A01N )2010.01(
‫שימוש בתאי מח למניעת מוות–חוזר של‬
‫תא עצב‬
H01L )2010.01(
‫מכשיר תא פוטו–וולטאי‬
C07D )2010.01(
‫ליגנדים לרצפטור לאצטילכולין ניקוטיני‬
‫ושימושם‬
B65D )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
CHILD-RESISTANT UNIT DOSE
PACKAGE FOR TRANSDERMAL
THERAPEUTIC SYSTEMS OR FILMAND SHEET-TYPE DOSAGE FORMS
LTS LOHMANN THERAPIE-SYSTEME
AG
US
61/191362
08/09/2008
PCT/EP/2009/006349
WO/2010/025899
22/09/2009
211571
FIXED DOSE COMBINATION IN
FORM OF A BILAYERED OR
MONOLAYERED TABLET OF
ALISKIREN AND AMLODIPINE
NOVARTIS AG
US
61/098945
22/09/2008
PCT/US/2009/057750
WO/2010/033954
15/09/2009
53
C07D )2010.01(
‫–יל–פיפראזין‬3–‫] איזוקסאזול‬D[‫תולדות בנזו‬
‫היעילות כמאפננים של רצפטורי דופאמין‬
D3
211574
GALENICAL FORMULATION
COMPRISING ALISKIREN AND
PROCESS FOR ITS PREPARATION BY
MELT EXTRUSION GRANULATION
NOVARTIS AG
US
61/099595
24/09/2008
A61K )2010.01(
‫שילוב מנה קבועה של אליסקירן‬
‫ואמלודיפין בצורת טבלייה דו–שכבתית או‬
‫חד–שכבתית‬
211572
BENZO[D] ISOXAZOL-3-YLPIPERAZIN DERIVATIVES USEFUL
AS MODULATORS OF DOPAMINE D3
RECEPTORS
F. HOFFMANN-LA ROCHE AG
EP
08164903.0 23/09/2008
PCT/EP/2009/061906
WO/2010/034646
23/09/2009
‫אריזת יחידת מנה עמידה בפני ילדים‬
‫למערכות רפואיות טרנסדרמאליות או‬
‫לצורות מינון מסוג יריעה ופילם‬
A61K )2010.01(
‫פורמולציה גלניקלית המכילה אליסקירן‬
‫ותהליך להכנתה על ידי המסת סילוק‬
‫גרעון‬
May 31, 2011-‫כ"ז באייר התשע"א‬
61/161799
US
PCT/US/2009/057993
WO/2010/036686
03/03/2011
20/03/2009
211575
A RECEIVER FOR A WIRELESS
TELECOMMUNICATION SYSTEM
WITH A CHANNEL DEINTERLEAVER
DESIGNART NETWORKS LTD
US
12/717153
04/03/2010
03/09/2009
211576
BARRIER SLURRY FOR LOW-K
DIELECTRICS
CABOT MICROELECTRONICS
CORPORATION
US
61/098600
19/09/2008
PCT/US/2009/004973
WO/2010/033156
29/09/2009
211577
SYSTEM FOR GUIDING A
PROJECTILE
MBDA FRANCE
FR
08/05366
30/09/2008
PCT/FR/2009/001160
WO/2010/037929
06/03/2011
A SHAVING GEAR
ELIEZER BABECOF
54
211578
H04L )2010.01(
‫מקלט למערכת תקשורת אלחוטית עם‬
‫דה–אינטרליבר של ערוץ‬
‫דזיינארט נטוורקס בע"מ‬
C09K )2010.01(
K ‫בליל מחסום עבור דיאלקטרים בעלי‬
‫נמוך‬
G05D )2010.01(
‫מערכת להנחיית קליע‬
B24B )2010.01(
‫מכשיר גילוח‬
‫אלי בבקוב‬
May 31, 2011-‫כ"ז באייר התשע"א‬
06/03/2011
211579
B32B )2010.01(
A STICKER AND MACHINE FOR
MANUFACTURING AND ATTACHING
THEREOF
EMMANUEL BASHARY
08/09/2008
‫מדבקה ומכונה ליצורה והדבקתה‬
‫עמנואל בשארי‬
211581
MEGANUCLEASE VARIANTS
CLEAVING A DNA TARGET
SEQUENCE FROM A GLUTAMINE
SYNTHETASE GENE AND USES
THEREOF
CELLECTIS
C12N )2010.01(
‫ואריאנטים של מגה–נוקלאז לביקוע רצף‬
‫מטרה של דנ"א מגן של גלוטמין סינתאז‬
‫ושימושים שלהם‬
PCT/IB/2008/003109
WO/2010/026443
05/09/2008
211582
PROCESS FOR THE PRODUCTION OF
HIGH-PURITY MAGNESIUM
HYDROXIDE
SERVICIOS ADMINISTRATIVOS
PENOLES, S.A. DE C.V
C01F )2010.01(
‫תהליך לייצור של מגנזיום–הידרוקסיד‬
‫בדרגת נקיון גבוהה‬
PCT/MX/2008/000117
WO/2010/027247
55
May 31, 2011-‫כ"ז באייר התשע"א‬
03/09/2009
211584
MACROCYCLIC PYRIMIDINE
COMPOUNDS, THEIR PREPARATION
AND USE
MERCK PATENTS GMBH
US
61/191505
08/09/2008
PCT/US/2009/055841
WO/2010/028116
06/03/2011
211585
COMBINED HARDWARE/SOFTWARE
FORWARDING MECHANISM AND
METHOD
MARVELL ISRAEL (M.I.S.L) LTD
US
61/314328
16/03/2010
13/037459
01/03/2011
US
06/03/2011
211586
MONITORING TISSUE
TEMPERATURE WHILE USING AN
IRRIGATED CATHETER
BIOSENSE WEBSTER (ISRAEL) LTD
US
61/312447
10/03/2010
10/09/2009
211587
TREATING INFLAMMATORY
CONDITIONS
ITH IMMUNE THERAPY HOLDINGS
AB
SE
0801938-2
10/09/2008
PCT/GB/2009/002196
WO/2010/029317
56
A61K )2010.01(
‫ הכנתן‬,‫תרכובות פירימידין מקרוציקליות‬
‫והשימוש בהן‬
G06F )2010.01(
‫מנגנון ושיטה לשליחה ע"י שילוב‬
‫תוכנה‬/‫חומרה‬
‫אל) בע"מ‬.‫אס‬.‫איי‬.‫מארוול ישראל (אמ‬
G06T )2010.01(
‫ניטור טמפרטורת רקמה תוך שימוש‬
‫בצנתר עם זרימת נוזל‬
C07K )2010.01(
‫טיפול במצבי דלקת‬
May 31, 2011-‫כ"ז באייר התשע"א‬
06/03/2011
211588
‫כיורים מתקפלים‬
‫לזנובסקי חיים‬
FOLDING SINKS
LAZANOVSKY HAIM
27/08/2009
211589
ABDOMINAL EXERCISE DEVICE
ROBSON SPLANE
US
12/230898
08/09/2008
12/545627
21/08/2009
US
PCT/US/2009/004867
WO/2010/027436
04/09/2008
E04B )2010.01(
211590
A BUFFER DEVICE FOR
CONVERSING THE ENERGY
PRODUCED ON A ROAD
LEE, CHIH-YANG
A63B )2010.01(
‫מתקן לתרגילי בטן‬
F03G )2010.01(
‫מתקן בולם זעזועים להמרת האנרגיה‬
‫המיוצרת בכביש‬
PCT/CN/2008/072262
WO/2010/025592
10/09/2009
211591
EDGE DETECTION FOR COMPUTED
TOMOGRAPHY PROJECTION DATA
COMPRESSION
SAMPLIFY SYSTEMS, INC.
US
12/208835
11/09/2008
PCT/US/2009/056475
WO/2010/030754
57
A61B )2010.01(
‫גילוי קצוות לדחיסת נתוני הקרנה‬
‫מטומוגרפיה ממוחשבת‬
May 31, 2011-‫כ"ז באייר התשע"א‬
09/09/2009
211592
PLATELET-DERIVED GROWTH
FACTOR COMPOSITIONS AND
METHODS FOR THE TREATMENT OF
TENDON AND LIGAMENT INJURIES
BIOMIMETIC THERAPEUTICS, INC.
US
61/191641
09/09/2008
61/144088
12/01/2009
US
61/144126
12/01/2009
US
PCT/US/2009/056418
WO/2010/030714
17/07/2003
‫תכשירי פקטור גדילה הנגזרים מטסיות דם‬
‫ושיטות לטיפול בפציעות גיד ורצועה‬
211593
PHARMACEUTICAL COMPOSITIONS
COMPRISING
DEXTROMETHORPHAN AND
QUINIDINE FOR THE TREATMENT
OF NEUROLOGICAL DISORDERS
AVANIR PHARMACEUTICALS
US
60/396661
17/07/2002
PCT/US/2003/022303
WO/2004/006930
07/03/2011
58
A61K )2010.01(
‫תכשירי רוקחות המכילים‬
‫דקסטרומתורפאן וקווינידין לטיפול‬
‫בהפרעות עצביות‬
211594
METHOD AND APPARATUS FOR
DISC
ROI HAIM
07/03/2011
A61L )2010.01(
B23C )2010.01(
‫ ומתקן של דיסק‬,‫שיטה‬
‫רועי חיים רחמים‬
211595
H02H )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
METHOD AND SYSTEM FOR A SAFE
ELECTRICITY FLOW FOR AN ELECTRICAL
DEVICES AND SYSTEMS AND FOR
CONTROLLING THE ELECTRICITY FOLW
IN THE WIRES AND REDUCING
ELECTRICITY RADIATION AND
ELECTRICITY CONSUMPTION
UZI EZRA HAVOSHA
WO
PCT/IL2009/000871 08/09/2008
61095328
09/09/2008
US
07/03/2011
211596
VEHICULAR POTABLE WATER
DISPENSING APPARATUS
OFER MOLCO
24/10/2008
‫שיטה ומערכת לזרימת חשמל‬
‫בטוחה למכשירי ומערכות חשמל‬
‫ולשליטה בזרימת החשמל והפחתת‬
‫קרינה חשמלית וצריכת חשמל‬
‫עוזי עזרא חבושה‬
B65B )2010.01(
‫מנפק מים נייד לרכב‬
‫עופר מולכו‬
211597
DEVICE FOR EXTEMPORANEOUSLY
PREPARING A HOT BEVERAGE
FROM A SOLUBLE POWDER
ALISTELLA S.A.
A47J )2010.01(
‫מכשיר להכנה מאולתרת של משקה חם‬
‫מאבקה מסיסה‬
PCT/EP/2008/064456
WO/2010/045983
29/09/2009
211598
CRYSTALLINE FORM OF AN
ALKOXYIMIDAZOL-1-YLMETHYL
BIPHENYL CARBOXYLIC ACID
THERAVANCE, INC.
US
61/194762
30/09/2008
PCT/US/2009/058803
59
C07D )2010.01(
–1–‫צורה גבישית של אלקוקסיאימידאזול‬
‫ילמתיל ביפניל חומצה קרבוקסילית‬
May 31, 2011-‫כ"ז באייר התשע"א‬
WO/2010/039719
18/09/2009
211599
SYNERGISTIC COMBINATIONS OF A
MACROCYCLIC INHIBITOR OF HCV
AND A NUCLEOSIDE
ORTHO-MCNEIL-JANSSEN
PHARMACEUTICALS, INC.
EP
08164612.7 18/09/2008
PCT/EP/2009/062096
WO/2010/031829
25/09/2009
‫צירופים סינרגיסטים של מעכב מקרוציקלי‬
‫ ונוקליאוזיד‬HCV ‫של‬
211600
MODIFIED ANIMAL
ERYTHROPOIETIN POLYPEPTIDES
AND THEIR USES
ELI LILLY AND COMPANY
US
61/100679
26/09/2008
61/100692
26/09/2008
US
PCT/US/2009/058482
WO/2010/036964
25/09/2009
211601
CHILLED AMMONIA BASED CO2
CAPTURE SYSTEM AND METHOD
WITH WATER WASH
ALSTOM TECHNOLOGY LTD.
US
61/102137
02/10/2008
61/102217
02/10/2008
US
12/556043
09/09/2009
US
PCT/US/2009/058388
WO/2010/039612
60
A61K )2010.01(
C07K )2010.01(
‫פוליפפטידים מותאמים של אריתרופויטין‬
‫מבעלי חיים ושימושים בהם‬
B01D )2010.01(
‫ מקוררת באמוניה‬CO2 ‫מערכת ללכידת‬
‫ושיטה לשטיפה עם מים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
18/09/2009
211602
PYRINE OR PYRAZINE DERIVATIVES
FOR TREATING HCV
F. HOFFMANN-LA ROCHE AG
US
61/194469
26/09/2008
PCT/EP/2009/062103
WO/2010/034671
17/09/2009
C07D )2010.01(
HCV–‫תולדות פירין או פיראזין לטיפול ב‬
211603
‫חזיה אתלטית‬
ATHILETIC BRA
NIKE INTERNATIONAL LTD.
US
12/234052
19/09/2008
PCT/US/2009/057258
WO/2010/033664
09/09/2009
211604
SYSTEM AND METHOD FOR
DELIVERING CONTENT
RGB NETWORKS, INC.
US
12/208122
10/09/2008
PCT/US/2009/056310
WO/2010/030627
09/09/2008
211605
NABULA GROUP (BVI) LIMITED
WO
PCT/MY2008/000096 09/09/2008
PCT/MY/2008/000096
WO/2010/030156
61
H04N )2010.01(
‫מערכת ושיטה לאספקת תוכן‬
ROTARY ATOMIZER WITH FOAM INSERTS
21/07/2005
A41C )2010.01(
211606
B05B )2010.01(
‫אוטומייזר סיבובי עם תוספות‬
‫ממתכת מוקצפת‬
‫קבוצת נבולה בע"מ‬
C07H )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
PREPARTION OF ALKYLSUBSTITUTED 2-DEOXY-2 FLURO-DRIBOFURANOSYL PYRIMIDINES
AND PURINES AND THEIR
DERIVATIVES
PHARMASSET, INC.
US
60/589866
21/07/2004
60/608320
09/09/2004
US
PCT/US/2005/025916
WO/2006/012440
07/03/2011
211607
A BUFFER MANAGER AND
METHODS FOR MANAGING
MEMORY
MARVELL ISRAEL (M.I.S.L) LTD
US
61/615327
18/03/2010
61/347947
25/05/2010
US
13/038266
01/03/2011
US
07/03/2011
211608
PACKET PROCESSING
OPTIMIZATION
MARVELL ISRAEL (M.I.S.L) LTD
US
61/315332
18/03/2010
13/038279
01/03/2011
US
10/09/2009
211612
ADAPTIVE COMPRESSION OF
COMPUTED TOMOGRAPHY
PROJECTION DATA
SAMPLIFY SYSTEMS, INC.
US
12/208839
11/09/2008
62
–‫–פלואורו–די‬2–‫–דאוקסי‬2 ‫תכשיר של‬
‫ריבופוראנוסיל מותמר–אלקיל פירידינים‬
‫ופורינים ונגזרותיהם‬
G06F )2010.01(
‫מנהל זכרון חוצץ ושיטות לניהול זכרון‬
‫אל) בע"מ‬.‫אס‬.‫איי‬.‫מארוול ישראל (אמ‬
G06F )2010.01(
‫אופטימיזציה של עיבוד חבילות‬
‫אל) בע"מ‬.‫אס‬.‫איי‬.‫מארוול ישראל (אמ‬
A61B )2010.01(
‫דחיסה מסתגלת של נתוני הקרנה‬
‫מטומוגרפיה ממוחשבת‬
May 31, 2011-‫כ"ז באייר התשע"א‬
PCT/US/2009/056469
WO/2010/030750
07/09/2009
211613
METHOD FOR PRODUCING
OPTICALLY ACTIVE
CYCLOPROPANE CARBOXYLIC
ACID ESTER COMPOUND,
ASYMMETRIC COPPER COMPLEX,
AND OPTICALLY ACTIVE
SALICYLIDENEAMINOALCOHOL
COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED
2008JP
10/09/2008
231921
PCT/JP/2009/065973
WO/2010/030017
08/03/2011
‫שיטה עבור ייצור תרכובת אופטית פעילה‬
‫של חומצת אסתר ציקלופרופאן‬
,‫ וקומפלקס נחושת אסימטרי‬,‫קרבוקסילית‬
‫ותרכובת סאליצילידנאמינואלכוהולית‬
‫אופטית פעילה‬
211614
WIRING IN AN ELECTRIC CIRUIT
BUILDING GAME
AMIR BOROHOVITCH
63
A47J )2010.01(
‫כפית מדידה מתכווננת לאבקת תחליפי‬
‫חלב‬
‫ליז שמש‬
ADJUSTABLE MEASUREMENT
SPOON FOR MILK POWDER
YOSEF HASIDIM RONEN
08/03/2011
C07C )2010.01(
211615
A63B )2010.01(
‫חיווט במשחקי בניה לילדים‬
‫אמיר בורוכוביץ‬
May 31, 2011-‫כ"ז באייר התשע"א‬
08/03/2011
211616
AN IMPLANT AND A METHOD FOR
USING SAME
DROR M. ALLON
08/03/2011
‫שתל ושיטה לשימוש בו‬
‫ אלון‬.‫דרור מ‬
211617
A VEHICULAR SEAT SYSTEM AND
METHOD FOR USING THEREOF
HAMRAM BLAU
07/09/2009
‫עמרם בלויא‬
211618
211619
P38 MAP KINASE INHIBITOR
RESPIVERT LIMITED
GB
0818033.3
02/10/2008
PCT/GB/2009/051303
WO/2010/038085
64
B60K )2010.01(
‫מערכת מושב לרכב ושיטה לשימוש בה‬
A METHOD AND SYSTEM FOR
VOLUMETRIC DISPLACEMENT
PACKLINE LTD
IL
193956
08/09/2008
PCT/IL/2009/000868
WO/2010/026593
02/10/2009
A61B )2010.01(
G01F )2010.01(
‫שיטה ומערכת להעתקה נפחית‬
‫פאקליין בע"מ‬
C07D )2010.01(
‫ קינאז‬MAP 38P ‫מעכב‬
May 31, 2011-‫כ"ז באייר התשע"א‬
02/10/2009
211620
P38 MAP KINASE INHIBITORS
RESPIVERT LIMITED
GB
0818033.3
02/10/2008
0822609.4
11/12/2008
GB
PCT/GB/2009/051304
WO/2010/038086
29/08/2007
211621
COMPRESSION DEVICE, SYSTEM
AND METHOD OF USE
COVIDIEN AG
US
11/533524
20/09/2006
28/09/2009
211622
PACKING FOR INSERTER
UNOMEDICAL A/S
US
61/100860
29/09/2008
PCT/EP/2009/062500
WO/2010/034830
30/09/2009
211623
ANTI-NOTCH2 ANTIBODIES AND
METHODS OF USE
GENENTECH, INC.
US
61/101917
01/10/2008
PCT/US/2009/059028
WO/2010/039832
30/09/2009
65
211624
C07D )2010.01(
‫ קינאז‬MAP 38P ‫מעכבי‬
A61M )2010.01(
‫ מערכת ושיטה לשימוש‬,‫התקן דחיסה‬
A61B )2010.01(
‫אריזה לאמצעי החדרה‬
A61K )2010.01(
‫ ושיטות לשימוש‬NOTCH2 ‫נוגדנים נגד‬
A61K )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
SYSTEMIC TREATMENT OF BLOODSUCKING AND BLOOD-CONSUMING
PARASITES BY ORAL
ADMINISTRATION OF A
PARASITICIDAL AGENT
BAYER B.V.
US
61/102774
03/10/2008
PCT/US/2009/059111
WO/2010/039892
29/09/2009
211625
COMBINATIONS OF A RATE
CONTROL AGENT AND AN A-2ALPHA RECEPTOR ANTAGONIST
FOR USE IN MULTIDETECTOR
COMPUTED TOMOGRAPHY
METHODS
GILEAD SCIENCES, INC.
US
61/101043
29/09/2008
PCT/US/2009/058850
WO/2010/037122
24/10/2009
–‫טיפול מערכתי בטפילים מוצצי–דם ואוכלי‬
‫דם באמצעות נתינה דרך הפה של גורם‬
‫קוטל טפילים‬
‫שילובים של גורם בקרת קצב ואנטגוניסט‬
‫–אלפא לשימוש בשיטות‬2 ‫לקולטן‬
‫טומוגרפיה ממוחשבות עם מספר רב של‬
‫גלאים‬
211626
PROVIDING FUNCTIONALITY TO
CLIENT SERVICES BY
IMPLEMENTING AND BINDING
CONTRACTS
MICROSOFT CORPORATION
US
12/258149
24/10/2008
PCT/US/2009/061974
WO/2010/048597
23/10/2009
211627
PARTITION MANAGEMENT IN A
PARTITIONED, SCALABLE, AND
AVAILABLE STRUCTURD STORAGE
MICROSOFT CORPORATION
66
A61K )2010.01(
G06F )2010.01(
‫מתן פונקציונליות לשירותי לקוח‬
‫באמצעות הטמעת וקישור חוזים‬
G06F )2010.01(
‫ניהול מפוצל באיחסון מובנה זמין מפוצל‬
‫הניתן להגדלה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
US
12/258050
PCT/US/2009/061972
WO/2010/048595
10/09/2009
24/10/2008
211628
INSECT LOADING SYSTEM
INSCENTINEL LIMITED
GB
0816917.9
16/09/2008
PCT/GB/2009/051166
WO/2010/032036
22/09/2009
211629
MULTHETEROARYL COMPOUNDS
AS INHIBITORS OF H-PGDS AND
THEIR USE FOR TREATING
PROSTAGLANDIN D2 MEDIATED
DISEASES
CAYMAN CHEMICAL COMPANY
US
61/098942
22/09/2008
PCT/US/2009/057813
WO/2010/033977
23/09/2009
211630
PYRAZOLE COMPOUNDS FOR
CONTROLLING INVERTEBRATE
PESTS
BASF SE
US
61/099784
24/09/2008
PCT/EP/2009/062317
WO/2010/034737
28/09/2009
67
211631
A01K )2010.01(
‫מערכת להטענת חרקים‬
C07D )2010.01(
‫תרכובות עם מספר רב של הטרוארילים‬
C07D )2010.01(
‫תרכובות פיראזול לשליטה במזיקים‬
‫חסרי–חוליות‬
A61K )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
LIQUID PHARMACEUTICAL
FORMULATION CONTAINING
PARACETAMOL
AZIENDE CHIMICHE RIUNITE
ANGELINI FRANCESCO A.C.R.A.F.
S.p.A.
EP
08425654.4 09/10/2008
PCT/EP/2009/062501
WO/2010/040652
03/09/2009
‫הרכב רוקחות נוזלי המכיל פאראצטמול‬
211633
METHOD AND SYSTEM FOR
ANALYZING HEALTH RELATED
DATA OF PATIENTS
HEALARIUM INC
US
61/094986
08/09/2008
61/138177
17/12/2008
US
PCT/IL/2009/000857
WO/2010/026583
06/09/2009
08/09/2009
A01N )2010.01(
–1–‫פעילות נוגדת נמק של אלפא‬
‫אנטיטריפסין‬
‫אוניברסיטת בן גוריון בנגב הרשות למחקר‬
‫ופיתוח‬
211635
THERAPEUTIC COMPOSITIONS
COMPRISING POLYHYDROXYLATE
FATTY ALCOHOL DERIVATIVES
AND USES THEREOF
POLYOL BIOTECH LTD
US
61/136468
08/09/2008
68
‫שיטה ומערכת לניתוח נתוני בריאות של‬
‫מטופלים‬
211634
ANTINECROTIC ACTIVITY OF
ALPHA 1-ANTITRYPSIN
BEN-GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
US
61/129707
10/09/2008
PCT/IL/2009/000861
WO/2010/029537
G06Q )2010.01(
A61K )2010.01(
‫תרכובות תרפויטיות המכילות נגזרות‬
‫אלכוהול שומניות של פוליהידרוקסילאט‬
‫ושימושים בהם‬
‫פוליאול ביוטק בע"מ‬
May 31, 2011-‫כ"ז באייר התשע"א‬
PCT/IL/2009/000875
WO/2010/026596
08/09/2009
211636
COSMETIC COMPOSITIONS
COMPRISING POLYHYDROXYLTATE
FATTY ALCOHOLS AND
DERIVATIVES AND USES THEREOF
POLYOL BIOTECH LTD
US
61/136469
08/09/2008
PCT/IL/2009/000874
WO/2010/026595
02/05/2002
‫תרכובות קוסמטיות המכילות אלכוהולים‬
‫שומניים של פוליהידרוקסילאט ונגזרות‬
‫ושימושים בהם‬
211637
ONCE-A-DAY OXYCODONE
FORMULATION
EURO-CELTIQUE S.A.
US
60/288211
02/05/2001
PCT/US/2002/014024
WO/2002/087512
11/09/2009
211638
ELASTOMERIC ARTICLE HAVING A
BROAD SPECTRUM ANTIMICROBIAL
AGENT AND METHOD OF MAKING
BACTERIN INTERNATIONAL, INC.
US
61/191730
11/09/2008
PCT/US/2009/005103
WO/2010/030374
24/09/2009
HIGH TITER ANTIBODY
PRODUCTION
69
A61Q )2010.01(
211639
‫פוליאול ביוטק בע"מ‬
A61K )2010.01(
‫תרכובות יומיות של אוקסיקודון‬
A61L )2010.01(
‫פריט אלסטומרי הכולל חומר קוטל‬
‫חיידקים בטווח רחב ושיטה להכנתו‬
C12N )2010.01(
‫ייצור נוגדן בטיטר גבוה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
SCHERING CORPORATION
US
61/100450
26/09/2008
PCT/US/2009/058164
WO/2010/036767
25/08/2009
211640
A01N )2010.01(
‫תכשירים להדברת מזיקים‬
PESTICIDAL COMPOSITIONS
DOW AGROSCIENCES LLC
US
61/096335
12/09/2008
PCT/US/2009/054869
WO/2010/030501
02/09/2009
211641
1-AMINO-ALKYLCYCLOHEXANE
DERIVATIVES FOR THE TREATMENT
OF COGNITIVE IMPAIRMENT IN
TINNITUS
MERZ PHARMA GMBH & CO. KGaA
EP
08015947.8 10/09/2008
61/191626
10/09/2008
US
PCT/EP/2009/006366
WO/2010/028769
10/09/2009
‫–אמינו–אלקילציקלוהקסאן‬1 ‫נגזרות של‬
‫לטיפול בליקויים קוגניטיביים הקשורים‬
‫לטנטון‬
211642
METHOD FOR THE TREATMENT OF
SUBSTRATES, SUBSTRATE AND
TREATMENT DEVICE FOR CARRYING
OUT SAID METHOD
GEBR. SCHMID GMBH & CO.
DE
102008048540.3 15/09/2008
PCT/EP/2009/006566
WO/2010/028825
70
A61K )2010.01(
H01L )2010.01(
‫ מצע והתקן ניקוי‬,‫שיטה לניקוי מצעים‬
‫לביצוע השיטה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
24/08/2009
211643
ENCLOSED REFLECTOR ANTENNA
MOUNT
ANDREW LLC
US
12/243033
01/10/2008
PCT/IB/2009/053718
WO/2010/038159
17/02/2005
‫כן משושת רפלקטור מוקף‬
211644
HAND-HELD ELECTRONICALLY
CONTROLLED INJECTION DEVICE
FOR INJECTING LIQUID
MEDICATIONS
ARES TRADING S.A.
EP
04100647.9 18/02/2004
PCT/EP/2005/050711
WO/2005/077441
15/09/2009
DOOR HANDLE
MOSHE DANINO
US
61/097264
PCT/IL/2009/000902
WO/2010/032239
09/03/2011
A61M )2010.01(
‫התקן הזרקה ידני מבוקר אלקטרונית‬
‫להזרקת תרופות נוזליות‬
211646
E05B )2010.01(
‫ידית לדלת‬
‫משה דנינו‬
16/09/2008
211647
SHOWER DRAINAGE SYSTEM
ASSEMBLY FOR OVER - THE FLOOR AND UNDER-THE-FLOOR
DERAINING
MOSHE FADIDA
US
61/312880
11/03/2010
71
H01Q )2010.01(
A47K )2010.01(
‫מערכת ניקוז לניקוז מי קולחין המצויים הן‬
‫או‬/‫מעל הריצוף של רצפה מרוצפת ו‬
‫מתחת לריצוף‬
‫משה פדידה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
11/09/2009
211648
A BASE TILE
DRAGON ENERGY PTE. LTD
200806823SG
12/09/2008
1
PCT/SG/2009/000330
WO/2010/030245
01/03/2007
211649
ARTERY IMAGING SYSTEM
THE BRIGHAM AND WOMEN'S
HOSPITAL, INC.
US
60/777999
01/03/2006
PCT/US/2007/063069
WO/2007/103726
11/09/2009
211650
AN ELECTRICAL CONNECTION
SYSTEM
DRAGON ENERGY PTE. LTD
200806820SG
12/09/2008
7
PCT/SG/2009/000333
WO/2010/030248
28/10/2004
211651
RESTRICTIVE REUSE FOR A
WIRELESS COMMUNICATION
SYSTEM
QUALCOMM INCORPORATED
US
60/516558
30/10/2003
10/871084
18/06/2004
US
PCT/US/2004/036285
72
H01L )2010.01(
‫אריח בסיס‬
A61B )2010.01(
‫מערכת דמות עורקים‬
F03D )2010.01(
‫מערכת חיבור חשמלי‬
H04W )2010.01(
‫שימוש חוזר מגביל למערכת תקשורת‬
‫אלחוטית‬
May 31, 2011-‫כ"ז באייר התשע"א‬
WO/2005/043948
11/09/2009
211652
PHOTOVOLTAIC CELL CIRCUIT
ALTERNATIVE ENERGY
TECHNOLOGY PTE. LTD
200806818SG
15/09/2008
1
PCT/SG/2009/000334
WO/2010/030249
11/09/2009
211653
PHOTOVOLTAIC TILE
DRAGON ENERGY PTE. LTD
200806822SG
15/09/2008
3
PCT/SG/2009/000331
WO/2010/030246
11/09/2009
211654
WIND ENERGY SYSTEM
DRAGON ENERGY PTE. LTD
200806820SG
12/09/2008
7
PCT/SG/2009/000333
WO/2010/030248
16/09/2009
211655
MEANS AND METHODS FOR
DETECTING BACTERIA IN AN
AEROSOL SAMPLE
OPTICUL DIAGNOSTICS LTD
US
61/097568
17/09/2008
73
H01L )2010.01(
‫מעגל תא חשמלורי‬
E04D )2010.01(
‫אריח חשמלורי‬
F03D )2010.01(
‫מערכת אנרגיית רוח‬
G06K )2010.01(
‫אמצעים ושיטות לזיהוי בקטריה בדגימת‬
‫תרסיס‬
‫אופטיקאל דיאגנוסטיקה בע"מ‬
May 31, 2011-‫כ"ז באייר התשע"א‬
PCT/IL/2009/000908
WO/2010/032245
09/09/2009
211656
MOLECULARLY IMPRINTED SMART
POLYMERS (MISPs)
SALIO NANOTECHNOLOGIES LTD
US
61/136487
09/09/2008
PCT/IL/2009/000878
WO/2010/029541
09/09/2009
‫פולימר חכם מוטבע באופן מולקולרי‬
‫סליו ננוטכנולוגיות בע"מ‬
211657
LCMS TECHNOLOGY AND ITS USES
A24D )2010.01(
G01N )2010.01(
‫טכנולוגיות ספקטרומטר מסות המבוססת‬
‫על כרומטוגרפיה בנוזל ושימושיה‬
DE STAAT DER NEDERLANDEN,
VERTEGENWOORDIGD DOOR DE
MINISTER VAN
VOLKSGEZONDHEID, WELZIJN EN
SPORT
EP
08163987.4 09/09/2008
PCT/NL/2009/050539
WO/2010/030178
10/03/2011
211658
MEASURE VOLTAGE WIRELESS FOR
12VDC OR 24VDC ON BATTERY
VEHICLE
YARON SAHAR
11/09/2009
74
211659
B60Q )2010.01(
‫ וולט ממצבר‬24 ‫ וולט או‬12 ‫מודד מתח‬
)‫הרכב ללא חיבור חוט מנוס (אלחוטי‬
‫ירון סהר‬
A61B )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
PHYSIOLOGICAL SENSOR DELIVERY
DEVICE AND METHOD
ACIST MEDICAL SYSTEMS, INC.
US
61/096216
11/09/2008
PCT/US/2009/056664
WO/2010/030882
02/02/2009
211660
COUPLING DEVICE FOR COUPLING
CONTAINERS, PARTICULARY
CONTAINERS USED IN CARGO SHIPS
CARGOTEC FINLAND OY
FI
20085866
16/09/2008
PCT/FI/2009/050086
WO/2010/031897
14/09/2009
211661
FIREARM HAVING A HYBRID
INDIRECT GAS OPERATING SYSTEM
COLT DEFENSE LLC
US
61/096697
12/09/2008
12/559047
14/09/2009
US
PCT/US/2009/056830
WO/2010/030987
11/09/2009
211662
FIREARM HAVING A DIRECT GAS
IMPINGEMENT OPRATING SYSTEM
COLT DEFENSE LLC
US
61/096710
12/09/2008
12/557815
11/09/2009
US
PCT/US/2009/056625
WO/2010/030854
75
‫התקן העברה עם חיישן פיזיולוגי ושיטה‬
B65D )2010.01(
‫ בפרט‬,‫התקן צימוד עבור צימוד מיכלים‬
‫מיכלים המשמשים בספינות משא‬
F41A )2010.01(
–‫נשק בעל מערכת הפעלה גזית בלתי‬
‫ישירה מוכלאת‬
F41A )2010.01(
‫נשק בעל מערכת הפעלה עם פגיעת גז‬
‫ישירה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
211664
20/12/2006
STREPTOCOCCUS PNEVMONIAE
IMMUNOGENIC
GLAXOSmithKLINE BIOLOGICALS S.A.
GB
0526232.4
22/12/2005
0607087.4
07/04/2006
GB
0607088.2
07/04/2006
GB
0609902.2
18/05/2006
GB
0620336.8
12/10/2006
GB
0620337.6
12/10/2006
GB
0620815.1
19/10/2006
GB
0620816.9
19/10/2006
GB
GB
PCT/GB06/004634 12/12/2006
PCT/EP/2006/069974
WO/2007/071707
18/04/2006
211665
ANTIBODIES TO IL-21 VARIANTS
NOVO NORDISK A/S
DK
PA200500562 18/04/2005
PCT/EP/2006/061635
WO/2006/111524
06/10/2009
211666
USE OF DITHIIN TETRBOXIMIDES
FOR TREATING PHYTOPATHOGENIC
FUNGI
BAYER CROPSCIENCE AG
EP
08166621.6 15/10/2008
PCT/EP/2009/007149
WO/2010/043319
18/09/2009
76
211667
A61K )2010.01(
‫תכשיר אימונוגני של דלקת‬
‫סטרפטוקוקוס‬
A61K )2010.01(
IL–21 ‫נוגדנים לוריאנטים של‬
A01N )2010.01(
‫שימוש בדיתאין טטראקרבוסימידים‬
‫לטיפול בפטריה פיטופתוגנית‬
A61K )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
METHOD FOR THE TREATMENT OF
RADIATION-INDUCED
NEUTROPENIA BY
ADMINISTRATION OF A MULTIPEGYLATED GRANULOCYTE
COLONY STIMULATING FACTOR (GCSF) VARIANT
MAXYGEN, INC.
US
61/098569
19/09/2008
PCT/US/2009/057600
WO/2010/033884
06/10/2009
211668
METHOD FOR IDENTIFYING AND
SELECTING DRUG CANDIDATES FOR
COMBINATORIAL DRUG PRODUCTS
SYMPHOGEN A/S
DK
PA200801405 06/10/2008
61/103,144
06/10/2008
US
PCT/DK/2009/050264
WO/2010/040356
21/11/2007
211679
A METHOD OF RECONSTRUCTING A
SHAPE INSPECTION METHOD AND
APPARATUS, LITHOGRAPHIC
APPARATUS, LITHOGRAPHIC
PROCESSING CELL AND DEVICE
MANUFACTURING METHOD
ASML NETHERLANDS B.V.
US
11/603257
22/11/2006
10/03/2011
FILTER ASSEMBLY FOR A WATER
DISPENSER
77
211680
‫שיטה לטיפול בנויטרופניה הנגרמת‬
‫מקרינה באמצעות מתן של וריאנט של‬
‫ מרובה פוליאתין גליקול‬G CSF–‫גורם‬
G01N )2010.01(
‫שיטה לזיהוי ובחירה של מועמדים‬
‫לתרופה עבור מוצרי תרופות משולבים‬
H01L )2010.01(
‫שיטה לשחזור צורה מכשיר ושיטה‬
‫ תא עיבוד‬,‫ מכשיר ליטוגרפי‬,‫לפיקוח‬
‫ליטוגרפי ושיטה ליצור מתקן‬
F25D )2010.01(
‫מיכלול פילטר למכשיר טיהור מים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
ELECTRA CONSUMER PRODUCTS
(1951) LTD
13/03/2011
‫) בע"מ‬1951( ‫אלקטרה מוצרי צריכה‬
211695
SUN SHINE ELECTRIC SOLAR
DEVICE
ABRAHAM SADEH
13/03/2011
"‫מיתקן סולארי חשמלי "סאן שיין‬
‫אברהם שדה‬
211696
CONNECTION PROFILE SHUTTER
SLATS PARTICULARLY FOR "LIGHT
SHUTER"
YADIDYA TZUR
13/03/2011
211697
LOCK ASSEMBLY WITH MOVABLE
ELEMENT
MUL-T-LOCK TECHNOLOGIES LTD.
13/03/2011
78
F24J )2010.01(
211698
E06B )2010.01(
‫ במיוחד‬,‫פרופיל מקשר בין שלבי תריס‬
"‫עבור "תריס אור‬
‫צור ידידיה‬
E05B )2010.01(
‫מכלול נעילה בעל אלמנט נע‬
‫מולטילוק טכנולוגיות בע"מ‬
G06F )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
ADDING CONTENT OF THIRD PARTY
OBJECTS TO A VISUAL DISPLAY
ARTIVISION TECHNOLOGIES LTD
05/11/2009
211699
SYSTEM AND METHOD FOR
ENRICHING VIDEO DATA
ARTIVISION TECHNOLOGIES LTD
US
61/193221
06/11/2008
PCT/IL/2009/001035
WO/2010/052709
13/03/2011
211706
HOUSEHOLD DRAIN TRAP WITH
MANUALLY OPERATED CLEANOUT
TAP
HULIOT (A.C.S) LTD
13/03/2011
211707
PLASTIC PIPE FITTINGS FOR USE IN
PLASTIC PIPE SYSTEMS AND CLAMP
FOR USE THEREWITH
HULIOT (A.C.S) LTD
79
‫הוספת תוכן של אוייקטי צד שלישי‬
‫לתצוגה ויזואלית‬
G06T )2010.01(
‫מערכת ושיטה להעשרת נתוני וידאו‬
B08B )2010.01(
‫מחסום דלוחים ביתי בעל מגופת–ניקוי‬
‫מופעל ידני‬
‫חוליות (אגש"ח) בע"מ‬
F16L )2010.01(
‫אביזרי צינור פלסטיק לשימוש במערכות‬
‫מצינורות פלסטיק ומלחציים לשימוש‬
‫איתם‬
‫חוליות (אגש"ח) בע"מ‬
May 31, 2011-‫כ"ז באייר התשע"א‬
13/03/2011
211709
THRUSTER MODULE FOR DUAL
MOTION SEALING FRAMELESS
GLASS FACADE
GLASTEEL LTD
US
61/312680
11/03/2010
14/03/2011
211715
211716
THE METHOD (DEVICE) FOR
CHARGING NUMBER OF CELLS
CONNEVTED TOGETHER IN A ROW
AND CREATE A SPECIFIC BATTERY
DAVID NACHMAN
14/03/2011
211717
MULTILIGUAL KEYBOARD SYSTEM
AND METHOD
ERAN YAIR
80
‫מודול דחפן לתנועה דואלית האוטם חזית‬
‫מזכוכית בלא מסגרת‬
GLASTEEL LTD
B65D )2010.01(
‫בקבוק לתינוק‬
‫עופר גולן‬
A BABY BOTTLE
OFER GOLLAN
14/03/2011
E06B )2010.01(
H01M )2010.01(
‫שיטה (התקן) לטעינת מספר תאים‬
‫המחוברים יחדיו ויוצרים סוללה מסוים‬
)‫(טעינת פסנתר‬
‫דוד נחמן‬
B41J )2010.01(
‫מערכת ושיטה למקלדת רב לשונית‬
‫ערן יאיר‬
May 31, 2011-‫כ"ז באייר התשע"א‬
14/03/2011
211725
BURIAL SYSTEMS AND
CONSTRUCTION METHODS
THEREFOR
WOLFMAN INDUSTRIES LTD
14/03/2011
‫מערכות קבורה ושיטות לבנייתן‬
‫וולפמן תעשיות בע"מ‬
211730
UV LAMP ASSEMBLY FOR WATER
DISPENSER
ELECTRA CONSUMER PRODUCTS
(1951) LTD
15/03/2011
EMERGENCY FLOW SHUT-OFF
DEVICE AND METHOD OF RESETTING IT
PLASSON LTD
81
B65B )2010.01(
‫ למכשיר טיהור מים‬UV ‫מיכלול מנורת‬
‫) בע"מ‬1951( ‫אלקטרה מוצרי צריכה‬
211733
METHOD FOR UTILIZATION OF
SUBTERRANENEOUS COLD AND
INSTALLATION FOR ITS
IMPLEMENTATION
LEVIN VICTOR
15/03/2011
E04H )2010.01(
F24F )2010.01(
‫שיטה לניצול קור קרקעי ומתקן ליישומו‬
‫ויקטור לוין‬
211734
G08B )2010.01(
‫מתקן לניתוק זרימה בשעת חירום ושיטה‬
‫לכוונונו מחדש‬
‫פלאסון בע"מ‬
May 31, 2011-‫כ"ז באייר התשע"א‬
14/05/2004
211748
INTERFERENCE AND NOISE
ESTIMATION IN AN OFDM SYSTEM
QUALCOMM INCORPORATED
US
60/470724
14/05/2003
10/809538
24/03/2004
US
PCT/US/2004/015204
WO/2004/104530
15/03/2011
RESIDENTIAL SOLAR AIRCONDITIONING AND WATER
HEATING SYSTEM
ZIADMAN MATI
15/03/2011
OFDM ‫הערכת הפרעה ורעש במערכת‬
211753
ROLLING STECL
YOSEF SHIR
82
F25B )2010.01(
‫מערכת ביתית למיזוג אוויר סולרי ולחימום‬
‫מים‬
‫מתי זידמן‬
211755
THE GEOWING ALGAE METHOD
AND ITS IMPLEMENTATION
OLEG ABEL
16/03/2011
H04J )2010.01(
C12M )2010.01(
‫שיטת גידול אצות ושימושה‬
‫אולג אבל‬
211757
B21B )2010.01(
‫סוכך גלילה‬
‫יוסף שיר‬
May 31, 2011-‫כ"ז באייר התשע"א‬
16/03/2011
211759
A SYSTEM AND METHOD FOR
DISPLAYING ADVERTISEMENTS ON
A USER DEVICE BASED ON USER
PREFERENCES WHILE OPERATIVE
BY THE USER
TEXT AWAY LTD.
US
61/315313
18/03/2010
13/047289
14/03/2011
US
16/03/2011
211761
SCANNING DURING A STAGE
ACCELARATION IN AN INSPECTION
SYSTEM
CAMTEK LTD.
US
61/316887
18/03/2010
17/03/2011
OCEAN SWELL ENERGY
CONVERSION APPARATUS
YOSSEF LEVY
83
211769
G09G )2010.01(
‫מערכת ושיטה להצגה של מודעות על‬
‫מתקן של משתמש על–פי העדפות‬
‫המשתמש ותוך כדי השימוש במתקן‬
‫טקסט אווי בע"מ‬
G03B )2010.01(
‫סריקה במהלך האצת אלמנט תומך‬
‫במערכת בדיקה‬
‫קמטק בע"מ‬
F03B )2010.01(
‫התקן להמרת אנרגית גלי ים‬
‫יוסף לוי‬
May 31, 2011-‫כ"ז באייר התשע"א‬
01/10/2002
211772
APO-2 LIGAND VARIANTS AND USES
THEREOF
GENENTECH, INC.
US
60/326622
02/10/2001
PCT/US/2002/031210
WO/2003/029420
29/10/2001
29/10/1998
TIME DOMAIN VIBRATION
REDUCTION AND CONTROL
84
C07K )2010.01(
A ‫חומצות גרעין וחלבונים מסטרפטוקוקוס‬
‫ השימוש‬,‫ תכשירים המכילים אותם‬,B –‫ו‬
‫בהם ושיטות להכנתם‬
211788
WNT-1 INDUCED SECRETED
POLYPEPTIDES: WISP-1', -2 AND -3
GENENTECH, INC.
US
60/063704
29/10/1997
60/073612
03/02/1998
US
60/081695
14/04/1998
US
PCT/US/1998/022991
WO/1999/021998
17/03/2011
‫ משתנים והשימוש בהם‬APO–2 ‫ליגנדים‬
211775
NUCLEIC ACIDS AND PROTEINS
FROM STREPTOCOCCUS GROUPS A
& B, COMPOSITIONS COMPRISING
THEM, USES THEREOF AND
METHODS FOR THEIR PREPARATION
NOVARTIS VACCINES AND
DIAGNOSTICS S.R.L,
GB
0026333.5
27/10/2000
0028727.6
24/11/2000
GB
0105640.7
07/03/2001
GB
PCT/GB/2001/004789
WO/2002/034771
C12N )2010.01(
C12Q )2008.04(
‫ – מופרשים‬3‫ – ו‬WISP ,2–1 ‫פוליפפטידים‬
WNT – 1 ‫והמושפעים על ידי‬
211790
G01M )2010.01(
‫הפחתה ובקרה של תנודת תחום – זמן‬
May 31, 2011-‫כ"ז באייר התשע"א‬
RAYTHEON COMPANY
US
12/787153
10/07/2005
25/05/2010
211796
IMPROVED PROCESS FOR THE
PREPARATION OF OXIDIZED
PHOSPHOLIPIDS
VASCULAR BIOGENICS LTD.
US
60/586219
09/07/2004
PCT/IL/2005/000735
WO/2006/006161
08/02/2006
‫תהליכים להכנת פוספוליפידים מחומצנים‬
211797
ANALYSIS INSTRUMENT FOR
PROCESSING A MICROFLUIDIC
DEVICE
LAB901 LIMITED
GB
0502556.4
08/02/2005
PCT/GB/2006/000444
WO/2006/085071
17/03/2011
211798
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
17/03/2011
211800
DEVICE FOR INJECTING FLUIDS OR
GELS
85
C07F )2010.01(
‫וסקולר ביוג'ניק בע"מ‬
B01L )2010.01(
‫כלי ניתוח בשביל עיבוד מכשיר‬
‫מיקרופלואידי‬
G06F )2010.01(
‫שיטות משופרות להכנת נתונים‬
‫בנימין פירוז גסביאן‬
B01D )2010.01(
‫התקן להזרקת נוזלים או קרישים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
LEA BRODSKY
US
61/315964
29/11/2007
‫לאה ברודסקי‬
21/03/2010
211805
A SCATTEROMETER, A
LITHOGRAPHIC APPARATUS AND A
FOCUS ANALYSIS METHOD
ASML NETHERLANDS B.V.
US
11/635787
08/12/2006
08/02/2005
‫ מכשיר ליטוגרפי ושיטה לניתוח‬,‫מד פיזור‬
‫מיקוד‬
211819
SITE-SPECIFIC SERINE
RECOMBINASES AND METHODS OF
THEIR USE
INTREXON CORPORATION
US
11/049552
02/02/2005
PCT/US/2005/003851
WO/2006/083253
08/02/2005
211820
SITE-SPECIFIC SERINE
RECOMBINASES AND METHODS OF
THEIR USE
INTREXON CORPORATION
US
11/049552
02/02/2005
PCT/US/2005/003851
WO/2006/083253
20/03/2011
86
G01B )2010.01(
211824
C12N )2010.01(
‫סרין רקומבינאזות לאתרים ספציפיים‬
‫ושימושיהם‬
C12N )2010.01(
‫סרין רקומבינאזות לאתרים ספציפיים‬
‫ושימושיהם‬
A63F )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
MAGNETIC CAPTURE GAME
YONA, ALON
US
61/315060
18/03/2010
21/03/2011
211826
MINING AND REMOVING BLOCKS
OFF A LAYER OF SEDIMENT
POSITIONED ACROSS THE BED OF
WATER AND/OR EVAPORATION
PONDS
ARROW OPERATIONS AND
TECHNOLOGIES LTD
21/03/2011
‫חץ ביצוע וטכנולוגיות בע"מ‬
211827
B01F )2010.01(
‫שסתום הסתעפות מורכב על צינור‬
‫השקיה ומופעל על ידי כיוון זרימת המים‬
‫דן מקלר‬
211829
NON-HOMOGENEOUS SYSTEMS
FOR THE RESOLUTION OF
ENANTIOMERIC
ALTUS PHARMACEUTICALS, INC.
US
60/103804
09/10/1998
PCT/US/1999/023405
WO/2000/022157
87
E21C )2010.01(
‫חציבת והסרת גושים משכבת משקע‬
‫או‬/‫המצטבר על קרקעית מקווי מים ו‬
‫בריכות אידוי‬
BIFURCATION VALVE ATTACHED
TO AN IRRIGATION LINE AND
OPERATED BY THE WATER FLOW
DIRECTION
DAN MEKLER
08/10/1999
‫משחק תופס מגנטי‬
‫יונה ניקול‬
C12P )2010.01(
‫מערכת לא הומוגנית לרזולוציה של‬
‫תערובות אננטיומרים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
18/01/2007
211835
THERAPEUTIC USES OF INHIBITORS
OF RTP801
SILENCE THERAPEUTICS AG
US
60/760586
20/01/2006
60/796901
01/05/2006
US
60/851000
10/10/2006
US
PCT/US/2007/001468
WO/2007/084684
21/03/2011
211838
A DIMENSIONALLY ADJUSTABLE
VEHICLE
BORIS TSUKERMAN
23/05/2002
88
RTP 801 ‫שימוש רפואי של מעכבי‬
G09B )2010.01(
‫רכב עם מידות מתכווננות‬
‫בוריס צוקרמן‬
211859
COOLING SYSTEM FOR A
PHOTOCOSMETIC DEVICE
PALOMAR MEDICAL
TECHNOLOGIES, INC.
US
60/292827
23/05/2001
10/052474
18/01/2002
US
60/363798
12/03/2002
US
60/363871
12/03/2002
US
PCT/US/2002/016435
WO/2002/094116
08/12/2005
A61K )2010.01(
211861
A61N )2010.01(
‫מערכת קירור להתקן פוטוקוסמטי‬
F41H )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
METHODS AND APARATUS FOR
PROVIDING BALLISTIC PROTECTION
ARMORDYNAMICS, INC.
US
60/634120
08/12/2004
60/689531
13/06/2005
US
PCT/US/2005/044482
WO/2006/083391
08/12/2005
211862
METHODS AND APPARATUS FOR
PROVIDING BALLISTIC PROTECTION
ARMORDYNAMICS, INC.
US
60/634120
08/12/2004
60/689531
13/06/2005
US
PCT/US/2005/044482
WO/2006/083391
22/03/2011
‫שיטות והתקנים להספקת הגנה בליסטית‬
‫שיטות והתקנים להספקת הגנה בליסטית‬
211871
A METHOD AND SYSTEM FOR HARQ
COMBINING IN A
TELECOMMUNICATION SYSTEM
DESIGNART NETWORKS LTD
US
12/728310
22/03/2010
12/04/2006
211874
WIRELESS TRANSCEIVER SYSTEM
IVY BIOMEDICAL SYSTEMS, INC.
US
60/671935
15/04/2005
60/672562
18/04/2005
US
PCT/US/2006/013927
WO/2007/024281
89
F41H )2010.01(
H03M )2010.01(
‫ במערכת‬HARQ ‫שיטה ומערכת לחיבור‬
‫תקשורת–רחק‬
‫דזיינארט נטוורקס בע"מ‬
H03F )2010.01(
‫משדר–מקלט אלחוטי‬
May 31, 2011-‫כ"ז באייר התשע"א‬
12/04/2006
211875
SYSEM FOR CANCELLATION OF
INDUCED CURRENTS FROM A
MAGNETIC GRADIENT
IVY BIOMEDICAL SYSTEMS, INC.
US
60/671935
15/04/2005
60/672562
18/04/2005
US
PCT/US/2006/013927
WO/2007/024281
23/03/2011
23/03/2011
‫מערכת לביטול זרם השראתי מגראדיאנט‬
‫מגנטי‬
211878
POLISHING PASTE ON
MONOCOMPONENT BASE FOR
FINISH POLISHING, SURFACE FINISH
AND ATTRITION AND A METHOD
FOR THE PRODUCTION OF THEREOF
RAY TECHNIQUES LTD
SUNSHADE
AVRAHAM DISKIN
90
C09G )2010.01(
‫משחת ליטוש על בסיס רכיב עבור ליטוש‬
‫ מירוק‬,‫ שחיקה‬,‫ גימור משטחים‬,‫סופי‬
‫שפשוף ולחיכה ושיטה ליצור משחה זו‬
211879
PERSONAL DIGITAL ASSISTANT
CASE
YOSI MAOR SARID
23/03/2011
H03F )2010.01(
‫ריי טכניקס בע"מ‬
B65D )2010.01(
‫נרתיק למסייע דיגיטלי אישי‬
‫יוסי מאור שריד‬
211880
A45B )2010.01(
‫סך שמש‬
‫אברהם דיסקין‬
May 31, 2011-‫כ"ז באייר התשע"א‬
23/03/2011
211881
A RETAINER STRUCTURE FOR A
VEHICLE TESTING PLATFORM, AND
USE OF THE RETAINER AND OF A
SPECIALIZED VEHICLE TESTING
PLATFORM TO TEST THE
ELECTRONIC STABILITY PROGRAM
(ESP) OF A VEHICLE
YONA BEN DAVID
US
12/731157
25/03/2010
23/03/2011
,‫מבנה מגן לפלטפורמה לבדיקת רכבים‬
‫ושימוש במגן ובפלטפורמה מיוחדת‬
‫ לבדיקת תוכנת יציבות‬,‫לבדיקת רכבים‬
‫) של רכב‬ESP( ‫אלקטרונית‬
‫יונה בן דוד‬
211887
211893
A GENETIC SCREENING METHOD
FOR IDENTIFYING AN
OLIGOADENYLATE SYNTHETASE
GENE MUTATION, POLYPEPTIDES
ENCODED BY THE MUTATED GENE
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
ILLUMIGEN BIOSCIENCES, INC.
US
60/513888
23/10/2003
60/542373
06/02/2004
US
60/554758
19/03/2004
US
60/560524
08/04/2004
US
60/578323
09/06/2004
US
60/583503
28/06/2004
US
91
G06F )2010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
22/10/2004
B60T )2010.01(
C07K )2010.01(
‫שיטה לסינון גנטית עבור זיהוי מוטציה של‬
‫ פוליפפטידים‬,‫גן אוליגואדנילט סינתטס‬
‫המקודדים על ידי הגן שעבר מוטציה‬
‫ותכשירי רוקחות המכילים אותם‬
May 31, 2011-‫כ"ז באייר התשע"א‬
60/605243
US
PCT/US/2004/035284
WO/2005/040428
26/08/2004
24/12/2004
211894
AMIDE DERIVATIVES
MITSUI CHEMICALS, INC.
2004JP
28/01/2004
019438
2004-048031 24/02/2004
JP
2004-209002 15/07/2004
JP
PCT/JP/2004/019770
WO/2005/073165
24/03/2011
211897
APPARATUS TO PROTECT AGAINST
RAIN OR SUNLIGHT
NIV KAUFMAN
24/03/2011
211898
A VEHICUAR AUDIO PLAYER AND
METHOD
YANIV KAPAH
24/03/2011
SIMANIM BADERCH-THINKING
PLAYING FAMILY
92
C07C )2010.01(
‫תולדות אמיד‬
G09C )2010.01(
‫התקן המגן מפני גשם או שמש‬
‫ניב קאופמן‬
H04B )2010.01(
‫נגן ושיטת שמע לרכב‬
‫יניב קאפח‬
211899
A63F )2010.01(
‫סימנים בדרך משחק חשיבה למשפחה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
‫מיכאל הרצל דוסטר‬
MICHAEL HERZEL DOUSTAR
211905
04/04/2007
A PROCESS FOR CONCENTRATION OF
A POLYPEPTIDE
ZYMENEX A/S
DK
PA200600488 04/04/2006
DK
PA200600922 05/07/2006
PCT/DK/2007/000177
WO/2007/112757
211910
04/04/2007
A PROCESS FOR CONCENTRATION OF
A POLYPEPTIDE
ZYMENEX A/S
DK
PA200600488 04/04/2006
DK
PA200600922 05/07/2006
PCT/DK/2007/000177
WO/2007/112757
08/02/2006
211916
SYSTEM AND METHOD FOR
COMPUTERIZED ORDERING
DOLPHIN SOFTWARE LTD.
US
60/655410
24/02/2005
60/719963
26/09/2005
US
PCT/IL/2006/000154
WO/2006/090360
24/03/2011
93
211924
C12N )2010.01(
‫תהליך לריכוז פוליפפטיד‬
C12N )2010.01(
‫תהליך לריכוז פוליפפטיד‬
G06Q )2010.01(
‫מערכת ושיטה לסידור ממוחשב‬
‫דולפין תוכנה בע"מ‬
E05B )2010.01(
May 31, 2011-‫כ"ז באייר התשע"א‬
‫מערכת נעילה משופרת‬
‫גריגורי אורנבך‬
IMPROVED LOCKING SYSTEM
GREGORY ORENBACH
25/10/2005
211935
SALTS OF ISOPHOSPHORAMIDE
MUSTARD AND ANALOGS THEREOF
AS ANTI-TUMOR AGENTS
DEKK-TEC INC
US
60/622087
25/10/2004
60/672707
18/04/2005
US
PCT/US/2005/038523
WO/2006/047575
25/10/2005
211936
SALTS OF ISOPHOSPHORAMIDE
MUSTARD AND ANALOGS THEREOF
AS ANTI-TUMOR AGENTS
DEKK-TEC INC
US
60/622087
25/10/2004
60/672707
18/04/2005
US
PCT/US/2005/038523
WO/2006/047575
09/10/2009
211947
METHOD AND APPARATUS FOR
ELECTRICAL, MECHANICAL AND
THERMAL ISOLATION OF
SUPERCONDUCTIVE MAGNETS
MAGNETIC-ELECTROSTATIC
CONFINEMENT (MEC)
CORPORATION
US
61/100,717
27/09/2008
PCT/IB/2009/054429
WO/2010/035246
94
C07F )2010.01(
‫מלחים של חרדל של איזופוספוראמיד‬
‫ואנלוגים שלהם כחומרים נגד גידולים‬
C07F )2010.01(
‫מלחים של חרדל של איזופוספוראמיד‬
‫ואנלוגים שלהם כחומרים נגד גידולים‬
H01F )2010.01(
‫ מכני‬,‫שיטה ומערכת עבור בידוד חשמלי‬
‫ותרמי של מגנטים סופר מוליכים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
27/03/2011
211959
SYSTEMS AND METHODS FOR
EXCITING LONG SLOT RADIATORS
OF AN RF ANTENNA
RAYTHEON COMPANY
US
12/836442
14/07/2010
27/03/2011
‫מערכות ושיטות לעירור רדיאטורים בעלי‬
‫חריץ ארוך של משושה‬
211960
211961
PRODRUGS OF PIPERAZINE AND
SUBSTITUTED PIPERIDINE
ANTIVIRAL AGENTS
BRISTOL-MYERS SQUIBB COMPANY
US
60/553320
15/03/2004
60/635231
10/12/2004
US
PCT/US/2005/006980
WO/2005/090367
06/03/2007
C07F )2010.01(
‫פרודראגים של תרכובות אנטיויראליות של‬
‫פיפרזין ופיפרידין מותמר‬
211963
METHODS AND COMPOSITIONS FOR
IDENTIFYING A CELL PHENOTYPE
ZETIQ TECHNOLOGIES LTD.
US
60/778839
06/03/2006
95
B65D )2010.01(
‫ערכת אביזרים טקסיים עבור סעודת חג‬
‫יהודי‬
‫אביגדור שמדרה‬
A CEREMONIAL ITEMS KIT FOR A
JEWISH FESTIVE MEAL
AVIGDOR SHMEDRA
03/03/2005
H01Q )2010.01(
A61K )2010.01(
‫שיטות ותכשירים לזיהוי פנוטיפ של תאים‬
‫זטיק טכנולוגיות בע"מ‬
May 31, 2011-‫כ"ז באייר התשע"א‬
60/778944
US
60/778900
US
60/778902
US
PCT/IL/2007/000281
WO/2007/102146
06/03/2006
06/03/2006
06/03/2006
27/03/2011
211965
METHODS AND SYSTEMS FOR
THREE-DIMENSIONAL RENDERING
OF A VIRTUAL AUGMENTED
REPLICA OF A PRODUCT IMAGE
MERGED WITH A MODEL IMAGE OF
A HUMAN-BODY FEATURE
SHTAINER, RAMI
US
12/748420
28/03/2010
28/03/2011
211967
FITTING FOR A FAUCET
CONNECTION
ZVI ZUCKER
28/03/2011
A DEVICE FOR REDUCIONG THE
AMOUNT OF A MATERIAL
EXTRACTED FROM A CONTAINER
TSUK CHEN
96
G06F )2010.01(
‫שיטות ומערכות להדמייה תלת–מימדית‬
‫של העתק וירטואלי מוגדל של תמונת‬
‫מוצר הממוזגת עם תמונת מודל של‬
‫מאפיין גוף האדם‬
‫ רמי‬,‫שטיינר‬
F16K )2010.01(
‫חלק עבור חיבור ברז‬
‫צבי צוקר‬
211971
B65D )2010.01(
‫התקן עבור הפחתת כמות של חומר‬
‫לחילוץ ממיכל‬
‫ערן גולדברג‬
May 31, 2011-‫כ"ז באייר התשע"א‬
28/03/2011
211974
TECHNOLOGY OF DIVIDING THE
LIQUID FROM THE IMPURITIES IN IT
JUDBAROVSKI DAVID
28/03/2011
‫טכנולוגיה לפצל את הנוזל מהמזהמים בו‬
‫דוד יודברובסקי‬
211978
211997
RECORD CARRIER COMPRISING AN
ADDITIONAL SYNC-COLOR
PATTERN AND METHOD AND
DEVICE FOR USE WITH SUCH
RECORD CARRIER
KONINKLIJKE PHILIPS
ELECTRONICS N.V.
EP
02079642.1 05/11/2002
PCT/IB/2003/004909
WO/2004/042720
12/09/2005
G11B )2010.01(
‫נשא מקליט המכיל בנוסף תזמון תבנית‬
‫צבע ושיטה והתקן לשימוש בו יחד עם‬
‫הנשא המקליט‬
211999
MULTI-THREAT DETECTION
SYSTEM AND METHOD
QYLUR SECURITY SYSTEMS
US
60/608689
10/09/2004
60/680313
13/05/2005
US
97
H04B )2010.01(
)UWB( ‫מקלט אולטרה–רחב סרט‬
‫אלביט מערכות בע"מ‬
ULTRA WIDEBAND RECEIVER
ELBIT SYSTEMS LTD.
04/11/2003
B01D )2010.01(
G01M )2010.01(
‫מערכת ושיטה לאיתור של מספר איומים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
11/223494
US
PCT/US/2005/032690
WO/2007/013879
09/09/2005
12/09/2005
212000
MULTI-THREAT DETECTION
SYSTEM AND METHOD
QYLUR SECURITY SYSTEMS
US
60/608689
10/09/2004
60/680313
13/05/2005
US
11/223494
09/09/2005
US
PCT/US/2005/032690
WO/2007/013879
29/03/2011
‫מערכת ושיטה לאיתור של מספר איומים‬
212020
212026
EMERGECY RADIO ACTIVATED
ALARM
IZRO BINYAMINOV
98
E05B )2010.01(
‫מנעול ושיטה עבורו‬
‫עזרא סיטון‬
A LOCK AND METHOD THEREFOR
EZRA SITON
29/03/2011
B60K )2010.01(
‫גיר רציף‬
‫גד תבורי‬
CONTINUOUS
GAD TAVORI
29/03/2011
G01M )2010.01(
212027
G08B )2010.01(
‫מתריע שקט מופעל רדיו למצבי חרום‬
‫איזרו בינימינוב‬
May 31, 2011-‫כ"ז באייר התשע"א‬
29/03/2011
212028
THE SCHEME-TECHNICAL STRONG
NOISE OPTIMAL PROCESSING ON
ITS BACKGROUND OF WEAK
SIGNAL FOR OVERCOMING THE
RECEIVER'S SENSITIVITY
THRESHOLD AND INCREASING ITS
PROTECTION FROM EXTERNAL
CONTINUOUS INTERFERENCES
BUNIN ILIA
99
H04B )2010.01(
‫עיבוד סכמה–טכני אופטימלי של רעש חזק‬
‫על רקע אות חלש להתגברות על סף‬
‫רגישות המקלט ושיפור הגנתו מפני‬
‫הפרעות חיצוניות מתמשכות‬
‫גנאדי בונין‬
May 31, 2011-‫כ"ז באייר התשע"א‬
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may, within three months from the date of this journal,
give to the Commissioner of Patents notice
under Section 30 of the Patents Law, in the
manner prescribed in regulations 57 et seq of
the Patents Regulations, 5728-1968
Particulars of the applications, where applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the language in which the specification is drawn up)
*Note:, patent applications published in this
journal were classified according to the
International Classification version that was
in force when this journal was prepared.
100
- ‫ לחוק הפטנטים תשכ"ז‬26 ‫הודעה לפי סעיף‬
1976
‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬
‫ כל המעונין‬.‫ לחוק הפטנטים‬17 ‫לפי סעיף‬
‫להתנגד למתן פטנט על פי בקשה מהבקשות‬
‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬
‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬
‫ לחוק‬30 ‫הודעת התנגדות לפי סעיף‬
‫ ואילך‬57 ‫הפטנטים בדרך הקבועה בתקנה‬
.1968 – ‫ תשכ"ח‬,‫לתקנות הפטנטים‬
‫פרטי הבקשות במידה ויישימים מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה‬
‫שם האמצאה‬
‫תאריך הבקשה‬
‫מספר ותאריך של בקשות החוץ – מדינת‬
‫האגוד‬
‫*סיווג בינלאומי‬
‫בקשה לפטנט מוסף‬
‫בקשת חלוקה‬
‫המבקש‬
‫הממציא‬
‫מס' פרסום של בקשה הבינלאומית‬
‫מען למסירת מסמכים‬
)‫תקציר האמצאה (בשפה בה ערוך הפירוט‬
‫ בקשות הפטנטים שפורסמו ביומן‬:‫**הערה‬
‫זה סווגו בהתאם לגרסת הסיווג הבינלאומי‬
‫שהייתה בתוקף בעת הכנת הבקשות‬
.‫לפרסום‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
137037
]54[
IL-18 RECEPTOR BETA
]22[
]31[
22.01.1999
60/072301
]32[ 23.01.1998
]33[
60/078835
20.03.1998
Int. Cl.(2010.01) C07K 14//715, C12N 15//12
IMMUNEX CORPORATION, U.S.A.
WO/1999/037773
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
IL–18 –‫קולטן בטה ל‬
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention is directed to purified and isolated novel ACPL polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of
such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
The applications for division
from this application have
not yet been published
,212140
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
101
141877
]54[
USES OF ANTIBODIES TO VLA-4,
VCAM-1 OR ALPHA4/BETA7
INTEGRIN FOR THE
PREPARATION OF
PHARMACEUTICAL
COMPOSITIONS
]22[
]31[
]51[
]71[
]87[
]74[
13.09.1999
60/100182
]32[ 14.09.1998
]33[ US
Int. Cl.(2010.01) A61K 39//395, A61P 19//00, 35//00, C07K 14//705, 16//18, 16//28
BIOGEN IDEC MA INC., U.S.A.
WO/2000/015247
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
May 31, 2011-‫כ"ז באייר התשע"א‬
‫ או‬VCAM–1,VLA–4 ‫שימושים בנוגדנים נגד‬
‫ בהכנת‬ALPHA4/BETA7 INTEGRIN
‫תכשירי רוקחות‬
]57[
JERUSALEM 91013
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
Antagonists of alpha4 integrin/alpha4 integrin ligand adhesion, which inhibit the biological effects of such adhesion are described and methods for their use are detailed.
Such antagonists are useful in suppressing bone destruction associated with multiple
myeloma. The homing of multiple myeloma cells to bone marrow and their alpha4
integrin-dependent release of bone-resorbing factors, resulting in bone destruction in
patients with multiple myeloma, is inhibited.
,197686
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
‫אנטיגנים של סטרפטוקוקוס‬
]54[
STREPTOCOCCUS ANTIGENS
]22[
]31[
]51[
]71[
20.12.1999
60/113800
]32[ 23.12.1998
]33[ US
Int. Cl.(2010.01) A61K 39//09, C07K 14//315, C12N 15//31, 15//62
ID BIOMEDICAL CORPORATION,
CANADA
WO/2000/039299
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
Streptococcus proteins and polynucleotides encoding them are disclosed. Said proteins
are antigenic and therefore useful vaccine components for the prophylaxis or therapy
of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus
bacterial infection.
]87[
]74[
]57[
102
143905
May 31, 2011-‫כ"ז באייר התשע"א‬
,194230
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
145638
]54[
C10 ESTER SUBSTITUTED
TAXANES AS ANTITUMOR
AGENTS
]22[
]31[
]51[
02.02.2001
60/179782
]32[ 02.02.2000
]33[ US
Int. Cl.(2010.01) A61K 31//337, 31//559, A61P 35//00, C07D 30/5/00, 30/5/14,
40/5/12, 40/7/12, 40/9/12
FLORIDA STATE UNIVERSITY
RESEARCH FOUNDATION, INC.,
U.S.A.
WO/2001/057032
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
7 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Taxanes having an ester substituent at C(10), a hydroxy substituent at C(7), and a
range of C(2), C(9), C(14), and side chain substituents.
]71[
]87[
]74[
]57[
‫ כגורמים‬C10–‫טקסנים מותמרים באסטר ב‬
‫אנטי סרטניים‬
__________________
]11[]21[
103
]54[
USE OF A LIPOSOME
ENCAPSULATED VINCRISTINE
FOR THE PREPARATION OF A
PHARMACEUTICAL
COMPOSITION FOR TREATING
CANCER
]22[
]31[
31.03.2000
60/127444
60/137194
]32[
01.04.1999
02.06.1999
145720
‫שימוש בוינקריסטין בקפסולת ליפוסומים‬
‫להכנת תכשיר רפואי לטיפול בסרטן‬
]33[
US
US
May 31, 2011-‫כ"ז באייר התשע"א‬
]51[
]71[
]87[
]74[
]57[
Int. Cl.(2010.01) A61K 09//00, 09//127, 31//475, 31//704
BOARD OF REGENTS, THE
UNIVERSITY OF TEXAS SYSTEM,
U.S.A.
HANA BIOSCIENCES INC., U.S.A.
WO/2000/059473
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
This invention provides methods for treating neoplasias in a mammal. In particular, the
invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration
of liposome-encapsulated vinca alkaloids, e.g. vincristine, to a mammal with a lymphoma.
The applications for division
from this application have
not yet been published
,212390,212389
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
‫שימוש של מדכא סוכר אמינו של סינטוז‬
‫ בייצור של‬GLUCOSYLCERAMIDE
‫תרופות‬
]54[
USE OF IMINO SUGAR
INHIBITOR OF
GLUCOSYLCERAMIDE
SYNTHESIS IN THE
MANUFACTURE OF
MEDICAMENTS
]22[
]31[
]51[
]71[
20.04.2000
9909064.9
]32[ 20.04.1999
]33[ GB
Int. Cl.(2010.01) A61K 31//445, 31//5375, 31//54, 31//70, 31//7032
ACTELION PHARMACEUTICALS
LTD., SWITZERLAND
STEVEN WALKLY, GORDON D.
HOLT
WO/2000/062780
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
The present invention relates to the treatment of conditions such as Niemann-Pick C
]72[
]87[
]74[
]57[
104
145907
May 31, 2011-‫כ"ז באייר התשע"א‬
storage disease, Alzheimer's disease, epilepsy, stroke and Parkinson's disease, and in
particular to the use of inhibitors of glucosylceramide synthesis in such treatment. Preferred inhibitors of glucosylceramide synthesis are imino sugar-structured, and include
N-butyldeoxynojirimycin (NB-DNJ), N-butyldeoxygalactonojirimycin (NB-DGJ) and
N-nonyldeoxynojirimycin (NN-DNJ).
__________________
]11[]21[
‫שיטות סינטזה אסימטרית של אנאנטיומטרים‬
‫של קאסודקס‬
]54[
METHODS OF
ASYMMETRICALLY
SYNTHESIZING ENANTIOMERS
OF CASODEX
]22[
]31[
]51[
]71[
]87[
]74[
18.10.2000
60/160412
]32[ 19.10.1999
]33[ US
Int. Cl.(2010.01) C07B 53//00, C07C 31/5/02, 31/7/46, 31/9/20, 32/3/60
BIOCON LIMITED, INDIA
WO/2001/028990
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
A method of synthesizing pure enantiomers of acylanalides such as Casodex® (bicalutamide) and its derivatives includes contacting a compound having a ring structure
that, when opened, provides a substituent having the structure of Formula (I), with a
compound having a structure of the Formula (II): R7-R6-X1H, under conditions sufficient to provide a compound having the structure of Formula (III) wherein X2 is oxygen, sulphur, sulphinyl (-SO-), sulphonyl (-SO2-), imino (-NH-), oxidized imino alkylimino (-NR8-) where R8 is alkyl having up to 6 carbon atoms, or oxidized alkylimino. The method further includes treating the compound of Formula (III) under
conditions sufficient to provide a pure enantiomer of acylanalides such as Casodex®
(bicalutamide) and/or derivatives thereof. In preferred embodiments, R1 is methyl, R2
is methylene, R6 is a direct link, R7 is 4-fluorophenyl, X1 is sulphur, the compound of
Formula (II) is 4-fluorobenzenethiol, and X2 is sulphonyl. Methods of synthesizing
acylanalides such as Casodex® (bicalutamide) and/or derivatives thereof from a starting material of citramalic acid are also provided.
]57[
105
149056
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
‫רזולוציה של חומרי ביניים בסינטזה‬
‫שלביקאלוטמיד הטהור בעיקרו‬
]54[
RESOLUTION OF
INTERMEDIATES IN THE
SYNTHESIS OF SUBSTANTIALLY
PURE BICALUTAMIDE
]22[
]31[
]51[
25.10.2000
60/161884
]32[ 27.10.1999
]33[ US
Int. Cl.(2010.01) C07B 57//00, C07C 22/9/22, 22/9/40, 31/5/06, 31/7/44, 32/3/62,
59//305, 59//64
BIOCON LIMITED, INDIA
WO/2001/034563
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
A method of preparing a substantially pure enantiomer of an acylanilide such as Casodex® (bicalutamide) and/or its derivatives includes resolving an intermediate compound having the structure of Formula (I), wherein: R1 is alkyl or haloalkyl having up
to 4 carbons; R2 is alkyl having up to 6 carbon atoms; R3 is a direct link or alkyl having up to 6 carbon atoms; R4 is alkyl, alkenyl, hydroxyalkyl or cycloalkyl each of up
to 6 carbons; or R4 is phenyl which bears one, two or three substituents independently
selected from hydrogen, halogen, nitro, carboxy, carbamoyl and cyano, and alkyl,
alkoxy, alkanoyl, alkylthio, alkylsulphinyl, alkylsulphonyl, perfluoroalkyl, perfluoroalkylthio, perfluoroalkylsulphinyl, perfluoroalkylsulphonyl, alkoxycarbonyl and Nalkylcarbamoyl each of up to 4 carbon atoms, and phenyl, phenylthio, phenylsulphinyl
and phenylsulphonyl; or R4 is naphthyl; or R4 is a 5- or 6-membered saturated or unsaturated heterocyclic which contains one, two or three heteroatoms selected from oxygen, nitrogen and sulfur, which heterocyclic may be a single ring or may be fused to a
benzo-ring, and which heterocyclic is unsubstituted or bears one or two halogen, cyano
]71[
]87[
]74[
]57[
106
149256
May 31, 2011-‫כ"ז באייר התשע"א‬
or amino, or alkyl, alkoxy, alkylthio, alkylsulphinyl or alkylsulphonyl each of up to 4
carbon atoms, or oxy or hydroxy substituents, or which if sufficiently saturated may
bear one or two oxo substituents; and X1 is oxygen, sulfur, sulphinyl (-SO-), sulphonyl
(-SO2-), imino (-NH-) or alkylimino (-NR5-) where R5 is alkyl having up to 6 carbon
atoms. The resolved intermediate compound of Formula (I) is then treated under conditions sufficient to provide a substantially pure enantiomer of an acylanilide such as
Casodex® (bicalutamide) and/or its derivatives.
__________________
]11[]21[
149498
‫תכשיר רוקחי בצורת תרחיף הכולל‬
‫אוקסקארבאזפין‬
]54[
PHARMACEUTICAL
COMPOSITION IN THE FORM OF
A SUSPENSION COMPRISING
OXCARBAZEPINE
]22[
]31[
]51[
]71[
]87[
]74[
19.12.2000
9930058.4
]32[ 20.12.1999
]33[ GB
Int. Cl.(2010.01) A61K 09//00, 09//10, 31//55
NOVARTIS AG, SWITZERLAND
WO/2001/045671
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
This invention provides a pharmaceutical composition in the form of a suspension
comprising oxcarbazepine.
]57[
__________________
]11[]21[
]54[
107
FORMULATION COMPRISING NACETYL-L-TRYPTOPHAN AND
150548
‫ – טריפטופן‬L – ‫ – אצטיל‬N ‫תכשיר המכיל‬
‫ומגנזיום סולפט ושימושו בהכנת תרופות לטיפול‬
May 31, 2011-‫כ"ז באייר התשע"א‬
‫ עמוד שדרה ועצבים‬,‫בפגיעות מוח‬
MAGNESIUM SULPHATE AND
USE THEREOF FOR THE
PREPARATION OF
MEDICAMENTS FOR THE
TREATMENT OF BRAIN, SPINAL
CORD AND NERVE INJURY
]22[
]31[
]51[
]71[
]87[
]74[
]57[
18.01.2001
PQ5146
]32[ 18.01.2000
]33[ AU
Int. Cl.(2010.01) A61K 45//00
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2001/052844
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A treatment for brain, spinal and nerve injury comprising use of a substance P receptor
antagonist optionally in combination with a magnesium compound. There is also provided a formulation for use in this treatment comprising a substance P receptor antagonist and a magnesium compound.
__________________
]11[]21[
‫–ניטרואקרידין‬1–‫–אלקילאמינו‬9 ‫תולדות‬
]54[
9-ALKYLAMINO-1NITROACRIDINE DERIVATIVES
]22[
]31[
]51[
]71[
16.02.2001
60/183530
]32[ 18.02.2000
]33[ US
Int. Cl.(2010.01) C07D 21/9/00, 21/9/06
NEW YORK MEDICAL COLLEGE,
U.S.A.
WO/2001/060801
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
The invention is directed to novel 9-hydroxyalkylamino-, 9-alkoxyalkylamino-1nitroacridine derivatives. Methods of preparation, pharmaceutical compositions comprising said derivatives and their medical use are also encompassed by this invention.
]87[
]74[
]57[
108
150979
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
152272
‫מבנה חומצת גרעין הכולל רצף חומצת גרעין‬
‫המווסת ביטוי‬
]54[
NUCLEIC ACID CONSTRUCT
COMPRISING AN EXPRESSIONREGULATING NUCLEIC ACID
SEQUENCE
]22[
]31[
]51[
]71[
17.04.2001
00201343.1
]32[ 13.04.2000
]33[ EP
Int. Cl.(2010.01) C07K 14//37, C12N 09//30, 15//56, 15//80
DYADIC INTERNATIONAL (USA),
INC.
WO/2001/079507
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The invention pertains to novel proteins corresponding to Chrysosporium glycosyl
hydrolases of families 7 and 10, exhibiting a minimum aminoacid identity of 70 and 75
%, respectively, with the amino acid sequence of SEQ ID No's 2 and 4, and to a protein corresponding to a Chrysosporium glyceraldehyde phosphate dehydrogenase, exhibiting at least 86 % amino acid identity with the partial amino acid sequence of SEQ
ID No. 6. The invention further relates to nucleic acid sequences encoding these proteins, and especially to promoter sequences regulating the expression of the corresponding genes. The preferred host for expressing these genes is a fungus, especially a
Chrysosporium strain.
__________________
]11[]21[
]54[
109
NASAL SPRAY FOR DELIVERING
PHARMACEUTICAL
COMPOSITION COMPRISING A
FENTANYL SALT AND USE OF A
FENTANYL SALT FOR THE
PREPARATION OF A
154041
‫תרסיס נחירי להעברת תכשיר פרמצאוטי‬
‫המכיל מלח פנטניל ושימוש במלח פנטניל‬
‫להכנת תרופה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
MEDICAMENT
]22[
]31[
]51[
]71[
]87[
]74[
]57[
31.07.2001
PA200001154 ]32[ 31.07.2000
]33[ DK
Int. Cl.(2010.01) A61K 31//4468, A61P 25//04, C07D 21/1/58
NYCOMED DANMARK A/S,
DENMARK
WO/2002/009707
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
The treatment of acute pain with a sufficient dosage by intranasal administration of
fentanyl results in a time to onset of action comparable to intravenous administration
and a significantly faster onset of action than nasal titration of fentanyl. The nasal administration of a sufficient amount of fentanyl to obtain pain relief has lower maximum plasma concentrations comparable to intravenous administration and results in
lower rates of adverse events like respiratory depression, nausea and vomiting. Compositions fur use in the method are also disclosed.
__________________
]11[]21[
110
155265
‫תכשיר קוטל מזיקים המכיל דלתמתרין‬
‫ואצטמיפריד‬
]54[
PESTICIDAL COMPOSITION
COMPRISING DELTAMETHRIN
AND ACETAMIPRID
]22[
]31[
]51[
]71[
]87[
]74[
20.09.2001
00121924.5
]32[ 07.10.2000
]33[ EP
Int. Cl.(2010.01) A01N 47//40, 53//08, C07C 25/5/39, C07D 21/3/36
NIPPON SODA, JAPAN
WO/2002/030200
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
May 31, 2011-‫כ"ז באייר התשע"א‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
Pesticidal compositions comprising deltamethrin and acetamiprid.
__________________
]11[]21[
111
155279
]54[
USE OF A WISP POLYPEPTIDE
FOR THE PREPARATION OF
MEDICAMENTS FOR THE
TREATMENT OF MAMMALIAN
CARTILAGE CELLS OR
MAMMALIAN CARTILAGE
TISSUE DAMAGED FROM A
DEGENERATIVE
CARTILAGENOUS DISORDER OR
INJURY
]22[
]31[
]51[
]71[
]87[
]74[
12.10.2001
60/241222
]32[ 16.10.2000
]33[
Int. Cl.(2010.01) A61P 19//02, C12N 15//12
GENENTECH, INC., U.S.A.
WO/2002/033085
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The present invention relates to methods for the treatment and repair of cartilage, including cartilage damaged by injury or degenerative cartilagenous disorders, including
arthritis, comprising the administration of WISP polypeptide. Optionally, the administration may be in combination with one or more cartilage agents (e.g., peptide growth
factor, catabolism antagonist, osteo-, synovial, anti-inflammatory factor). Alternatively, the method provides for the treatment and repair of cartilage damaged by injury or
degenerative cartilagenous disorders comprising the administration of WISP polypeptide in combination with standard surgical techniques. Alternatively, the method provides for the treatment and repair of cartilage damaged by injury or degenerative cartilagenous disorders comprising the administration of chondrocytes previously treated
with an effective amount of WISP polypeptide.
‫ להכנת תרופות‬WISP ‫שימוש בפוליפפטידים‬
‫לטיפול בתאי סחוס מיונקים או ברקמת סחוס‬
‫פגועה ממחלה ניוונית של הסחוס או מפציעה‬
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
May 31, 2011-‫כ"ז באייר התשע"א‬
The applications for division
from this application have
not yet been published
,200484
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
156280
‫צורה גבישית של מלח אטורוואסטאטין קלציום‬
‫ תהליך להכנתו ופורמולציה המכילה אותו‬,)2:1(
]54[
CRYSTALLINE POLYMORPHIC
FORM OF ATORVASTATIN CA
(2:1), PROCESS FOR ITS
PREPARATION AND
PHARMACEUTICAL
COMPOSITION COMPRISING IT
]22[
]31[
]51[
]71[
19.12.2001
00811249.2
]32[ 27.12.2000
]33[ EP
Int. Cl.(2010.01) A61K 31//40, A61P 03//06, C07D 20/7/34
TEVA PHARMACEUTICAL
‫ פתח‬,‫טבע תעשיות פרמצבטיות בע"מ‬
INDUSTRIES LTD.
‫תקווה‬
]87[
]57[
WO/2002/051804
The present invention is directed to new crystalline forms of Atorvastatin calcium
(2:1), referred to hereinafter as polymorphic Forms X, A, B, B2, C, D and E. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and pharmaceutical compositions comprising the crystalline forms.
__________________
]11[]21[
112
157705
‫פפטידים מלאכותיים אנטאגוניסטים לגורם‬
‫גידול דומה אינסולין ותכשירים וערכות‬
‫המכילים אותם‬
]54[
ARTIFICIAL IGF ANTAGONIST
PEPTIDES AND COMPOSITIONS
AND KITS COMPRISING SAME
]22[
]31[
]51[
]71[
]87[
]74[
13.03.2002
60/275904
]32[ 14.03.2001
]33[ US
Int. Cl.(2010.01) A61K 45//00, A61P 03//08, 09//00, 35//00, 43//00, C07K 07//08
GENENTECH, INC., U.S.A.
WO/2002/072780
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
May 31, 2011-‫כ"ז באייר התשע"א‬
‫רמת החייל‬
RAMAT HACHAYAL 69710
]57[
Peptides are provided that antagonize the interaction of IGF-1 with its binding proteins, insulin receptor, and IGF receptor. These IGF antagonist peptides are useful in
treating disorders involving IGF-1 as a causative agent, such as, for example, various
cancers.
__________________
]11[]21[
]54[
METHOD FOR REMOVING
TOXIC GASES FROM WASTE
GAS
]22[
]51[
]71[
]72[
10.12.2003
Int. Cl.(2010.01) B01D 53//14, 53//64
LEXTRAN LTD.
GREGORY PIPKO, ALBERT
MEINTZ, HAIM STERNFINE,
AHARON ARNON
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
113
159305
‫שיטה לסילוק גזים רעילים מגזי פליטה‬
‫ קצרין‬,‫לקסטרן בע"מ‬
,‫ חיים שטרנפיין‬,‫ אלברט מיינץ‬,‫גרגורי פיפקו‬
‫אהרון ארנון‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A method for removing mercury vapors from waste gas generated by chemical and
industrial processes, or from combustion flue gas, comprising contacting said waste
gas in an oxidation environment with a scrubbing agent comprising organic sulfoxides.
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
160131
‫הרכב טופיקלי לשחרור של מעכב אורניטין‬
‫דהקרבוקסילאז באופן ממוקד לזקיק‬
]54[
TOPICAL COMPOSITION FOR
FOLLICULAR DELIVERY OF AN
ORNITHINE DECARBOXYLASE
INHIBITOR
]22[
]31[
]51[
]71[
]87[
]74[
13.08.2002
60/312657
]32[ 15.08.2001
]33[ US
Int. Cl.(2010.01) A61K 31//13
SKINMEDICA, INC., U.S.A.
WO/2003/015729
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Polyethylene glycol ethers of alkyl alcohols having the general formula
CH3(CH2)xCH2(OCH2CH2)nOH wherein x is 8 to 20 (of which ceteareth-20, steareth-20 and steareth-100 are preferred), poloxamer 185, poloxamer 407, N,N-dimethyl
dodecylamine N-oxide, and mixtures thereof, are employed to increase follicular delivery and/or follicular residence time of certain water soluble ornithine decarboxylase
inhibitors of which 2(difluoromethyl)-2,5-diamino pentanoic acid and its pharmaceutically acceptable salts, hydrates, optical enantiomers and racemic mixture are preferred.
]57[
__________________
]11[]21[
]54[
DIAGNOSTIC DATA
INTERCHANGE
]22[
]31[
]51[
]71[
04.09.2002
09/946461
]32[ 04.09.2001
]33[
Int. Cl.(2010.01) A47J 37//12, G06Q 10//00
TECHNOLOGY LICENSING
CORPORATION, U.S.A.
WO/2003/021399
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
114
160747
‫חילוף מידע דיאגנוסטי‬
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]57[
‫רמת החייל‬
The present invention provides a bi-directional communication network (100) which
provides monitoring, data collection, and control of food service industry operations.
The system includes a computer and control logic (170) implemented by the computer
which may be configured to perform various tasks. A communication network (100)
may be provided linking the computer with equipment and appliances (110) having a
microprocessor based controller (140) capable of communicating with the system
(100). In one embodiment, the system (100) automatically verifies the performance of
equipment- related manual tasks in food preparation. In another embodiment, the system provides a hold timer for tracking the hold time of cooked food products and determines when the hold time elapses. In yet another embodiment, the system manages
the inventory of cooked food products in a food preparation establishment.
__________________
]11[]21[
‫חיידקים יוצרי חומצת חלב לשמוש כאורגניזמים‬
‫פרוביוטיים בנרתיק אנושי‬
]54[
LACTIC ACID PRODUCING
BACTERIA FOR USE AS
PROBIOTIC ORGANISMS IN THE
HUMAN VAGINA
]22[
]31[
]51[
]71[
]72[
19.09.2002
0103127-7
]32[ 20.09.2001
]33[ SE
Int. Cl.(2010.01) A61K 35//74
ELLEN AB, SWEDEN
CAROLINA SAMUELSSON, ENDRE
KVANTA, ANNA WEINER JIFFER
WO/2003/038068
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
7 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention discloses novel isolated strains of lactic acid producing bacteria
]87[
]74[
]57[
115
160937
May 31, 2011-‫כ"ז באייר התשע"א‬
of the genera Lactobacillus and Pediococcus, and a method for isolation of such bacterial strains, having the ability to colonise and become established in a human vagina,
even during menstrual discharge. Furthermore, a composition comprising said bacterial strains and a sanitary article comprising said bacterial strains, such as a tampon, for
prophylaxis and/or treatment of infections of the urogenital tract, are described. The
present invention also describes a method for prophylaxis and/or treatment of infections of the urogenital tract, wherein at least one of said bacterial strains are administered vaginally.
__________________
]11[]21[
161358
‫תהליך להכנת תרכובות אינסולין‬
]54[
PROCESS FOR PREPARING
INSULIN COMPOUNDS
]22[
]31[
]51[
]71[
]87[
]74[
15.11.2002
PA200101716 ]32[ 19.11.2001
]33[ DK
Int. Cl.(2010.01) C07K 01//02, 01//10, 14//62, C12P 21//00, 21//02
NOVO NORDISK A/S, DENMARK
WO/2003/044210
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]57[
A preferred way of converting insulin precursors into insulin compounds is to perform
an enzymatic peptide cleavage in an aqueous medium and, thereafter, without removal
of the intermediate product formed, to add an amino acid ester or a peptide ester and
an organic solvent so that the desired coupling takes place.
__________________
]11[]21[
116
]54[
METHOD AND APPARATUS FOR
OPTICAL AUTHENTICATION
]22[
]51[
19.05.2004
Int. Cl.(2010.01) G06K 07//14
162063
‫מכשיר לזיהוי אופטי‬
May 31, 2011-‫כ"ז באייר התשע"א‬
‫ כרמיאל‬,‫שמואל קוסולאפוב‬
‫שמואל קוסולאפוב‬
,‫שמואל קוסולאפוב‬
9 ‫רח' צופית‬
‫כרמיאל‬
]71[
]72[
]74[
SAMUEL KOSOLAPOV
SAMUEL KOSOLAPOV
SAMUEL KOSOLAPOV,
9 TZOFIT ST., CARMIEL
]57[
An optical authentication device comprising:
a plurality of elements having optical polarizing properties distributed in a pseudo
random manner over a predetermined area;
at least three optically detectable markers positioned in predetermined positions with
respect to the predetermined area;
whereby, when viewing the predetermined area with an optical imaging sensor of a
reader under an illumination having specific polarization properties a first image is
obtained that is different from one or more other images obtained under one or more
illuminations having different polarization properties, thus by comparing two or more
images of at least a portion of the device to saved images of the same device or a portion thereof taken under the same illuminations, using the markers for aligning images
to be compared, authentication is achieved.
__________________
]11[]21[
‫שיטה לסולפונציה של תרכובות המכילות‬
‫קבוצות הידרוקסיל חופשיות או אמינים‬
‫ראשיים או משניים‬
]54[
METHOD FOR THE
SULFONATION OF COMPOUNDS
COMPRISING FREE HYDROXYL
(OH) GROUPS OR PRIMARY OR
SECONDARY AMINES
]22[
]31[
]51[
]71[
28.11.2002
01/15444
]32[ 29.11.2001
]33[ FR
Int. Cl.(2010.01) C07B 45//00, C07C 30/3/00, C08B 37//00, 37//02
ORGANES, TISSUS:
REGENERATION, REPARATION,
REMPLACEMENT-OTR3, FRANCE
WO/2003/046014
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The invention concerns a method for sulfonation of a compound having one or several
free hydroxyl functions and/or one or several substituted or unsubstituted primary or
secondary amine functions. The invention is characterized in that it comprises treating
said compound with the SO3-DMF complex in the presence of an acid capturing agent.
The acid capturing agent is advantageously selected in the group comprising alkenes or
May 31, 2011-‫כ"ז באייר התשע"א‬
]87[
]74[
]57[
117
162192
alkines with boiling point lower than 100 °C or a mixture thereof.
__________________
]11[]21[
163216
‫נגזרות של נפתוכינון ושימושן לטיפול במחלות‬
‫של הלב וכלי הדם ושל גידולים ממאירים‬
]54[
NAPHTHOQUINONE
DERIVATIVES AND THEIR USE
FOR TREATING
CARDIOVASCULAR DISEASES
AND MALIGNANCIES
]22[
]51[
]71[
26.07.2004
Int. Cl.(2010.01) C07C 50//00, 50//12
BEN GURION UNIVERSITY OF
‫ הרשות למחקר‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
THE NEGEV RESEARCH AND
‫ באר שבע‬,‫ופיתוח‬
DEVELOPMENT AUTHORITY
YOSSI GRANOT, SHMUEL
‫ שמואל ביטנר‬,‫יוסי גרנות‬
BITTNER
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A compound of formula (II) as depicted in the specification wherein R1 is selected
from H, C1-C6alkylamino, heterocycle comprising 1 or 2 nitrogen atoms and from 4 to
6 carbon atoms; R2 is selected from H, C1-C6alkyl, aryl comprising from 5 to 14 carbon atoms, and aralkyl comprising from 8 to 18 carbon atoms; and R5 is selected from
H, hydroxyl, fluoro, chloro, bromo, iodo, amino, C 1-C6alkyl, and C1-C6alkoxy.
]72[
]74[
]57[
__________________
]11[]21[
118
]54[
DERIVATIVES OF 4(DIARYLMETHYL)-PIPERAZINE
AND PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]22[
27.03.2003
164196
‫–(די–ארילמתיל)–פיפראזין ותכשירי‬4 ‫נגזרות‬
‫רוקחות המכילים אותן‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]31[
]51[
]71[
]72[
]87[
]74[
]57[
302/MUM/2002 ]32[ 27.03.2002
]33[ IN
Int. Cl.(2010.01) A61K 31//495, A61P 37//08, C07D 29/5/08
SUN PHARMA ADVANCED
RESEARCH COMPANY (SPARC
LTD.), INDIA
AJAY SOHANLAL MIDHA, HEMANT
ASHVINBHAI CHOKSHI, TRINADHA
RAO CHITTURI, RAJAMANNAR
THENNATI
WO/2003/079970
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A compound of formula (I) wherein X, Y, X' & Y' are selected from hydrogen, halogen, substituted or unsubstituted alkyl (linear, branched or cyclo), aryl, alkyloxy and
haloalkyl group; R1, R2, R3 & R4 are selected from hydrogen, substituted or unsubstituted alkyl groups (linear, branched or cyclo), aryl, heteroaryl groups or aralkyl groups,
heterocycles containing one or more of hetero atoms (viz., N, S, O), substituted or unsubstituted alkenyl or alkynyl groups of carbon 2 to 6, wherein the substituents R1 &
R2 on the piperazinyl moiety are either syn or anti to each other and optionally R3 and
R4 together with the carbons to which they are attached form a monocyclic saturated
or aryl or substituted aryl or heteroaryl or substituted heteroaryl ring containing one or
more hetero atoms selected from N, S and O with a ring size ranging from 3 to 6; with
a proviso that when R3 & R4 together do not form part of a ring they may exist in either E or Z configuration;R5 is (CH2)n-O-CH2-CO-Z wherein n is 1 to 6; Z is selected
from OH, OR, NRR', N(OR)R', N(R)-N(R)R' and wherein R & R' are selected from
hydrogen, substituted or unsubstituted alkyl groups (linear, branched or cyclo), aryl,
heteroaryl groups or aralkyl groups, heterocycles containing one or more of hetero
atoms (viz., N, S, O), substituted or unsubstituted alkenyl or alkynyl groups of carbon
2 to 6; and B is selected from -(CH2)n- (n is 1 to 6) and -(CH2)x-D-(CH2)y where D is
O, NR, S or SO2, x and y are independently 1 to 6; and m is selected from 1 to 6; and
pharmaceutically acceptable salts thereof.
__________________
]11[]21[
]54[
119
ANTICOAGULANT FUSION
PROTEINS
164733
‫חלבוני איחוי הפועלים כנוגדי קרישה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
30.04.2003
60/376566
]32[ 01.05.2002
]33[ US
Int. Cl.(2010.01) A61K 39//395, 48//00, A61P 07//02, 29//00, 35//00, C07K 14//485,
14//745, 16//36, 16//40, 19//00, C12N 15//13
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT,
GERMANY
WO/2003/092602
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
This invention relates to novel fusion proteins which are comprised of a targeting protein that binds tissue factor (TF), which is operably linked to the thrombomodulin (TM
) EGF456 domain alone or in combination with at least one other TM domain selected
from the group consisting of the N-terminal hydrophobic region domain, the EGF123
domain, the interdomain loop between EGF3 and EGF4, and the O-glycosylated
Ser/Thr-rich domain, or analogs, fragments, derivatives or variants thereof. The fusion
protein binds at the site of injury and prevents the initiation of thrombosis. The fusion
protein can be used to treat a variety of thrombotic conditions including but not limited
to deep vein thrombosis, disseminated intravascular coagulation, and acute coronary
syndrome.
__________________
]11[]21[
120
]54[
STABLE ADENOVIRAL VECTORS
AND METHODS FOR
PROPAGATION THEREOF
]22[
]31[
24.04.2003
PCT/NL02/00281
PCT/NL02/00656
02102631.5
]32[
25.04.2002
15.10.2002
25.11.2002
164802
‫וקטורי אדנווירוס יציבים ושיטות להפצתם‬
]33[
WO
WO
EP
May 31, 2011-‫כ"ז באייר התשע"א‬
]51[
]71[
]72[
]87[
]74[
]57[
Int. Cl.(2010.01) C12N 15//09, 15//861
CRUCELL HOLLAND B.V., THE
NETHERLANDS
RONALD VOGELS, JANS EMCO
HAVENGA MENZO, DAVID
ADRIANUS THEODORUS
ZUIJDGEEST
WO/2004/001032
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
The present invention provides methods and means to increase the stability and/or the
packaging capacity of recombinant adenoviruses, by overexpression of pIX in an adenoviral packaging cell, by retaining at least a part of the E1B 55K region in the recombinant adenoviral vector or by regulating pIX with a heterologous promoter. The invention further relates to methods and means for the production of such adenoviruses
on complementing cell lines, wherein the early region 4 open reading frame 6 (E4orf6) encoding nucleic acid is present in the adenovirus and wherein the E4-orf6 gene
product is compatible with one or more products of the E1 gene products in the complementing cell, such that the adenoviral vector can be efficiently produced by the
complementing cell.
__________________
]11[]21[
]54[
[1,4] DIAZEPINO [6,7,1-IJ]
QUINOLINE DERIVATIVES AS
ANTIPSYCHOTIC AND
ANTIOBESITY AGENTS
]22[
]31[
]51[
]71[
]87[
]74[
24.04.2003
60/375,592
]32[ 25.04.2002
]33[ US
Int. Cl.(2010.01) A61K 31//551, A61P 25//00, C07D 47/1/06, 48/7/06
WYETH LLC, U.S.A.
WO/2003/091250
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
7 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Compounds of formula I or pharmaceutically acceptable salts thereof are provided
]57[
121
164806
‫] נגזרת של קווינולין‬IJ – 6,7,1 [ ‫] דיאזפינו‬4,1[
‫כנוגד פסיכוזה וחומר נוגד השמנה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
wherein R1 through R7 are as defined in the specification. The compounds of formula I
are 5HT2c agonists or partial agonists, and are useful for treating a variety of disorders.
__________________
]11[]21[
]54[
N-ACYLMINOBENZENE
DERIVATIVES, PROCESS FOR
THEIR PREPARATION,
MEDICAMENTS CONTAINING
SAME AND USE THEREOF FOR
THE MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF DISEASES
MEDIATED BY MONOAMINE
OXIDASE B INHIBITORS
]22[
]31[
]51[
21.05.2003
02011639.8
]32[ 29.05.2002
]33[ EP
Int. Cl.(2010.01) A61K 31//167, 31//195, 31//221, 31//275, A61P 25//28, C07C
23/5/80, 23/7/22, 25/5/32
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2003/099763
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
This invention relates to N-acylamino aryl derivatives of the general formula (I),
wherein R1 is halogen, halogen-(C1-C6)-alkyl, cyano, C1-C6-alkoxy or halogen-(C1C6)-alkoxy; R21, R22, R23 and R24 independently from each other are selected from the
group consisting of hydrogen, (C1-C6)-alkyl, halogen, halogen-(C1-C6)-alkyl, hydroxy,
]71[
]87[
]74[
]57[
122
165055
,‫ תהליך להכנתן‬,‫– אצילאמינובנזן‬N ‫תולדות‬
‫תרופה הכוללת אותן ושימושן בהכנת תרופות‬
‫לטיפול במחלות המתווכות על ידי מעכבים של‬
B ‫מונואמין אוקסידאז‬
May 31, 2011-‫כ"ז באייר התשע"א‬
C1-C6-alkoxy or -CHO; R3 is hydrogen or C1-C3-alkyl; R4, R5 independently from each
other are selected from the group consisting of hydrogen, C 1-C6-alkyl, C1-C6-alkoxy or
-COO(C1-C6)alkyl; or R4 and R5 form together with the C-atom to which they are attach a C3-C7-cycloalkyl ring; R6 is -CO-NR7R8; -COO(C1-C6)-alkyl, -CN, -NR2 or NHC(O)R; R7 and R8 independently from each other are selected from the group consisting of hydrogen, C1-C6-alkyl, NH2 or hydroxy; R is hydrogen or C1-C6-alkyl; n is 0,
1, 2 or 3. X is -CHRO, -OCHR, -CH2S-, -SCH2-, -CH2CH2-, -CH=CH- or -C≡C-; and
to pharmaceutically active acid addition salts thereof. It has been found that the compounds of general formula (I) are selective monoamine oxidase B inhibitors and they
are therefore useful in the treatment of diseases mediated by monoamine oxidase B
inhibitors, for example for the treatment of Alzheimer’s disease or senile dementia.
__________________
]11[]21[
‫תכשירי אינסולין חומצי בעלי עמידות משופרת‬
]54[
ACIDIC INSULIN PREPARATIONS
WITH IMPROVED STABILITY
]22[
]31[
]51[
05.06.2003
10227232.8
]32[ 18.06.2002
]33[ DE
Int. Cl.(2010.01) A61K 09//08, 38//28, 47//04, 47//10, 47//12, 47//14, 47//26, 47//36,
47//42, A61P 03//10, C07K 14//62
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2003/105888
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
7 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to a pharmaceutical formulation comprising a polypeptide selected from a group containing insulin, an insulin metabolite, an insulin analogue, an insulin derivative or combinations thereof and also comprising a surfactant or combinations of several surfactants, optionally a preservative or combinations of several preservatives and optionally an isotonic agent, buffers or additional auxiliary agents or
combinations thereof. According to the invention, said pharmaceutical formulation has
an acidic pH value.
]71[
]87[
]74[
]57[
123
165788
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
166668
‫תחבושות המכילות טולובוטרול‬
]54[
PATCHES CONTAINING
TULOBUTEROL
]22[
]31[
]51[
]71[
16.06.2004
2003-176799 ]32[ 20.06.2003
]33[ JP
Int. Cl.(2010.01) A61K 09//00, 09//70, 31//135, C07C 21/5/28
TEIKOKU SEIYAKU CO., LTD.,
JAPAN
WO/2004/112770
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
An adhesive patch which comprises a substrate and, superposed thereon, a pressuresensitive adhesive layer comprising a rubber, a tackifier resin, and a softener, wherein
the pressure-sensitive adhesive layer contains tulobuterol as an active ingredient in a
concentration as low as 1 to 4 wt.% in a dissolved state and further contains a higher
fatty acid as a release control agent in an amount of 0.1 to 3 wt.%. The adhesive patch
contains tulobuterol in a low concentration and has the ability to stably control the
release.
]87[
]74[
]57[
__________________
]11[]21[
124
166676
‫התקן קריפטוגרפי לשיטות קשורות‬
]54[
CRYPTOGRAPHIC DEVICE AND
ASSOCIATED METHODS
]22[
]31[
]51[
]71[
]74[
03.02.2005
780848
]32[ 18.02.2004
Int. Cl.(2010.01) H04L 09//06
HARRIS CORPORATION, U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A cryptographic device comprising:
an input stage receiving an input data block and a key data block comprising a plurality of sub-key data blocks, and generating a plurality of first signals therefrom; an in-
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
May 31, 2011-‫כ"ז באייר התשע"א‬
termediate stage connected to the input stage and comprising a plurality of substitution units, each substituting data within a respective first signal, and a diffuser connected to said plurality of substitution units for mixing data to generate a diffused signal;
and an output stage connected to said intermediate stage for repetitively looping back
the diffused signal to said input stage for combination with a next sub-key data block.
The output stage provides an output signal (Y) for the cryptographic device after the
repetitively looping back is complete. The invention enhances the cryptographic
strength of an algorithm such as the advanced encryption standard (AES) algorithm, by
dint of the added diffusion layer associated with the plurality of substitution units and
the diffuser connected thereto. In addition, rather than using the mapping specified in
the AES standard, the substitution units (27a-27n) are comprised of programmable
functions.
125
May 31, 2011-‫כ"ז באייר התשע"א‬
‫__________________‬
‫‪166796‬‬
‫שיטה‪ ,‬מערכת ותוצרת תוכנית מחשב לעיבוד‬
‫מידע של מעקב עצמי של רמות גלוקוז בדם‬
‫להגברת ניהול עצמי של סכרת‬
‫כ"ז באייר התשע"א‪May 31, 2011-‬‬
‫[‪]11[]21‬‬
‫‪METHOD, SYSTEM AND‬‬
‫‪COMPUTER PROGRAM‬‬
‫‪PRODUCT FOR THE‬‬
‫[‪]54‬‬
‫‪126‬‬
PROCESSING OF SELFMONITORING BLOOD GLUCOSE
(SMBG) DATA TO ENHANCE
DIABETIC SELF-MANAGEMENT
]22[
]31[
]51[
]71[
]87[
]74[
]57[
08.08.2003
60/402976
]32[ 13.08.2002
60/478377
13.06.2003
Int. Cl.(2010.01) G06F 19//00
UNIVERSITY OF VIRGINIA
PATENT FOUNDATION, U.S.A.
WO/2004/015539
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A method, system, and computer program product related to the maintenance of optimal control of diabetes, and is directed to predicting the long-term exposure to hyperglycemia, and the long-term and short-term risks of severe or moderate hypoglycemia
in diabetics, based on blood glucose readings collected by a self-monitoring blood glucose device(710). The method, system, and computer program product pertain directly
to the enhancement of existing home blood glucose monitoring devices, by introducing
an intelligent data interpretation component capable of predicting both HbA1c and
periods of increased risk of hypoglycemia, and to the enhancement of emerging continuous monitoring devices by the same features. With these predictions the diabetic
can take steps to prevent the adverse consequences associated with hyperglycemia and
hypoglycemia
__________________
]11[]21[
127
167780
]54[
USPA1 LIGAND AND USES
THEREOF
]22[
]31[
]51[
01.10.2003
0222764.3
]32[ 02.10.2002
]33[ GB
Int. Cl.(2010.01) A61K 39//104, A61P 11//00, 31//04, 35//00, C07K 14//21
‫ ושימושים שלו‬USPA1 ‫ליגנד‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]71[
]87[
]74[
]57[
THE UNIVERSITY OF BRISTOL,
UNITED KINGDOM
WO/2004/031236
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention provides a ligand isolated from Moraxella catarrhalis outer
membrane protein which binds to CEACAM receptors, said ligand comprising a receptor binding domain comprising an amino acid sequence selected from the group disclosed, or a fragment, homologue, functional equivalent, derivative, degenerate or hydroxylation, sulphonation or glycosylation product or other secondary processing
product thereof. The invention also provides medicaments and vaccines comprising
said ligand, and their use in the treatment or prophylaxis of infection. Also provided is
a screening method for the identification of novel therapeutic compounds.
__________________
]11[]21[
]54[
CUTTING TOOL FOR ROTATING
AND DRILLING INTO SOLID
BLOCKS
]22[
]31[
]51[
]71[
12.08.2003
GM550/2002
]32[ 16.08.2002
Int. Cl.(2010.01) B23B 27//04
CERATIZIT AUSTRIA
GESELLSCHAFT M.B.H, AUSTRIA
WO/2004/016378
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]87[
]74[
]57[
128
167867
‫מכשיר חיתוך לרוטציה וקידוח בבלוקים‬
‫מוצקים‬
]33[
AT
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
The invention relates to a cutting tool for rotating and drilling into solid blocks, comprising a drill shank (1) and a cutting head (2) on one end. The cutting head (2) has a
straight, front-face cutting edge (4) extending approximately crosswise in relation to
the drill axis (3). The cutting head (2) also comprises a section (8) protruding from the
shank of the drill (1) at a height (h) ranging from at least 5 % to a maximum of 40 %
of the diameter (d) of the drill and at a width (b) ranging from at least 5 % to a maximum of 40 % of the diameter (d) of the drill. The section (8) comprises a straight, lateral cutting edge (5) which merges into a straight, rear-sided cutting edge (7) extending
in an approximately parallel manner in relation to the front-faced cutting edge (4).
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
‫שיטה להגברת יעילות יוננות בספקטוגרפית‬
‫מסות‬
]54[
METHOD FOR INCREASING
IONIZATION EFFICIENCY IN
MASS SPECTROSCOPY
]22[
]31[
]51[
]71[
]87[
]74[
28.10.2003
60/422393
]32[ 29.10.2002
]33[ US
Int. Cl.(2010.01) G01J 03//28, G01N 30//72
TARGET DISCOVERY, U.S.A.
WO/2004/088271
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A mass spectrometry ionization method in which electrospray droplets or solid sample
matrices are exposed to an ion beam thereby increasing the unbalanced charge of the
analyte is provided. In another embodiment, a mass spectrometry ionization method in
which ionization of the sample is achieved by directing an ion beam at a liquid or solid
sample matrix containing analyte thereby ionizing and adding unbalanced charge to
the analyte is provided.
]57[
The applications for division
from this application have
not yet been published
129
168006
,212234
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
168114
‫הרכבי טראמאדול לשחרור מושהה וטבליה‬
‫המכילה אותו‬
]54[
SUSTAINED-RELEASE
TRAMADOL FORMULATIONS
AND A TABLET CONTAINING
SAME
]22[
]31[
27.10.2003
10/281026
]32[ 25.10.2002
]33[ US
60/510378
10.10.2003
US
Int. Cl.(2010.01) A61K 09//00, 09//20, 09//22, 09//24, 47//36
LABOPHARM INC, CANADA
LABOPHARM EUROPE LIMITED,
IRELAND
LABOPHARM (BARBADOS)
LIMITED, BARBADOS
WO/2004/037222
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A sustained-release tramadol formulation oral administration is provided which, upon
initial administration of one dose, provides an analgesic effect within 2 hours, which
analgesic effect continues for at least 24 hours after administration.
__________________
]11[]21[
]54[
130
PYRIMIDINE-4,6DICARBOXAMIDES FOR THE
168340
‫–פירמידין דיקרבוקסיאמידים למניעה‬4,6
,‫ תהליך להכנתם‬,‫סלקטיבית של קולגנזות‬
‫תכשירים רפואיים המכילים אותם ושימושם‬
May 31, 2011-‫כ"ז באייר התשע"א‬
SELECTIVE INHIBITION OF
COLLAGENASES, PROCESS FOR
THEIR PREPARATION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USES THEREOF
]22[
]31[
]51[
]71[
]87[
]74[
]57[
18.10.2003
10251019.9
]32[ 02.11.2002
]33[ DE
10254092.6
20.11.2002
DE
Int. Cl.(2010.01) A61K 31//506, A61P 19//02, 19//08, 35//00, C07D 23/9/28, 40/1/12,
40/3/12, 40/5/12, 40/5/14, 41/3/12, 41/3/14, 41/7/12
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2004/041788
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Pyrimidine-4,6-dicarboxamides of formula (I), are suitable for the selective inhibition
of collagenase (MMP 13). The pyrimidine-4,6-dicarboxamides can thus be used for the
treatment of degenerative joint diseases.
__________________
]11[]21[
‫נגזרות אימידאזוקווינולין כליגנדים לקולטני‬
A3 ‫אדנוזין‬
]54[
IMIDAZOQUINOLINE
DERIVATIVES AS ADENOSINE A3
RECEPTOR LIGANDS
]22[
]31[
]51[
11.11.2003
P0203976
]32[ 15.11.2002
]33[ HU
Int. Cl.(2010.01) A61K 31//415, A61P 03//00, 09//00, 11//00, 13//12, 17//00, 25//00,
29//00, 35//00, C07D 47/1/00, 47/1/04
SANOFI-AVENTIS, FRANCE
WO/2004/046146
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
]71[
]87[
]74[
131
168516
May 31, 2011-‫כ"ז באייר התשע"א‬
]57[
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Compounds of general formula (I), wherein X, Z, R1-R10, m, n, o, p, r as described in
the description are strong adenosine A3 receptor ligands preferably antagonists.
__________________
]11[]21[
168603
‫הרכבים פרמצבטיים או קוסמטיים למניעה‬
‫וטיפול בגירוי של תאי עור ותאי ריר‬
]54[
PHARMACEUTICAL OR
COSMETIC COMPOSITION FOR
THE PREVENTION AND
TREATMENT OF IRRITATION
OF MUCOUS CELLS OR SKIN
CELLS
]22[
]51[
]71[
16.05.2005
Int. Cl.(2010.01) A61K 08//34, 08//42, 08//60, 09//00, 47//10, 47//18, 47//32
RESDEVCO RESEARCH AND
,‫רסדבקו חברה למחקר ולפתוח בע"מ‬
DEVELOPMENT CO.
‫ירושלים‬
]87[
]74[
WO/2006/123324
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
]57[
,‫דר' אייל ברסלר עו"פ‬
11 ‫תובל‬
‫ גן‬- ‫רמת‬
The present invention provides new topical pharmaceutical or cosmetic compositions
for the prevention and treatment of irritation of mucous cells, or skin cells, comprising
a combination of: xylitol, myoinositol or mannitol or any combination of these; glycerol and/or urea; water; in the absence of any oil in water or wax in water emulsion.
__________________
132
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
168744
‫ המעכב‬1‫בטא‬5‫נוגדן אנטי אינטגרין אלפא‬
‫היווצרות כלי דם‬
]54[
ANTI-Α5ß1 INTEGRIN ANTIBODY
THAT INHIBITS ANGIOGENESIS
]22[
]31[
]51[
]71[
26.11.2003
60/429743
]32[ 26.11.2002
]33[ US
Int. Cl.(2010.01) A61K 39//395, C07K 01//22, 16//18, C12N 15//13
ABBOTT BIOTHERAPEUTICS
CORP.
WO/2004/056308
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The present invention provides chimeric and humanized antibodies that specifically
recognize alpha5beta1 integrin, and methods for using the antibodies for reducing or
inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.
]87[
]74[
]57[
__________________
]11[]21[
133
169370
‫תיאנופירימידינדיאונים ושימושם באפנון‬
‫מחלות כשל חיסוני‬
]54[
THIENOPYRIMIDINEDIONES
AND THEIR USE IN THE
MODULATION OF AUTOIMMUNE
DISEASE
]22[
]31[
]51[
]71[
]72[
15.01.2004
0300119-5
]32[ 17.01.2003
]33[ SE
Int. Cl.(2010.01) A61K 31//519, A61P 37//02, C07D 51/3/04
ASTRAZENECA AB, SWEDEN
SIMON DAVID GUILE
May 31, 2011-‫כ"ז באייר התשע"א‬
]87[
]74[
]57[
WO/2004/065394
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to thienopyrimidinediones of formula (1) wherein R1 and R2 each
independently represent a C1-6akyl, C3-6alkyl, C3-6alkenyl, C3-5cycloalkylC1-3alkyl or
C3-6cycloalkyl; each of which may be optionally substituted by 1 to 3 halogen atoms R 3
is a group CO-G or SO2-G where G is a 5- or 6-membered ring containing a nitrogen
atom and a second heteroatom selected from oxygen and sulphur adjacent to the nitrogen; the ring being substituted by at least one group as defined in the specification, Q
is CR4R5 where R4 is hydrogen, fluorine or C1-6 alkyl and R5 is hydrogen, fluorine or
hydroxy; and Ar is a 5-10-membered aromatic ring system wherein up to 4 ring atoms
may be heteroatoms independently selected from nitrogen, oxygen and sulphur, the
ring system being optionally substituted by one or more groups defined in the specification; as well as pharmaceutically acceptable salts and solvates thereof. Processes for
their preparation of the compounds, pharmaceutical compositions containing them and
their use in therapy, in particular in immunosuppression therapy are also described.
__________________
]11[]21[
134
169417
‫שיטה ומכשיר לשיפור קליטת אותות במערכות‬
‫אלחוטיות בהן קיימות הפרעות הנובעות‬
‫מתשדורות בתאים סמוכים‬
]54[
METHOD AND APPARATUS FOR
IMPROVING SIGNAL
RECEPTION IN WIRELESS
NETWORKS SUBJECTED TO
INTERFERENCE CAUSED BY
TRANSMISSIONS IN
NEIGHBORING CELLS
]22[
]51[
]71[
]72[
27.06.2005
Int. Cl.(2010.01) H04B 01//707, H04J 11//00, H04W 52//04, 52//12, 52//16
ALVARION LTD.
‫ תל אביב‬,‫אלווריון בע"מ‬
DAN STOPLER
‫דן סטופלר‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]74[
]57[
ALEF GIMEL - INTELLECTUAL
,‫ ייעוץ לקניין רוחני בע"מ‬- .‫ג‬.‫א‬
PROPERTY CONSULTING LTD.,
‫רחובות‬2079 .‫ד‬.‫ ת‬,
P.O.B. 2079,
REHOVOT 76120
A method is provided for estimating a signal received at a wireless cell along a channel where the frequency used for conveying traffic is substantially equal to frequency
used for conveying traffic along at least one other channel extending from/to at least
one substantially interfering cell. The method comprises: associating a pilot sequence
with operative cells; providing a receiver with information to allow estimation of the
pilot sequence by a respective transmitter; providing the receiver with information to
allow estimation of pilot sequences associated with other transmitters communicating
with other receivers located at the geographical proximity of that receiver; estimating
the signal associated with the pilot sequence used by the first transmitter; subtracting
the estimated signal from an input signal received by that receiver; estimating the pilot
signal associated with a pilot sequence used by other transmitters; and modifying the
estimation of the pilot signal used by the first transmitter.
__________________
]11[]21[
]54[
JOINING APPARATUS WITH
ROTATABLE MAGNET THEREIN
AND BUILT-UP TYPE TOY WITH
THE SAME
]22[
]31[
14.01.2004
10-2003]32[ 14.01.2003
0002395
10-200318.03.2003
0016688
Int. Cl.(2010.01) A63H 33//04
ORDA KOREA CO, LTD., REPUBLIC
OF KOREA
WO/2004/062760
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
]57[
135
169424
‫ציוד לחיבור עם מגנט הניתן לסובבו בתוכן‬
‫וצעצוע מסוג בניה למעלה איתו‬
]33[
KR
KR
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Disclosed is a built-up type toy having plural parts 10a of polyhedron shape equipped
with joining surfaces 11a that are joined with other joining surfaces 11b of other parts
10b. The built-up type toy of the present invention has the parts respectively having
magnet portions 10a on the joining surfaces 11a thereof, wherein the magnet portion
100a of the part 10a and the magnet portion 100b on the joining surface 11b of the
parts 10b are joined with each other by magnetic force thereof. The built-up type toy of
May 31, 2011-‫כ"ז באייר התשע"א‬
the present invention provides the effects that it is easy to assemble and disassemble,
the assemble state is not likely to be demolished easily, and it is helpful to develop the
initiative of infant as it can be assemble to various shapes.
The applications for division
from this application have
not yet been published
,196835,196834,196833
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
169559
‫מערכת ושיטה לחיובי ביטוח לכלי רכב‬
]54[
VEHICLE RELATED SERVICES
SYSTEM AND METHODOLOGY
]22[
]31[
]51[
]62[
]71[
]74[
03.12.2000
60/192199
]32[ 27.03.2000
]33[ US
Int. Cl.(2010.01) G06Q 30//00, G07B 15//02, G07C 01//30, 05//04
DIVISION FROM 141790
PDM CO. LTD., BELIZE
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A vehicle-related services system comprising:
at least one sensor mounted on a vehicle and automatically sensing at least one of the
time during which said vehicle is being operated;
at least one communicator mounted on said vehicle providing an output indicating at
least the time during which said vehicle is being operated; and
at least one data processor receiving said output from said at least one communicator
and providing a billing data output in respect of a vehicle-related use fee which is dependent on the time during which said vehicle is being operated,
wherein the only variables sensed by at least one sensor, which are considered in the
billing data, are duration of vehicle use and time of day or night of vehicle use.
]57[
__________________
136
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
]54[
MISSILE WITH ODD NUMBER OF
TAIL FINS
]22[
]31[
]51[
]71[
]87[
]74[
20.05.2004
10/444653
]32[ 23.05.2003
Int. Cl.(2010.01) F42B 10//32
RAYTHEON COMPANY, U.S.A.
WO/2005/022075
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
169563
‫טיל עם מספר לא זוגי של סנפירים אחוריים‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A missile (10), either a powered missile or an unpowered projectile, includes a freelyrolling tail assembly (14) having an odd number of fins (32). Having an odd number of
fins may reduce oscillations caused by the rotation of the freely-rotating tail. This may
make a more stable platform for a seeker (22), such as an uncooled focal point array or
other imaging infrared (IIR) or millimeter wave radio frequency (MMW) seeker, in the
body of the missile. Also, minimizing oscillation by using an odd number of fins may
facilitate control of the missile.
__________________
]11[]21[
137
169586
]54[
WIRING SUBSTRATE AND
RADIATION DETECTOR USING
SAME
]22[
]31[
]51[
08.01.2004
2003-002541 ]32[ 08.01.2003
]33[
Int. Cl.(2010.01) G01T 01//20, H01L 23//52
‫מצע לחיווט וגלאי קרינה המשתמש בו‬
JP
May 31, 2011-‫כ"ז באייר התשע"א‬
]71[
]72[
]87[
]74[
]57[
HAMAMATSU PHOTONICS K.K.,
JAPAN
KATSUMI SHIBAYAMA, YUTAKA
KUSUYAMA, MASAHIRO
HAYASHI
WO/2004/064163
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A wiring substrate portion (2) is disposed between a radiation detection portion (1)
constituted of a scintillator (10) and a PD array (15) and a signal processing device
(30) for processing a detection signal outputted from the PD array (15). The wiring
substrate portion (2) has a conductive path for conducting a detection signal from the
PD array (15) to the signal processing device (30). The wiring substrate portion (2)
further has a first wiring substrate (20) and a second wiring substrate (25). The first
wiring substrate (20) is provided with a conductive member (21) serving as a conductive path for the PD array (15) and disposed in a through hole (20c). The second wiring
substrate (25) is provided with a conductive member (26) serving as a conductive path
for the signal processing device (30) and disposed in a through hole (25c). The position of the through hole (20c) in the wiring substrate (20) is different, when viewed in
the direction of array, from that of the through hole (25c) in the wiring substrate (25).
As a result a wiring substrate through which the transmission of radiation is suppressed
and a radiation detector using the same are provided.
__________________
]11[]21[
]54[
138
SOLAR COLLECTOR WITH
INTEGRAL STAGNATION
TEMPERATURE CONTROL, A
SOLAR ENERGY SYSTEM
COMPRISING THE SAME AND
METHOD OF CONTROLLING
TEMPERATURE IN A SOLAR
169971
‫קולטי שמש בעל מערכת אינטגרלית לבקרת‬
‫ מערכת אנרגיה סולארית‬,‫טמפרטורות סטגנציה‬
‫המכילה אותו ושיטה לבקרת טמפרטורה בקולט‬
‫שמש‬
May 31, 2011-‫כ"ז באייר התשע"א‬
COLLECTOR
]22[
]31[
]51[
]71[
]87[
]74[
]57[
06.02.2004
60/445457
]32[ 07.02.2003
Int. Cl.(2010.01) F24J 02//46
QUEENS UNIVERSITY AT
KINGSTON, CANADA
WO/2004/070289
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
This invention relates to a method and apparatus for a solar collector having integral
control of the maximum temperature that it can reach, thereby avoiding excessive
stagnation temperatures in the collector. In one embodiment, a solar collector comprises a top portion comprising glazing, a bottom portion; an absorber disposed between
said top portion and said bottom portion for absorbing solar energy received through
said glazing, said absorber in a spaced relationship above said bottom portion such that
a channel is defined between a lower surface of said absorber and an upper surface of
said bottom portion; an inlet and an outlet associated with and at substantially opposite
ends of said channel between said absorber and said bottom portion, for ventilating
said channel; and a damper for opening said outlet at a temperature equal to or above a
first selected temperature and for closing said outlet at a temperature equal to or below
a second selected temperature; wherein said first and second selected temperatures are
below a stagnation temperature of the solar collector.
__________________
]11[]21[
139
]54[
SYSTEM FOR SUPPLYING
POWER AND METHODS FOR
CONSTRUCTING AND ADDING
A POWER SUPPLY TO SUCH A
SYSTEM
]22[
]51[
]71[
]74[
04.08.2005
Int. Cl.(2010.01) H02J 09//00
AVIEM SYSTEMS LTD.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
170118
‫מערכת לאספקת כח ושיטות להרכבת והוספת‬
‫ספק כח למערכת‬
‫ נתניה‬,‫אביאם מערכות בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]57[
A system for supplying power to a site having a load, the system comprising:
(a) a number n of power source units, the value of n being greater than or equal
to 3;
(b) a number t≤tmax of loads groups, each load group having a number i of inputs,
the value of I being greater than or equal to 2 and less than the value of n;
wherein each load group receives power from i power source units, at least one of
which provides power to one or more of the other load groups, such that each load
group is connected to a unique combination of i power source units, and tmax being
such that every possible combination of i power source units is connected to a unique
load group.
__________________
]11[]21[
170253
]54[
PROCESS FOR THE
PREPARATION OF NSUBSTITUTED FORMAMIDES
]22[
]31[
]51[
]71[
]87[
]74[
19.02.2004
60/448123
]32[ 20.02.2003
]33[
Int. Cl.(2010.01) C07C 23/1/10, 23/3/03
LONZA AG, SWITZERLAND
WO/2004/074234
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
N–‫תהליך להכנת פורמאמידים המותמרים‬
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
N-Aryl- or N-heteroarylformamides are prepared by hydrogenating a corresponding
nitroarene or nitroheteroarene with formic acid and/or ammonium formate as hydrogen
donor and formylating agent in the presence of at least one noble metal-based hydrogenation catalyst and a vanadium or molybdenum compound as co-catalyst.
__________________
]11[]21[
]54[
140
NUCLEIC ACID SEQUENCES
ENCODING POLYPEPTIDES
WITH Δ-4 DESATURASE
ACTIVITY, ACTIVE PEPTIDES
ENCODED THEREBY, GENE
170560
‫רצפי חומצות גרעין מקודדים פוליפפטידים בעלי‬
‫ תוצרים פפטידיים‬,‫ דיסטורייז‬D –4 ‫פעילות‬
‫ וקטורים ויצורים טרנסגניים כוללים‬,‫שלהם‬
‫ ושמנים כוללים‬PUFA ‫ תהליכים להכנת‬,‫אותם‬
‫אותם‬
May 31, 2011-‫כ"ז באייר התשע"א‬
CONSTRUCTS AND TRANSGENIC
ORGANISMS INCLUDING SAME
AND PROCESSES TO PRODUCE
PUFA AND OILS CONTAINING
SAME
]22[
]31[
]51[
]71[
]87[
]74[
]57[
06.04.2004
10316267.4
]32[ 08.04.2003
]33[ DE
Int. Cl.(2010.01) C12N 01//19, 09//02, 15//53, 15//82
BASF PLANT SCIENCE GMBH,
GERMANY
WO/2004/090123
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to an improved method for the specific production of unsaturated
omega 3-fatty acids and a method for producing triglycerides containing an increased
number of unsaturated fatty acids, especially omega-3 fatty acids comprising more
than three double bonds. Disclosed is the production of a transgenic organism, preferably a transgenic plant, or a transgenic microorganism containing an increased number
of fatty acids, oils, or lipids comprising delta-4 double bonds as a result of a delta-4
desaturase being expressed from Euglena gracilis. The invention further relates to expression cassettes containing a nucleic acid sequence, a vector, and organisms containing at least one nucleic acid sequence or an expression cassette. Also disclosed are
unsaturated fatty acids and triglycerides having an increased fatty acid content and the
use thereof. Fatty acids and triglycerides are used in a plurality of application in the
food industry, in animal nutrition, cosmetics, and pharmaceuticals and are suitable for
many different applications depending on whether free saturated or unsaturated fatty
acids or triglycerides having an increased saturated or unsaturated fatty acid content
are used.
__________________
]11[]21[
141
]54[
PEN-TYPE INJECTOR WITH
DOSE DIAL SLEEVE
]22[
]31[
]51[
03.03.2004
0304822.0
]32[ 03.03.2003
Int. Cl.(2010.01) A61M 05//315
170619
‫מזרק דמוי עט עם גוף מתווה מנה‬
]33[
GB
May 31, 2011-‫כ"ז באייר התשע"א‬
]71[
]87[
]74[
]57[
DCA DESIGN INTERNATIONAL
LIMITED, UNITED KINGDOM
WO/2004/078241
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to a pen-type injector comprising a housing; a piston rod (20)
adapted to operate through the housing; a dose dial sleeve (70) located between the
housing and the piston rod (20), the dose dial sleeve (70) having a helical thread of
first lead; a drive sleeve (30) located between the dose dial sleeve (70) and the piston
rod (20), the drive sleeve (30) having a helical groove (38) of second lead. The first
lead of the helical thread and the second lead of the helical groove (38) are the same.
__________________
]11[]21[
170924
‫שיטה והתקן לטיפול באותות לקביעת טווח‬
‫במערכת תקשרות אלחוטית‬
]54[
METHOD AND DEVICE FOR
HANDLING RANGING SIGNALS
IN A WIRELESS
COMMUNICATIONS NETWORK
]22[
]51[
]71[
]72[
18.09.2005
Int. Cl.(2010.01) H04J 11//00, H04W 56//00, 74//00
ALVARION LTD.
‫ תל אביב‬,‫אלווריון בע"מ‬
DAN STOPLER, TAL KAITZ,
‫ יניב בר‬,‫ טל קיץ‬,‫דן סטופלר‬
YANIV BAR
ALEF GIMEL - INTELLECTUAL
,‫ ייעוץ לקניין רוחני בע"מ‬- .‫ג‬.‫א‬
PROPERTY CONSULTING LTD.,
‫רחובות‬2079 .‫ד‬.‫ ת‬,
P.O.B. 2079,
REHOVOT 76120
In a wireless communications network, a method for detecting and/or estimating a
ranging signal which comprises a plurality of tiles, said method comprising the steps
of:
(i) for one or more of said plurality of tiles but less than all of said plurality of tiles,
carrying out a plurality of mathematical correlations;
(ii) summing the results of said correlations;
(iii) based on the summed results, detecting a code characterizing said ranging signal
and/or estimating the timing offset of said ranging signal.
]74[
]57[
__________________
142
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
170967
‫שיטה להכנת אנטנת כרטיס חכם על גבי תומך‬
‫תרומופלסטי והכרטיס החכם המיוצר בשיטה זו‬
]54[
METHOD FOR MAKING A
SMART CARD ANTENNA ON A
THERMOPLASTIC SUPPORT AND
RESULTING SMART CARD
]22[
]31[
]51[
]71[
]87[
]74[
26.03.2004
03/03817
]32[ 28.03.2003
Int. Cl.(2010.01) G06K 19//077
ASK S.A., FRANCE
WO/2004/088582
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The invention concerns a method for making a hybrid contact/non-contact or noncontact smart card comprising a support (10, 11) whereon is produced the antenna, two
card bodies (32, 42, 34, 44) on either side of the support, each of the card bodies consisting of at least one thermoplastic layer, and one chip (30) or module connected to
the antenna. Said method comprises the following steps: depositing a layer of a material consisting of a major amount of resin on a predetermined zone (12, 13) of the antenna support; making the antenna which consists in screen-printing turns (14, 15) and
two connection pads (16, 18, 17, 19) of conductive polymer ink on the zone previously
produced on the support and subjecting the support to a heat treatment to cure the ink.
]33[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]11[]21[
]54[
143
INHIBITOR PROTEINS OF
KALLIKREIN
171158
‫חלבונים מעכבי קליקראין‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]22[
]31[
]51[
]71[
]72[
]87[
]74[
]57[
05.04.2004
60/460345
]32[ 04.04.2003
]33[ US
Int. Cl.(2010.01) A61K 38//57, C07K 14//81, C12N 15//09
UNIVERSITE DE LAUSANNE,
SWITZERLAND
DAVID DEPERTHES, SYLVAIN
CLOUTIER
WO/2004/087912
SOROKER-AGMON,
,‫אגמון‬-‫סורוקר‬
14 SHENKAR ST.,
14 ‫ רחוב שנקר‬,‫בית נולטון‬
HERZLIYA PITUAH 46725
‫הרצליה פיתוח‬
The present invention relates to a chimeric inhibitor protein of a protease comprising
an inhibiting polypeptidic sequence and at least one polypeptidic sequence of a substrate-enzyme interaction site specific for a protease. Other objects of the invention are
to provide a purified and isolated DNA sequence encoding the chimeric inhibitor protein of a protease, an expression vector characterized in that it comprises said purified
and isolated DNA sequence, a eukaryotic or prokaryotic host cell transformed with this
expression vector and a method of producing a chimeric inhibitor protein.
__________________
]11[]21[
144
171694
–‫נגזרות של פיפרידיניל– ופיפראזיניל–אלקיל‬
‫תכשירים‬, ‫ תהליך להכנתן‬,‫קרבמאטים‬
‫פרמצבטיים הכוללים את הנגזרות ושימוש‬
‫בנגזרות להכנה של תרופות‬
]54[
DERIVATIVES OF PIPERIDINYLAND PIPERAZINYL-ALKYL
CARBAMATES, PROCESS FOR
PREPARATION THEREOF,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
SAID DERIVATIVES AND USE OF
SAID DERIVATIVES FOR THE
PREPARATION OF
MEDICAMENTS
]22[
]31[
]51[
06.05.2004
03/05540
]32[ 07.05.2003
]33[ FR
Int. Cl.(2010.01) A61K 31//435, 31//44, 31//495, 31//506, 31//519, 31//55, A61P
25//00, 43//00, C07D 21/1/14, 24/1/04, 24/3/06, 40/1/04, 40/1/14, 40/3/04, 40/5/04,
41/3/04, 41/7/04, 47/1/04, 48/7/02, 49/1/048, 49/5/04
May 31, 2011-‫כ"ז באייר התשע"א‬
]71[
]87[
]74[
]57[
SANOFI-AVENTIS, FRANCE
WO/2004/099176
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The invention relates to a compound having general formula (I), wherein: A = N or
CR2; R2 = H, F, OH, CN, CF3, C1-6-alkyl, C1-6-alcoxy; n = 2 or 3 and m = 2 when A =
N; n = 1, 2 or 3 and m = 1 or 2 when A = CR2; B = covalent bond or C1-8-alkylene; R1
= optionally-substituted heteroaryl; R3 = CHR4CONHR5; R4 = H or C1-6-alkyl; R5 = H,
C1-6-alkyl, C3-7-cycloalkyl, C3-7-cycloalkyl-Cl-6-alkylene; the base, the acid addition
salt, the hydrate or the solvate thereof. The invention also relates to the application
thereof in therapeutics.
__________________
]11[]21[
‫ניהול רשת תקשורת באמצעות מדידות נקודתיות‬
‫של סימנים‬
]54[
NETWORK MANAGEMENT
USING PERIODIC
MEASUREMENTS OF
INDICATORS
]22[
]31[
]51[
]71[
13.05.2004
60/470256
]32[ 14.05.2003
]33[
Int. Cl.(2010.01) H04W 48//00, 48//14, 84//12
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2004/104737
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
145
171717
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A beacon signal used in data communications, such as the IEEE 802.11, is provided
with data extensions. The data extensions permit additional information to be provided
by the beacon signal. Periodic beacon requests are made during connection between a
May 31, 2011-‫כ"ז באייר התשע"א‬
wireless transmit/receive unit (WTRU, 17, 18, 19) and an access point (AP) on a
WLAN (12, 13). A Measurement Request field (26) corresponding to a beacon request
contains a measurement duration value and channel number for which the request applies. The beacon request permits a scan mode, which includes 'Active Scan' mode,
'Passive Scan' mode and 'Beacon Table' mode.
__________________
]11[]21[
‫ציפוי שטח מרוקם לכפפות ושיטה ליצורו‬
]54[
TEXTURED SURFACE COATING
FOR GLOVES AND METHOD OF
MAKING
]22[
]31[
30.06.2004
60/484602
]32[ 02.07.2003
]33[ US
10/882016
30.06.2004
US
Int. Cl.(2010.01) A41D 19//00, B29C 41//00, 41//22
ANSELL HEALTHCARE PRODUCTS
LLC, U.S.A.
WO/2005/002375
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
146
172468
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
There is provided, in accordance with the principles of the present invention, a glove
having a textured surface or textured foam coating produced by embedding a layer of
discrete particles, such as a salt, into a previously formed liquid layer, gelling or curing
the layer and dissolving the discrete particles to leave a textured or textured foamed
surface.
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
‫תאי גליאה העוטפים עצב הרחה שהונצחו באופן‬
‫חוזר ותכשירי רוקחות המכילים אותן‬
]54[
REVERSIBLY IMMORTALISED
OLFACTORY ENSHEATHING
GLIA AND PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]22[
]31[
]51[
19.07.2004
0316882.0
]32[ 18.07.2003
]33[ GB
Int. Cl.(2010.01) A61K 35//30, 48//00, A61P 25//00, C12N 05//071, 05//10, 15//63,
C12R 01//91
CONSEJO SUPERIOR DE
INVESTIGACIONES CIENTIFICAS,
SPAIN
UNIVERSIDAD AUTONOMA DE
MADRID, SPAIN
WO/2005/012513
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention is based on the capacity of the Olfactory Ensheathing Glia
(OEG) to foster axonal regeneration in the adult mammalian central nervous system
(CNS). This specific capacity is probably due to a combination of several factors, such
as the molecular composition of cellular membrane and/or the capacity to secrete some
molecules; combined with the capacity to reduce glial scar and accompany new growing axon in the damaged CNS. We have developed immortalised cell lines from primary human OEGs. The cells were cultured from post-mortem human tissue from donors
and immortalised using a reversible system. Some of these OEG human clonal cell
lines were selected by their ability to promote axonal regeneration from adult rat retinal ganglion neurons in a similar fashion to primary OEGs. These cell lines, alone or
in pharmaceutical compositions comprising these cells, may be used to repair neuronal
]71[
]87[
]74[
]57[
147
172831
May 31, 2011-‫כ"ז באייר התשע"א‬
damage in the CNS.
__________________
]11[]21[
173064
‫שיטה לבקרת מלאי עבור מוצרים רפואיים‬
]54[
METHOD FOR INVENTORY
CONTROL FOR MEDICAL
PRODUCTS
]22[
]31[
]51[
]71[
]74[
10.01.2006
11/053341
]32[ 08.02.2005
]33[
Int. Cl.(2010.01) G04F 01//00, G08B 01//00
CORDIS CORPORATION, U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A method for controlling inventory of a time sensitive medical product includes
providing packaging for the medical product, setting an expiration date for the medical
product; and displaying the expiration date with the medical product in a visible manner on or within the packaging or on or within the medical product. A warning period
is set for warning of an upcoming expiration for the medical product in advance of the
expiration date and elapsed time is monitored with the packaging or with the medical
product after setting the expiration date for the medical product. A warning indicator is
displayed on or within the packaging or on or within the medical product of the upcoming expiration for the medical product upon commencement of the warning period.
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]11[]21[
]54[
148
USE OF C-DI-GMP OR A CYCLIC
173065
‫ או שמשלוגי‬C di–GMP–‫שימוש ב‬
May 31, 2011-‫כ"ז באייר התשע"א‬
DINUCLEOTIDE ANALOGUE
THEREOF IN THE
MANUFACTURE OF A
MEDICAMENT,
MEDICAMENTS SO PRODUCED
AND METHODS OF USING THE
SAME
‫ מחזורית שלו בייצור‬DINUCLEOTIDE
‫תרופה תרופות שיוצרו כך ושיטות שימושן‬
]22[
]31[
]51[
]71[
]87[
]74[
22.07.2004
60/490029
]32[ 28.07.2003
]33[ US
Int. Cl.(2010.01) A61K 31//7084, C07H 21//00
DAVID K.R. KARAOLIS, U.S.A.
WO/2005/030186
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The present invention relates to the use of the cyclic dinucleotide c-di-GMP and cyclic
dinucleotide analogues thereof in a method for attenuating virulence of a microbial
pathogen or for inhibiting or reducing colonization by a microbial pathogen. This
method further inhibits microbial biofilm formation and is capable of treating bacterial
infections. The microbial colonization or biofilm formation inhibited or reduced may
be on the skin or on nasal or mucosal surface. The microbial colonization or biofilm
formation inhibited can also be on the surfaces of medical devices, especially those in
close contact with the patient, as well on the surfaces of industrial and construction
material where microbial colonization and biofilm formation is of concern.
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]11[]21[
]54[
149
CASING FOR INSTALLATION
WITHIN A GROUND SURFACE,
AT A NODE OF A SUBSURFACE
173172
‫ בצומת של רשת‬,‫מארז להתקנה במשטח קרקעי‬
‫כבלים אופטיים תת–קרקעית‬
May 31, 2011-‫כ"ז באייר התשע"א‬
FIBRE OPTIC CABLE NETWORK
]22[
]31[
]51[
]71[
]72[
]87[
]74[
]57[
16.07.2004
60/487595
]32[ 17.07.2003
Int. Cl.(2010.01) G02B 06//44, 06//50
TERASPAN NETWORKS INC.,
CANADA
DARREN DOFHER
WO/2005/008307
WEBB & CO.,
2 PEKERIS ST., P.O.B. 2189,
REHOVOT 76121
]33[
US
,'‫ד"ר וב ושות‬
2 ‫רח' פקריס‬
‫רחובות‬2189 .‫ד‬.‫ ת‬,
A system for protecting buried optic fibre nodes which permits surface inlay installation of cable without the need to expose free ends of the cable for threading through
any apertures, includes a protective housing (10) composed of spaced apart panels
(14,16) which define an interior space. The panels open to expose the interior for installation of a length of cable (50) therein. An insert (30) fits within the space, which
includes a channel (38) which is exposed when the panels (14,16) open for insertion of
a cable. The insert includes a void (32) to receive a cable junction box (34). A removable protective outer casing may be provided, either in the form of a pair of outer walls
with a removable cap or base, or a can-like container having a removable top and two
or more opposed slots communicating with the upper rim of the container. The housing
fits within the container, with the cable entering and exiting through the slots, which
also permit a saw cut to pass through the slots to facilitate installation of the system.
The system also includes a pre-assembled cable network including nodes, cable and
housings that may be buried within trenches cut into a surface.
__________________
]11[]21[
150
]54[
LOCK AGAINST IMPACTPICKING
]22[
]51[
]71[
26.01.2006
Int. Cl.(2010.01) E05B 27//04
MUL-T-LOCK TECHNOLOGIES
173378
‫מנעול נגד פתיחה ע"י מכה‬
‫ יבנה‬,‫מולטילוק טכנולוגיות בע"מ‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]72[
]74[
]57[
LTD.
DANY MARKBREIT, EFFI BENAHARON
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.,
REHOVOT 76209
‫אהרן‬-‫ אפי בן‬,‫דני מרקברייט‬
,‫דקל פטנט בע"מ‬
27 ‫חדר‬, 18 ‫מנוחה ונחלה‬
‫רחובות‬
A lock comprising:a plurality of lock pins comprising a plurality of driver pins slidably and biasedly disposed in driver pin bores formed in a lock body and a plurality of
tumbler pins aligned with said driver pins and disposed in tumbler pin bores formed in
a tumbler rotatably disposed in a bore formed in said lock body, said tumbler being
formed with a keyway for receiving therein a key having key cuts adapted to contact
said tumbler pins, wherein at least one of said tumbler pins comprises a first portion
and a second portion, the first portion having a thicker portion than the second portion,
wherein the tumbler pin bore, which receives said at least one tumbler pin with the
first portion and second portion, is formed with counterbore defining a larger bore in
which the first portion is movable and smaller bore in which the second portion is
movable, and wherein said second portion does not extend into the keyway enough to
touch one of the key cuts of the key.
__________________
]11[]21[
‫ שיטות‬,‫נגזרות של בנזוקסאזול סולפונאמיד‬
‫להכנתם ושימושים בהם להכנת מעכבי‬
. ‫פרןטאזות של רטרווירוסים‬
]54[
BENZOXAZOLE SULFONAMIDE
DERIVATIVES, METHODS FOR
THEIR PREPARATION AND USES
THEREOF FOR THE
PREPARATION OF RETROVIRUS
PROTEASE INHIBITORS
]22[
]31[
30.09.2004
03103630.4
]32[ 30.09.2003
]33[ EP
60/507996
02.10.2003
US
Int. Cl.(2010.01) C07D 26/3/58, 40/1/00, 41/3/12, 41/7/12
TIBOTEC PHARMACEUTICALS
LTD., IRELAND
WO/2005/030739
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
151
173891
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to methods for the preparation of benzoxazole sulfonamide compounds of formula (9) as well as novel intermediates of formula (6) for use
in said method. More in particular the invention relates to methods for the Preparation
of 2-amino-benzoxazole sulfonamide compounds which make use of 2-mercaptoMay 31, 2011-‫כ"ז באייר התשע"א‬
benzoxazole sulfonamide intermediates, more in particular methods employing the
intermediate 1-Benzy1-2-hydroxy-3-[isobutyl(2-methylsulfanyl-benzoxazole-6sulfonyl)-amino)-propyl)-carbamic ester, and to methods amenable to industrial scaling up. Said benzoxazole sulfonamide compounds are particularly useful as HIV protease inhibitors. The substituents are defined in the claims.
__________________
]11[]21[
‫ תהליך להכנתן ושימושן‬,‫נגזרות של מלונאמיד‬
‫בהכנת תרופות לטיפול במחלת אלצהיימר‬
]54[
MALONAMIDE DERIVATIVES,
PROCESS FOR THEIR
PREPARATION AND USE
THEREOF IN THE PREPARATION
OF MEDICAMENTS FOR
TREATING ALZHEIMER'S
DISEASE
]22[
]31[
]51[
31.08.2004
03019683.6
]32[ 09.09.2003
]33[ EP
Int. Cl.(2010.01) A61K 31//335, 31//55, 31//5513, A61P 25//28, C07D 22/3/16,
22/3/18, 24/3/12, 31/3/14
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2005/023772
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to malonamide derivatives of formula (I), wherein: R 1 is one of
the following groups (Formulae a), b), c), d)); R 2 is lower alkyl, lower alkinyl, -(CH2)nO-lower alkyl, -(CH2)n-S-lower alkyl, -(CH2)n-CN, -(CR'R')n-CF3, -(CR'R')n-CHF2, (CR'R')n-CH2F, -(CH2)n-C(O)O-lower alkyl, -(CH2)n-halogen, or is -(CH2)n-cycloalkyl,
optionally substituted by one or more substituents, selected from the group consisting
of phenyl, halogen or CF3; R',R' are independently from n and from each other hydrogen, lower alkyl, lower alkoxy, halogen or hydroxy; R3, R4 are independently from
each other hydrogen, lower alkyl, lower alkoxy, phenyl or halogen; R 5 is hydrogen,
lower alkyl, -(CH2)n-CF3 or -(CH2)n-cycloalkyl; R6 is hydrogen or halogen; R7 is hydrogen or lower alkyl; R8 is hydrogen, lower alkyl, lower alkinyl, -(CH2)n-CF3,(CH2)n-cycloalkyl or -(CH2)n-phenyl, optionally substituted by halogen; R9 is hydrogen, lower alkyl, -C(O)H, -C(O)-lower alkyl, -C(O)-CF3,-C(O)-CH2F,-C(O)-CHF2,C(O)-cycloalkyl,-C(O)-(CH2)n-O-lower alkyl,-C(O)O-(CH2)n-cycloalkyl, -C(O)phenyl, optionally substituted by one or more substituents selected from the group
consisting of halogen or -C(O)O-lower alkyl, or is -S(O)2-lower alkyl, -S(O)2-CF3,-
]71[
]87[
]74[
]57[
152
173905
May 31, 2011-‫כ"ז באייר התשע"א‬
(CH2)n-cycloalkyl or is -(CH2)n-phenyl, optionally substituted by halogen; n is 0, 1, 2,
3 or 4; and to pharmaceutically suitable acid addition salts, optically pure enantiomers,
racemates or diastereomeric mixture thereof. These compounds may be used for the
treatment of Alzheimer's disease.
__________________
]11[]21[
]54[
SYSTEMS, METHODS AND
COMPUTER-READABLE MEDIA
FOR INVOKING AN
ELECTRONIC INK OR
HANDWRITING INTERFACE
]22[
]31[
]51[
]71[
02.03.2006
11/083013
]32[ 18.03.2005
Int. Cl.(2010.01) G06F 17//30
MICROSOFT CORPORATION,
U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
153
174085
‫ שיטות ומדיה קריאה במחשב להצגת‬,‫מערכות‬
‫דיו אלקטרוני או ממשק כתב יד‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
User interfaces, methods, systems and computer-readable media for activating and/or
displaying text input systems on display devices may include:(a) displaying a text input system activation target at a user changeable location on a display device; (b) receiving user input directed to the activation target; and (c) activating a text input system in response to the user input. Such user interfaces, methods and systems further
may include (d) displaying a pre-interaction condition of the activation target; (e) receiving user input directed to the activation target in this pre-interaction condition; and
(f) changing an appearance of the activation target from the pre-interaction condition
to a larger size and/or a different visual appearance in response to this user input. Additional aspects of this invention relate to computer-readable media for providing user
interfaces, systems and methods as described above.
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
‫מודול ממברנלי לסיב חלול הנוצר עקב לחץ‬
‫חיצוני‬
]54[
EXTERNAL PRESSURE TYPE
HOLLOW FIBER MEMBRANE
MODULE
]22[
]31[
]51[
]71[
28.09.2004
2003-338160 ]32[ 29.09.2003
]33[ JP
Int. Cl.(2010.01) B01D 63//02, 65//00, C02F 01//44
ASAHI KASEI CHEMICALS
CORPORATION, JAPAN
WO/2005/030375
REINHOLD COHN AND
PARTNERS,
]87[
]74[
154
174177
,‫ריינהולד כהן ושותפיו‬
May 31, 2011-‫כ"ז באייר התשע"א‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
An external pressure type hollow fiber membrane module, comprising a hollow fiber
membrane bundle formed of a plurality of hollow fiber membranes, a housing, and an
inlet/outlet nozzle for fluid, wherein hollow fiber membranes are fixedly adhered to
each other and the hollow fiber membranes are fixedly adhered to the inner wall of the
housing at both ends of the hollow fiber membrane bundle. The hollow part at one or
both side adhesively fixed ends is opened, and the inlet/outlet nozzle for fluid is installed at the side face of the housing at least at one adhesively fixed end in which the
hollow part is opened. Where the membrane occupied rates of the nozzle in a neighboring area (A) and a non-neighboring area (B) among membrane chargeable areas on
the inside of the adhesively fixed part at at least one adhesively fixed end positioned
near the nozzle and where the hollow part is opened are PA and PB, the ratio of the
membrane occupied rates PB/PA is 0.50 to 0.95.
__________________
]11[]21[
‫תהליך עבור ייצור של ביקלוטאמיד ושיטה של‬
‫טיהור חומר ביניים עבור זה‬
]54[
PROCESS FOR PRODUCING
BICALUTAMIDE AND METHOD
OF PURIFYING INTERMEDIATE
THEREFOR
]22[
]31[
]51[
]71[
15.10.2004
2003-357038 ]32[ 16.10.2003
]33[ JP
Int. Cl.(2010.01) C07C 31/5/02, 31/5/06, 31/7/46, 31/9/28, 32/3/62
SUMITOMO CHEMICAL
COMPANY, LIMITED., JAPAN
WO/2005/037777
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
]87[
]74[
155
174781
May 31, 2011-‫כ"ז באייר התשע"א‬
]57[
A process for producing bicalutamide, which is represented by the formula (4), (4)
which comprises: a step (A) in which the compound represented by the formula (1) is
reacted with a peroxycarboxylic acid to obtain the compound (2) represented by the
formula (2); (2) a step (B) in which the compound (2) is reacted with 4fluorothiophenol to obtain crude crystals of the compound (3) represented by the formula (3) and the crude crystals are dissolved in a solvent and crystallized therefrom to
obtain purified crystals of the compound (3); and a step (C) in which the purified crystals of the compound (3) are reacted with a peroxycarboxylic acid to obtain bicalutamide. Also provided is a method of purifying crystals of the compound (3), which comprises dissolving crude crystals of the compound (3) in a solvent and crystallizing it.
__________________
]11[]21[
‫שימוש של מגבירי שעתוק אנדותליאל ניטריק‬
‫אוקסיד סינתז להכנת תרופה לריפוי תאים‬
‫במחלות לב איסכמיות‬
]54[
USE OF ENOS TRANSCRIPTION
ENHANCERS FOR THE
PRODUCTION OF A
MEDICAMENT FOR CELL
THERAPY OF ISCHEMIC HEART
DISEASES
]22[
]31[
]51[
]71[
22.10.2004
03025512.9
]32[ 06.11.2003
]33[ EP
Int. Cl.(2010.01) A61K 31//00, 31//167, 31//277, 35//00, A61P 09//00
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2005/044249
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention relates to the use of compounds which enhance the transcription
of endothelial nitric oxide synthase (eNOS) for treating stem and progenitor cells in
the cell therapy of patients with ischemic heart diseases such as coronary heart disease
]87[
]74[
]57[
156
174807
May 31, 2011-‫כ"ז באייר התשע"א‬
or ischemic cardiomyopathy. Treatment of such cells which are isolated from bone
marrow, for example, with an eNOS transcription enhancer prior to their administration improves their functional activity and ameliorates neovascularization of the heart
and cardiac regeneration.
__________________
]11[]21[
–‫–אמינו‬3–‫–דיהלואציל‬2 ‫אסטרים של חומצה‬
‫ שימוש בהם ליצור‬,‫ שיטה ליצורם‬,‫אקרילית‬
–H1 –‫–דיהלומתיל‬3 ‫אסטרים של חומצה‬
–3 ‫–אצטית ואסטרים של חומצה‬4–‫פיראזול‬
‫ –קרבוקסילית‬4 –‫דיכלורומטילפיראזול‬
]54[
2-DIHALOACYL-3-AMINOACRYLIC ACID ESTERS, A
PROCESS FOR THEIR
PREPARATION, THEIR USE FOR
PRODUCING 3-DIHALOMETHYL1H-PYRAZOLE-4-CARBOXYLIC
ACID ESTERS AND 3DICHLOROMETHYLPYRAZOLE4-CARBOXYLIC ACID ESTERS
]22[
]31[
]51[
]71[
12.10.2004
10349500.2
]32[ 23.10.2003
]33[
Int. Cl.(2010.01) C07C 22/9/36, C07D 23/1/14
BAYER CROPSCIENCE AG,
GERMANY
WO/2005/042468
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
157
175024
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a method for producing 2-dihaloacyl-3-amino-acrylic acid
esters of formula (I). Said method is characterised in that acid halides of formula (II)
are reacted with dialkyl amino-acrylic acid esters of formula (III), in which R, R 1, R2,
X1, X2 and Hal are defined as cited in the description, in a water-immiscible organic
solvent in the presence of a base. The invention also relates to the novel 2-dihaloacyl3-amino-acrylic acid esters of formula (I), to their use for producing 3-dihalomethylpyrazoles, to a method for producing 3-dihalomethyl-pyrazoles, in addition to novel 3dihalomethyl-pyrazoles.
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
175196
‫ייצור גל ע"י פיצוי תזוזת פזה בהתפשטות גל‬
‫בחומר אופטי לא לינארי‬
]54[
WAVE GENERATION BY WAVE
PROPAGATION PHASE SHIFT
COMPENSATION IN A NONLINEAR OPTICAL MEDIUM
]22[
]31[
]51[
]71[
25.04.2006
0504145
]32[ 25.04.2005
]33[ FR
Int. Cl.(2010.01) G02F 01//35
ONERA (OFFICE NATIONAL
D'ETUDES ET DE RECHERCHES
AEROSPATIALES), FRANCE
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
31 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
TEL AVIV 61013
A method of generating, from first and second collinear incident monochromatic
waves crossing a nonlinear optical medium, a third monochromatic wave, the method
comprising applying the first and second waves to the medium that induces between
the three waves a propagation phase-shift having a value π in response to the three
waves travelling a coherence length in said medium and that is compensated at the
value 0 modulo 2π in response to said three waves travelling a periodic distance in said
medium, periodic distance being less than the coherence length.
]74[
]57[
__________________
158
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
175409
‫תולדות היברידים של אקסאזולידינון–קווינולין‬
‫ותכשירי רוקחות המכילים אותן‬
]54[
OXAZOLIDINONE-QUINOLONE
HYBRID DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]22[
]31[
20.12.2004
60/530822
]32[ 18.12.2003
]33[ US
04001506.7
23.01.2004
EP
Int. Cl.(2010.01) A61K 31//422, 31//4375, 31//4709, 31//6615, A61P 31//04, C07D
21/5/233, 40/1/14, 41/3/10, 41/3/12, 41/3/14, 47/1/04, C07F 09//48, 09//59
MORPHOCHEM AG, GERMANY
WO/2005/058888
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention relates to compounds of the Formula (I) that are useful antimicrobial agents and effective against a variety of multi-drug resistant bacteria:
]51[
]71[
]87[
]74[
]57[
__________________
]11[]21[
]54[
DRUG DELIVERY DEVICE
]22[
]51[
]71[
]72[
07.05.2006
Int. Cl.(2010.01) A61M 05//145, 05//20
STEADYMED LTD.
DORON AURBACH, GRIGORY
SALITRA, MIKHAIL LEVI, ELENA
MARKEVICH
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]74[
]57[
159
175460
‫התקן למתן תרופה‬
‫ תל אביב‬,‫סטדימד בע"מ‬
‫דורון אורבך‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
The present application provides a drug-delivery device comprising a drug reservoir
chamber, containing a substance to be delivered, in fluid connection with a drug adMay 31, 2011-‫כ"ז באייר התשע"א‬
ministration means, and an electrically-controlled battery unit comprising at least one
displacement-generating battery cell coupled to the drug reservoir chamber by a coupling means, the arrangement being such that the displacement derived from the battery unit is conveyed by the coupling means to the drug reservoir chamber such that
the substance is expelled from the drug reservoir chamber towards the drug administration means.
__________________
]11[]21[
]54[
FLUID SAMPLE ANALYSIS
DEVICE WITH SEALABLE
SAMPLE STORAGE RESERVOIR
]22[
]31[
]51[
]71[
15.11.2004
60/520437
]32[ 14.11.2003
Int. Cl.(2010.01) G01N 31//22, 33//48
ALERE SWITZERLAND GMBH,
SWITZERLAND
JIELIN DAI, HSIAOHO EDWARD
TUNG, YING YANG, WU
YUZHANG
WO/2005/050166
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
]72[
]87[
]74[
]57[
175626
‫התקן לאנליזה של דגימה ניגרת בעל מאגר הניתן‬
‫לאטימה לאחסון הדגימה‬
]33[
US
,‫אגמון‬-‫סורוקר‬
14 ‫ רחוב שנקר‬,‫בית נולטון‬
‫הרצליה פיתוח‬
A test device (100) comprising a casing (110), a fluid collection well (120), a top
(240), a base (245), port (150), test element (280), a window (160), an upper chamber
(130), an expression plate (320), a lower chamber (330) and a samaple outlet (270).
__________________
160
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
]54[
RAPID SAMPLE ANALYSIS AND
STORAGE DEVICES AND
METHODS OF USE
]22[
]31[
]51[
]71[
15.11.2004
60/520437
]32[ 14.11.2003
Int. Cl.(2010.01) G01N 31//22, 33//48
ALERE SWITZERLAND GMBH,
SWITZERLAND
YUZHANG WU, JIELIN DAI,
HSIAOHO EDWARD TUNG, YING
YANG
WO/2005/050165
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
]72[
]87[
]74[
]57[
175627
‫התקנים לאנליזה ולאחסון מהירים של דגימות‬
‫ושיטות לשימוש בהם‬
]33[
US
,‫אגמון‬-‫סורוקר‬
14 ‫ רחוב שנקר‬,‫בית נולטון‬
‫הרצליה פיתוח‬
A device (100) comprising a casing (120), a sample collection well (130) and a sample
applicator (110). The sample applicator (110) further comprises a rigid handle (114), a
rime (116) and an absorbent member (112).
__________________
]11[]21[
161
]54[
SAMPLE COLLECTION CUP
WITH INTEGRATED SAMPLE
ANALYSIS SYSTEM
]22[
]31[
]51[
15.11.2004
60/520237
]32[ 14.11.2003
Int. Cl.(2010.01) G01N 31//00
175628
‫ספלון לאיסוף דגימות משולב עם מערכת של‬
‫דגימות‬
]33[
US
May 31, 2011-‫כ"ז באייר התשע"א‬
]71[
]72[
]87[
]74[
]57[
ALERE SWITZERLAND GMBH,
SWITZERLAND
YUZHANG WU, LIJIAN GUO,
JIELIN DAI, HSIAOHO EDWARD
TUNG
WO/2005/050168
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
,‫אגמון‬-‫סורוקר‬
14 ‫ רחוב שנקר‬,‫בית נולטון‬
‫הרצליה פיתוח‬
The present invention is directed to devices and methods for collecting liquid samples
and of testing the sample for the presence of an analyte of interest and/or a physical
property. In one embodiment the device is a urine cup having an interior for containing
a liquid sample, a lid, and a chamber for holding liquid. The device contains a test
component for determining the presence of an analyte in the liquid sample and/or a
physical property. A tube is immersed in liquid sample when the device is filled with
liquid sample to be tested. When the lid is applied to the device (e.g., by screwing or
snapping on), liquid sample is forced through the tube and into the chamber holding
the test component.
__________________
]11[]21[
‫סינטאזות ססקוויטרפן מפצ'ולי‬
]54[
SESQUITERPENE SYNTHASES
FROM PATCHOULI
]22[
]31[
19.11.2004
60/525512
]32[ 26.11.2003
]33[ US
PCT/IB03/06459
09.12.2003
IB
Int. Cl.(2010.01) C12N 01//21, 05//10, 09//88, 15//60
FIRMENICH SA, SWITZERLAND
MICHEL SCHALK, FABIENNE
DEGUERRY
WO/2005/052163
]51[
]71[
]72[
]87[
162
175728
May 31, 2011-‫כ"ז באייר התשע"א‬
]74[
]57[
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to sesquiterpene synthases from Patchouli plants (Pogostemon
cablin), and methods of their production and use. In one embodiment, the invention
provides nucleic acids comprising a nucleotide sequence as described herein that encodes for at least one sesquiterpene synthase. In a further embodiment, the invention
also provides for sesquiterpene synthases and methods of making and using these enzymes. For example, sesquiterpene synthases of the invention may be used to convert
farnesyl-pyrophosphate to various sesquiterpenes including patchoulol, ϝcurcumene and other germacrane-type sesquiterpenes.
__________________
]11[]21[
‫מכסה לבקבוק עם משאבה‬
]54[
PUMP BOTTLE CAP
]22[
]31[
]51[
]71[
]72[
]87[
]74[
09.09.2004
10/725007
]32[ 02.12.2003
]33[ US
Int. Cl.(2010.01) B65B 31//04
CAPTECH LTD.
‫ אור עקיבה‬,‫קפטק בע"מ‬
SHLOMO HAIMI
‫שלמה חיימי‬
WO/2005/054058
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A container lid assembly (2) that includes an integral pump (6P) so as to create pressure differential within a container. This pressure differential may be lower than atmospheric pressure so as to be at least a partial vacuum within the container. Alternatively, the pressure differential may be a state of higher than atmospheric pressure
within the container. There are several features of the present invention that can be
used in synergy, but are of value when implemented separately. These features include
a pump configuration (120) that activates the reciprocating linear motion of the piston
(10) by the rotational movement of a pump actuating element; a contents-dispensing
mechanism (150) for removing contents from the container while maintaining the at
least a partial vacuum within the container; a vacuum indicator; and a filter configured
to filter the gases entering the pump from the interior of the container.
]57[
163
175925
May 31, 2011-‫כ"ז באייר התשע"א‬
,206754
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
176262
‫שיטה תשלום בטוחה‬
]54[
SECURE AND FRIENDLY
PAYMENT SYSTEM
]22[
]51[
]71[
]72[
]74[
12.06.2006
Int. Cl.(2010.01) G06Q 20//00, 40//00, G07F 19//00
ENCOTONE LTD.
‫ הרצליה פיתוח‬,‫אנקוטון בע"מ‬
ISAAC LABATON
‫יצחק לבטון‬
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
Payment systems are provided that utilize a portable device, and in particular, payment
systems that utilize a first portable device that belongs to a seller and a second portable
device that belongs to a buyer, but do not utilize a point of sale (POS) device.
]57[
The applications for
division from this
application have not yet
been published
,210361
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
164
PROCESS FOR THE
176420
‫– דיכלורופירידין‬3 ,2 ‫תהליך לייצור‬
May 31, 2011-‫כ"ז באייר התשע"א‬
MANUFACTURE OF 2,3DICHLOROPYRIDINE
]22[
]31[
]51[
]71[
]87[
]74[
]57[
21.01.2005
60/539068
]32[ 23.01.2004
]33[ US
Int. Cl.(2010.01) C07D 21/3/61, 21/3/73, 21/3/82
E.I. DU PONT DE NEMOURS AND
COMPANY, U.S.A.
WO/2005/070888
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method for preparing 2,3-dichloropyridine is disclosed in which 3-amino-2chloropyridine is contacted with an alkali metal nitrite in the presence of aqueous hydrochloric acid to form a diazonium salt; and the diazonium salt is subsequently decomposed in the presence of copper catalyst wherein at least about 50% of the copper
is the copper(II) oxidation state.
__________________
]11[]21[
]54[
DATA TRANSMISSION WITH
SPATIAL SPREADING IN A MIMO
COMMUNICATION SYSTEM
]22[
]31[
11.01.2005
60/536307
]32[ 13.01.2004
11/009200
09.12.2004
Int. Cl.(2010.01) H04L 01//06
QUALCOMM INCORPORATED,
U.S.A.
WO/2005/071864
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
]57[
165
176768
‫שידור נתונים בעל הפצה מרחבית במערכת‬
‫תקשורת של קלט–פלט–מרובים‬
]33[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
For data transmission with spatial spreading, a transmitting entity (1) encodes and
modulates each data packet to obtain a corresponding data symbol block, (2) multiplexes data symbol blocks onto Ns data symbol streams for transmission on Ns transmission channels of a MIMO channel, (3) spatially spreads the Ns data symbol streams
with steering matrices, and (4) spatially processes Ns spread symbol streams for fullCSI transmission on Ns eigenmodes or partial-CSI transmission on Ns spatial channels
of the MIMO channel. A receiving entity (1) obtains N R received symbol streams via
May 31, 2011-‫כ"ז באייר התשע"א‬
NR receive antennas, (2) performs receiver spatial processing for full-CSI or partialCSI transmission to obtain Ns detected symbol streams, (3) spatially despreads the Ns
detected symbol streams with the same steering matrices used by the transmitting entity to obtain Ns recovered symbol streams, and (4) demodulates and decodes each recovered symbol block to obtain a corresponding decoded data packet.
__________________
]11[]21[
‫פולימורפים גבישיים של ליגנד לרצפטור הקושר‬
‫– כמוקין‬CXC
]54[
CRYSTALLINE POLYMORPHS
OF A CXC-CHEMOKINE
RECEPTOR LIGAND
]22[
]31[
]51[
]71[
]87[
]74[
28.01.2005
60/540487
]32[ 30.01.2004
]33[ US
Int. Cl.(2010.01) A61K 31//341, A61P 29//00, 35//00, C07D 30/7/52
SCHERING CORPORATION, U.S.A.
WO/2005/075447
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The present invention relates to four distinct crystalline polymorphs of a monohydrate
of Compound A having the following chemical structure (A). These four polymorphic
forms, herein referred to as Forms I, II, III and IV are active as a CXC-chemokine receptor ligands. The invention is further directed to formulations, methods of treatment,
and processes of synthesis of these polymorphic forms.
]57[
166
177033
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
‫התקן ושיטה לחיבור אביזר צנרת לצינור‬
]54[
DEVICE AND METHOD FOR
COUPLING A PIPE FITTING TO
A PIPE
]22[
]51[
]71[
23.07.2006
Int. Cl.(2010.01) B23P 19//02, B25B 13//00, 13//50, 27//10, F16L 13//16, 37//256
SAGIV AGUDAH SHITUFIT
‫ קבוץ‬,‫שגיב אגודה שיתופית חקלאית בע"מ‬
CHAKLAIT BE'AM
‫משאבי שדה‬
]74[
BLUM, GADOR & CO.,
53 HASHALOM RD.,
GIVATAYIM 53454
]57[
167
177036
,'‫ גדור ושות‬,‫בלום‬
‫ מגדל הורד‬23 ‫ קומה‬,53 ‫דרך השלום‬
‫גבעתיים‬
A device and method for coupling a pipe and a fitting. The device includes a pipe
holder for releasably gripping a pipe, a fitting retainer for releasably retaining a pipe
fitting substantially coaxially with a pipe in the pipe holder, and means for driving
together the pipe holder and the fitting retainer along a longitudinal axis in a relative
motion between them. The device may optionally slide a reinforcing sleeve along the
pipe to cover the end of the pipe on the fitting.
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
]54[
TEST ELEMENT AND METHOD
FOR TESTING BLOOD
]22[
]31[
]51[
]71[
02.02.2005
102004005139.9 ]32[ 02.02.2004
]33[
Int. Cl.(2010.01) B01L 03//00, G01N 33//80
MEDION DIAGNOSTICS AG,
SWITZERLAND
WO/2005/072876
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
168
177144
‫פריט בדיקה ושיטה לבדיקת דם‬
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A test element for diagnostic tests, particularly for testing blood prior to a transfusion.
The test element comprises at least two test units for carrying out at least two tests. The
test element is provided a fixing means for fixing said test element.
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
177183
‫תולדות קרובניל אמינו ביציקליות השימושיות‬
‫ תהליכים‬,‫כאנטגוניסטים של קולטן כמוקין‬
‫להכנתן ושימושן בהכנת תרופות‬
]54[
BICYCLIC CARBONYL AMINO
DERIVATIVES USEFUL AS
CHEMOKINE RECEPTOR
ANTAGONISTS, PROCESSES FOR
THEIR PREPARATION AND USE
THEREOF IN THE PREPARATION
OF MEDICAMENTS
]22[
]31[
]51[
10.02.2005
0403038.3
]32[ 11.02.2004
]33[ GB
Int. Cl.(2010.01) C07D 20/9/42, 40/1/12, 40/1/14, 40/5/12, 40/5/14, 40/9/12, 41/3/14,
45/1/06, 45/5/02
NOVARTIS AG, SWITZERLAND
WO/2005/077932
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester
thereof, wherein the variants R, R9, Z, X, Q and Y are defined in the specification.
]71[
]87[
]74[
]57[
__________________
169
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
177375
‫התקן הזרקה ידני מבוקר אלקטרונית להזרקת‬
‫תרופות נוזליות‬
]54[
HAND-HELD ELECTRONICALLY
CONTROLLED INJECTION
DEVICE FOR INJECTING LIQUID
MEDICATIONS
]22[
]31[
]51[
]71[
17.02.2005
04100647.9
]32[ 18.02.2004
]33[ EP
Int. Cl.(2010.01) A61M 05//20, 05//24, 05//34
ARES TRADING S.A.,
SWITZERLAND
VINCENT PONGPAIROCHANA,
TIMOTHY JOHN MACLEAN,
ROBERT PRASSER, GERHARD
LAUCHARD, WERNER
WURMBAUER, GERHARD KOGLER
WO/2005/077441
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
There is described a hand-held, electronically controlled injection device (1) for injecting preset doses of liquid medications, having a housing (2) for receiving a cartridge
(4) containing the liquid medication and having a contact surface (16) for contacting a
patient's skin; and actuator means (41) for moving the cartridge (4) within the housing
(2) to and from the contact surface (16).
]72[
]87[
]74[
]57[
The applications for division
from this application have
not yet been published
,205525
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
170
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
177500
‫תהליך ליצירת תרכובות מקרוציקליות‬
]54[
PROCESS FOR
MANUFACTURING
MACROCYCLIC COMPOUNDS
]22[
]31[
17.02.2005
60/545131
]32[ 17.02.2004
]33[ US
11/059796
17.02.2005
US
Int. Cl.(2010.01) A61K 31//40, 31//555, C07B 47//00, C07D 29/1/00, 29/1/08,
31/3/00, 32/3/00, 48/7/22, 49/1/08
THOMAS E. JOHNSON, U.S.A.
BILLY T. FOWLER, U.S.A.
]51[
]71[
]87[
]74[
]57[
WO/2006/025859
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
This invention relates to methods, compositions, and apparatuses for producing macrocyclic compounds. First, one or more reactants are provided in a reaction medium,
which are capable of forming the macrocyclic compound through a desired reaction
pathway that includes at least cyclization, and which are further capable of forming
undesired oligomers through a undesired reaction pathway that includes undesirable
oligomerization. Oligomerization of such reactions in the reaction medium is modulated to reduce formation of undesired oligomers and/or to reduce separation of the undesired oligomers from the reaction medium, relative to a corresponding unmodulated
oligomerization reaction, thereby maximizing yields of the macrocyclic compound.
The macrocyclic compound so formed is then recovered from the reaction medium.
Preferably, the macrocyclic compound spontaneously separates from the reaction medium via phase separation. More preferably, the macrocyclic compound spontaneous
precipitates from the reaction medium and therefore can be easily recovered by simple
filtration.
The applications for division
from this application have
not yet been published
,207967
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
171
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
]54[
COTTON CONDITIONER FOR A
COTTON HARVESTER
]22[
]31[
]51[
]71[
]74[
28.08.2006
11/214253
]32[ 29.08.2005
Int. Cl.(2010.01) D01G 09//00
DEERE & COMPANY, U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
177732
‫תוספת למקצרת כותנה המייעלת את הכנסת‬
‫הכותנה‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A conditioning mechanism is placed forwardly of the cotton harvesting mechanism on
a cotton harvester. Opposing elements compress portions of the cotton plant to compress the cotton bolls and deform the cotton boll hulls. The deformation loosens the
cotton fiber relative to the hulls to improve the ability of the harvesting mechanism to
harvest the seed and fiber. In one embodiment, differential surface velocity of the opposing elements improves boll opening and fiber orientation for more effective spindle
contact.
__________________
]11[]21[
‫מערכות לשליחת הודעות מולטימדיה למכשירים‬
‫ניידים נודדים‬
]54[
INBOUND ROAMER
MULTIMEDIA MESSAGING
SYSTEMS
]22[
]31[
]51[
]71[
]72[
]87[
]74[
10.03.2005
60/551716
]32[ 10.03.2004
]33[ US
Int. Cl.(2010.01) H04L 12//28, H04W 04//06, 08//02, 08//06
ROAMWARE, INC., U.S.A.
JUN JIANG YUE
WO/2005/086927
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
Inbound Roamer Multimedia Messaging Systems ('IRMMS') are described that transfer Welcome Multimedia Messages ('MM') ('WMM') or Welcome Roaming Content
('WRC') to devices of inbound roamers. The IRMMS transfers MMs to inbound roamers without involving components of the corresponding home network (HPMN). The
MMs include text messages, music clips, voice clips, video clips, photographs, and
May 31, 2011-‫כ"ז באייר התשע"א‬
]57[
172
177986
drawings, but are not so limited. Use of the IRMMS eliminates payment by a VPMN
with which a subscriber is roaming to the subscriber's HPMN because components of
the HPMN are not included in the transfer of the MMs. Thus, charges typically incurred by the VPMN for transmission of free WMM/WRC sent to the inbound roamer
via the HPMN are avoided.
__________________
]11[]21[
5 ‫תכשירי רוקחות המכילים נוגדני אנטי–אלפא‬
‫ביטא לעיכוב שגשוג תא סרטני‬
]54[
PHARMACEUTICAL
COMPOSITIONS CONTAINING
ANTI-ALPHA5BETA1
ANTIBODIES FOR INHIBITING
CANCER CELL PROLIFERATION
]22[
]31[
24.03.2005
60/556421
]32[ 24.03.2004
]33[ US
60/556422
24.03.2004
US
60/625049
03.11.2004
US
60/651098
07.02.2005
US
60/657514
28.02.2005
US
Int. Cl.(2010.01) A61K 39//395, 49//00, C07K 16//28
ABBOTT BIOTHERAPEUTICS
CORP.
WO/2005/092073
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
]57[
173
178042
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The present invention provides methods for direct killing of cancer cells using antialpha5beta1 antibodies. Generally, the method comprises contacting a cancer cell that
expresses alpha5beta1 on its surface with an anti-alpha5beta1 antibody, and thereby
inducing the death of the cancer cell. The methods of the invention may be employed
at an early stage of cancer development in a patient to prevent tumor establishment. In
addition, the methods may be used to treat previously formed tumors especially in canMay 31, 2011-‫כ"ז באייר התשע"א‬
cer that have not proven susceptible to anti-angiogenesis therapy. The methods may be
employed as a combination therapy of anti-alpha5beta1 antibodies together with cancer chemotherapeutic agents or other molecular-based cancer therapeutic agents.
__________________
]11[]21[
]54[
METHOD AND APPARATUS FOR
TREATING WASTE
]22[
]31[
09.03.2005
60/554879
]32[ 19.03.2004
10/820651
08.04.2004
Int. Cl.(2010.01) F23G 05//08, 05//10
PEAT INTERNATIONAL, INC.,
U.S.A.
WO/2005/093323
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
174
178044
‫שיטה ומערכת לטיפול בפסולת‬
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
An apparatus (5) for treating waste includes a vessel (20) and AC plasma torches
(35A, 35B) with a variable flame mounted with the vessel. The flames generated by
the torches can be adjusted depending on the characteristics of the waste being treated.
Waste can be introduced into the vessel and heated with energy from the flame. The
energy can melt or vitrify the inorganic portion of the waste and gasify and dissociate
the organic portion of the waste. This dissociation can destroy the hazardous or toxic
constituency of the waste.
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
178152
,‫אנטגוניסטים של קולטן אצטילכולין מוסקריני‬
‫תכשירים רפואיים המכילים אותם ושימושם‬
‫בהכנת תרופות‬
]54[
MUSCARINIC ACETYLCHOLINE
RECEPTOR ANTAGONISTS,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS
]22[
]31[
]51[
]71[
27.04.2005
60/565623
]32[ 27.04.2004
]33[
Int. Cl.(2010.01) A61K 31//44, C07D 45/3/02
GLAXO GROUP LIMITED, UNITED
KINGDOM
WO/2005/104745
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
]57[
US
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.
__________________
]11[]21[
]54[
175
POLYMER DISSOLUTION AND
BLEND FORMATION IN IONIC
LIQUIDS
178281
‫היפרדות פולימרים מתמיסה ויצירת מיזוג‬
‫בנוזלים יוניים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
25.03.2005
60/556484
]32[ 26.03.2004
]33[ US
Int. Cl.(2010.01) B01F 17//32, C07D 24/7/02, C08B 01//00, C08J 03//28, D01F
02//02
THE UNIVERSITY OF ALABAMA,
U.S.A.
WO/2005/098546
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The present invention relates to processes utilizing ionic liquids for the dissolution of
various polymers and/or copolymers, the formation of resins and blends, and the reconstitution of polymer and/or copolymer solutions, and the dissolution and blending
of 'functional additives' and/or various polymers and/or copolymers to form advanced
composite materials.
__________________
]11[]21[
]54[
PASSENGER TRANSPORTATION
SYSTEM, ESPECIALLY AN
ESCALATOR OR MOVING WALK
]22[
]31[
]51[
]71[
]74[
05.10.2006
05109858.0
]32[ 21.10.2005
Int. Cl.(2010.01) B66B 25//00
INVENTIO AG, SWITZERLAND
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
176
178466
‫מערכת הסעה לנוסעים במיוחד מדרגות נעות או‬
‫מסוע‬
]33[
EP
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The escalator has a revolving belt with master and slave control units and a drive station. The slave control unit has a first conductor plate with a first set of electronic
components for transmitting to the master control unit data relating to the function of
May 31, 2011-‫כ"ז באייר התשע"א‬
the escalator whilst the master control unit has a second conductor plate of identical
structure with electronic components to evaluate data and control the escalator. The
two sets of electronic components can also be identical. The conductor plates can have
switches and can be configured as a master control unit or slave control unit depending
on the position of the switch.
__________________
]11[]21[
‫ תכשירי רוקחות‬,‫תולדות אינדול אנדרוגניות‬
‫ ושימושיהן‬,‫המכילים אותן‬
]54[
ANDROGENIC INDOLE
DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME AND USES THEREOF
]22[
]31[
21.04.2005
60/565043
]32[ 23.04.2004
]33[ US
04101700.5
23.04.2004
EP
Int. Cl.(2010.01) A61K 31//404, A61P 05//26, 15//16, C07D 20/9/40, 40/1/04,
40/1/12, 40/3/04, 40/5/04, 41/3/04, 41/7/04
N.V. ORGANON, THE
NETHERLANDS
WO/2005/102998
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]51[
]71[
]87[
]74[
]57[
177
178562
The compounds of the subject invention have a structure according to formula I:
wherein X is S or SO2; R1 is (1C-6C)alkyl, (3C-6C)alkenyl, or (3C-6C)alkynyl, each
optionally subst ituted with (3C-6C)cycloalkyl, OH, OC(O)(1C-4C)alkyl, (1C4C)alkoxy, halogen, cyano, formyl, C(O)(1C-4C)alkyl, CO2H, CO2(1C- 4C)alkyl,
C(O)NR5R6, S(O)(1C-4C)alkyl or S(O)2(1C-4C)alkyl; R2 is hydrogen, (1C-4C)alkyl or
C(O)(1C-4C)alkyl; R3 is a phenyl group optionally substituted with (1C-4C)alkyl, (1C4C)fluoroalkyl, (1C-4C)alkoxy, (1C-4C)fluoroalkoxy, halogen, cyano or nitro; or R3 is
a 5- or 6-membered aromatic heterocyclic ring structure optionally substituted with
(1C-4C)alkyl, (1C-4C)fluoroalkyl, (1C-4C)alkoxy, halogen or cyano; R4 is a phenyl
group or an aromatic 6-membered heterocycle, substituted at the ortho position with 1hydroxy(1C-4C)alkyl, (1C-4C)alkoxy, C(O)(1C- 4C)alkyl, CO2(1C-4C)alkyl,
C(O)NH2, cyano, nitro, or CH=NOR7, and optionally further substituted with (1C2C)alkyl, (1C-2C)fluoroalkyl or halogen; R5 is 2-pyridyl optionally substituted with
(1C-2C)alkyl, (1C- 2C)fluoroalkyl or halogen; or R5 and R6 are independently hydrogen or (1C-4C)alkyl; R7 is hydrogen or C(O)(1C-4C)alkyl; R8 , R9 , R10 are independently hydrogen, (1C-2C)alkyl, fluoro or chloro; or a salt or hydrate form thereof.
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
‫מערכת ושיטה לתמיכת פרוטוקולים מבוססי‬
‫בלוקים בהתקן אחסון וירטואלי הפועל בתוך‬
‫התקן אחסון פיסי‬
]54[
SYSTEM AND METHOD FOR
SUPPORTING BLOCK-BASED
PROTOCOLS ON A VIRTUAL
STORAGE APPLIANCE
EXECUTING WITHIN A
PHYSICAL STORAGE
APPLIANCE
]22[
]31[
]51[
]71[
11.04.2005
10/822431
]32[ 12.04.2004
]33[ US
Int. Cl.(2010.01) G06F 03//06, 12//00
NETWORK APPLIANCE, INC.,
U.S.A.
GUILLERMO ROA
WO/2005/101181
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
An architecture provides the ability to create and maintain multiple instances of virtual
servers, such as virtual filers (vfilers), within a server, such as a storage appliance. A
vfiler is a logical partitioning of network and storage resources of the storage appliance
platform to establish an instance of a multi-protocol server. Each vfiler is allocated a
subset of dedicated units of storage resources, such as volumes or logical sub-volumes
(qtrees), and one or more network address resources. Each vfiler is also allowed shared
access to a file system resource of a storage operating system. To ensure controlled
access to the allocated and shared resources, each vfiler is further assigned its own
security domain for each access protocol. A vfiler boundary check is performed by the
file system to verify that a current vfiler is allowed to access certain storage resources
for a requested file stored on the filer platform.
]72[
]87[
]74[
]57[
178
178576
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
‫כלי תעופה בעל כנף מסתובבת‬
]54[
ROTARY WING VEHICLE
]22[
]31[
]51[
]71[
14.04.2005
60/562081
]32[ 14.04.2004
Int. Cl.(2010.01) B64C 27//10
PAUL E. ARLTON, U.S.A.
DAVID J. ARLTON, U.S.A.
]87[
]74[
WO/2005/099415
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
A rotary wing vehicle includes a body structure having an elongated tubular backbone
or core, and a counter-rotating coaxial rotor system having rotors with each rotor having a separate motor to drive the rotors about a common rotor axis of rotation. The
rotor system is used to move the rotary wing vehicle in directional flight.
]57[
The applications for division
from this application have
not yet been published
179
178592
]33[
,212280
US
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
]54[
FIBERS, NONWOVENS AND
ARTICLES CONTAINING
NANOFIBERS PRODUCED FROM
BROAD MOLECULAR WEIGHT
DISTRIBUTION POLYMERS
]22[
]31[
]51[
]71[
19.04.2005
60/563330
]32[ 19.04.2004
Int. Cl.(2010.01) D04H 01//00, 03//00
THE PROCTER & GAMBLE
COMPANY, U.S.A.
WO/2005/103355
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
178706
‫ אריגים לא סרוגים ופריטים המכילים‬,‫סיבים‬
‫סיבים זעירים המיוצרים מפולימרים בעלי‬
‫התפלגות רחבה של משקל מולקלרי‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention is directed to articles comprising nanofibers. The nanofibers,
having a diameter of less than 1 micron, may comprise a significant number of the
fibers in one layer of the web contained by the article. Preferably, the nanofibers are
produced in a melt film fibrillation process. The articles include diapers, training pants,
adult incontinence pads, catamenials products such as feminine care pads and pantiliners, tampons, personal cleansing articles, personal care articles, and personal care
wipes including baby wipes, facial wipes, and feminine wipes.
__________________
]11[]21[
180
]54[
PROCESS FOR PREPARING
POLYMORPHIC CRYSTALLINE
FORMS OF THE BISULPHATE
SALT OF ATANAZAVIR , NEW
FORM E3 AND A
PHARMACEUTICAL
FORMULATION CONTAINING
FORM E3
]22[
03.05.2005
178965
‫תהליך להכנת צורות פולימורפיות של גבישים‬
‫ צורה‬, ‫של מלח אטאזאנאביר ביסולפאט‬
‫ חדשה ותכשיר פרמצבתי המכיל‬E3 ‫פולימורפית‬
E3
May 31, 2011-‫כ"ז באייר התשע"א‬
]31[
]51[
]71[
]87[
]74[
]57[
60/568043
]32[ 04.05.2004
]33[ US
60/607533
07.09.2004
US
11/119558
02.05.2005
US
Int. Cl.(2010.01) A61K 31//16, A61P 31//12, C07D 21/3/56, 26/3/34
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2005/108349
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
A process is provided for preparing the HIV protease inhibitor atazanavir bisulfate
wherein a solution of atazanavir free base is reacted with concentrated sulfuric acid in
an amount to react with less than about 15% by weight of the free base, seeds of Form
A crystals of atazanavir bisulfate are added to the reaction mixture, and as crystals of
the bisulfate form, additional concentrated sulfuric acid is added in multiple stages at
increasing rates according to a cubic equation, to effect formation of Form A crystals
of atazanavir bisulfate. A process is also provided for preparing atazanavir bisulfate as
Pattern C material. A novel form of atazanavir bisulfate is also provided which is Form
E3 which is a highly crystalline triethanolate solvate of the bisulfate salt from ethanol.
__________________
]11[]21[
‫מתקן לחיבור ברז מים אל לוח‬
]54[
ADAPTER FOR ATTACHING A
WATER TAP TO A BOARD
]22[
]51[
]71[
]74[
02.11.2006
Int. Cl.(2010.01) A47K 01//00, E03C 01//042
UDI RAHMANI
‫ זיכרון יעקב‬,‫עודי רחמני‬
UDI RAHMANI,
,‫עודי רחמני‬
59 HAMEYASDIM ST.
59 ‫המייסדים‬
ZICHRON YAHRON YACOV
‫זיכרון יעקב‬
30900
An adapter (40) for attaching a water tap (20) to a board (50) from one side of said
board, said board comprising: a hooking device (6), for hooking said adapter to the
other side of said board through a cylindrical hoe (52) in said board, wherein said
hooking device comprises a leg (66) and a substantially elliptic corbel (68) attached to
said leg, wherein the greater axis of said corbel is greater than the diameter of said
hole and the smaller axis of said corbel is smaller than the diameter of said hole;
a fastening device (42, 62), for fastening said hooking device to said board; and a connecting device (70), for connecting said hooking device to said water tap.
]57[
181
179002
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
‫ שיטה להדבקה למשטח מתכת‬,‫תרכובת דביקה‬
‫וגומי לדבק מתכת‬
]54[
ADHESIVE COMPOSITION,
METHOD FOR BONDING TO A
METAL SURFACE AND RUBBER
TO METAL ADHESIVE
]22[
]31[
]51[
]71[
]87[
]74[
16.06.2005
60/580306
]32[ 16.06.2004
]33[ US
Int. Cl.(2010.01) C09J 12/3/28
LORD CORPORATION, U.S.A.
WO/2006/007438
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Disclosed is a rubber-metal adhesive in the form of dispersed solids in a volatile liquid
carrier, with a specified pigment grind and is sprayable at uniform film coatings on
metal surfaces at 25 ± 2 solids content wt.% and a viscosity of from 50 to about 500
cps (Brookfield LVT 2 @ 30 rpm). The adhesive comprises a dispersion of solid particles comprising nitroso compound, halogenated polyolefin, acid acceptor and from 5%
to 35 wt.% of inert, incompressible, spheroidal particles having a BET surface area of
from 0.1 to 10 m2/g and a 50th percentile particle diameter (D50) of 5 to 25 µm.
]57[
182
179395
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
‫פוליאורתנים מעכבי בערה ותוספים עבורם‬
]54[
FLAME RETARDANT
POLYURETHANES AND
ADDITIVES THEREFOR
]22[
]51[
]71[
28.05.2004
Int. Cl.(2010.01) C08L 75//04
ALBEMARLE CORPORATION,
U.S.A.
WO/2005/118720
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]87[
]74[
]57[
179584
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
A free-flowing, stable liquid flame retardant mixture comprised of or formed by mixing together components comprised of: A) at least one organic halogen-containing
reactive flame retardant in which the halogen is bromine, chlorine or both; and B) a
liquid additive that is comprised of at least one aliphatic polyepoxide of the formula
R(EP)n, wherein R is a straight chain or branched chain aliphatic moiety which consists of carbon, hydrogen, and optionally, one or more ether oxygen atoms and/or one
or more epoxy oxygen atoms; Ep is a terminal epoxy group: and n is a whole or fractional number in the range of 2 to about 6. Such mixtures can be effectively used in
the preparation of flame retardant rigid polyurethanes and rigid foams thereof, and
rigid polyisocyanurates and rigid foams thereof. Component B) serves as an effective
hardener for such polymers and foams. It is preferable to include in the liquid flame
retardant mixture one or more phosphorus-containing flame retardant additives such a
fully-esterified ester of a pentavalent
__________________
]11[]21[
]54[
183
USE OF SUBSTITUTED
QUINOLINE DERIVATIVES FOR
THE PREPARATION OF
MEDICAMENTS FOR THE
179630
‫שימוש בתולדות קווינולין מותמרות להכנת‬
‫תרופות לטיפול במחלות מיקובקטריאליות‬
‫העמידות בפני תרופות‬
May 31, 2011-‫כ"ז באייר התשע"א‬
TREATMENT OF DRUG
RESISTANT MYCOBACTERIAL
DISEASES
]22[
]31[
]51[
]71[
]87[
]74[
]57[
24.05.2005
04102402.7
]32[ 28.05.2004
]33[ EP
Int. Cl.(2010.01) A61K 31//47, A61P 31//06, C07D 21/5/00
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM
WO/2005/117875
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to the use of a substituted quinoline derivative for the
preparation of a medicament for the treatment of an infection with a drug resistant Mycobacterium strain wherein the substituted quinoline derivative is a compound according to Formula (Ia) or Formula (Ib) the pharmaceutically acceptable acid or base addition salts thereof, the stereochemically isomeric forms thereof, the tautomeric forms
thereof and the N-oxide forms thereof. Also claimed is a composition comprising a
pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the above compounds and one or more other antimycobacterial agents.
__________________
]11[]21[
]54[
INJECTION DEVICE
]22[
]31[
]51[
]71[
27.05.2005
0412049.9
]32[ 28.05.2004
Int. Cl.(2010.01) A61M 05//20
CILAG GMBH INTERNATIONAL,
SWITZERLAND
WO/2005/115512
]87[
184
179653
‫התקן הזרקה‬
]33[
GB
May 31, 2011-‫כ"ז באייר התשע"א‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
]74[
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
An injection device (210, 110) is described. A housing (212; 112) receives a syringe
and includes a return spring (226; 126) for biasing the syringe from an extended position in which its needle (218; 118) extends from the housing to a retracted position in
which the it does not. A drive spring (230; 130) acts on a first drive element (232; 132)
and a second drive element (234; 134) acts upon the syringe to advance it from its retracted position to its extended position and discharge its contents through the needle.
The first drive element is capable of movement relative to the second once a nominal
decoupling position has been reached. A release mechanism is activated when the first
drive element is further advanced to a nominal release position, to release the syringe
(214; 114) from the action of the drive spring, whereupon the return spring restores the
syringe to its retracted position. The nominal decoupling and release positions are defined relative to the syringe. This may be achieved by interaction between a moving
component and a decoupling component (162, 262) that moves with the syringe as it is
advanced.
__________________
]11[]21[
]54[
ELECTROACOUSTIC
TRANSDUCER ARRANGEMENT
FOR UNDERWATER ANTENNAS
]22[
]31[
]51[
]71[
15.06.2005
102004038032.5 ]32[ 05.08.2004
Int. Cl.(2010.01) G10K 11//00
ATLAS ELEKTRONIK GMBH,
GERMANY
RAINER BUSCH
WO/2006/015646
DEKEL PATENT LTD.,
]72[
]87[
]74[
185
179948
–‫מערך מתמר אלקטרואקוסטי לאנטנות תת‬
‫ימיות‬
]33[
DE
,‫דקל פטנט בע"מ‬
May 31, 2011-‫כ"ז באייר התשע"א‬
27 ‫חדר‬, 18 ‫מנוחה ונחלה‬
‫רחובות‬
The invention relates to an electroacoustic transducer arrangement for underwater antennas comprising: interspaced transducer elements (11); a reflector (12) that, in a
sound incidence direction, is situated behind the transducer elements (11), said reflector being comprised of a metal plate (13) facing the transducer elements (11) and of a
foam material plate (14) located on the side of the metal plate (13) facing away from
the transducer elements (11), and; an elastomer hard enclosing cast that encloses the
transducer elements (11) and the reflector (12). The aim of the invention is to obtain a
lightweight transducer arrangement with unchanged favorable performance data
whereby having a broadened field of application. To this end, the metal plate (13) has a
honeycomb structure, and a double layer (15) consisting of a foam material layer (16)
adjacent to the metal plate (13) and of a cork layer (17) adjacent to the foam material
plate (14) are arranged between the metal plate (13) and the foam material plate (14).
18 MENUHA VENAHALA ST.,
REHOVOT 76209
]57[
__________________
]11[]21[
]54[
ELECTROACOUSTIC
UNDERWATER ANTENNA
]22[
]31[
]51[
]71[
15.06.2005
102004037987.4 ]32[ 05.08.2004
Int. Cl.(2010.01) B63G 08//39
ATLAS ELEKTRONIK GMBH,
GERMANY
RAINER BUSCH, AXEL BRENNER
WO/2006/015645
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.,
REHOVOT 76209
]72[
]87[
]74[
]57[
186
179950
‫אנטנה אלקטרואקוסטית תת–ימית‬
]33[
DE
,‫דקל פטנט בע"מ‬
27 ‫חדר‬, 18 ‫מנוחה ונחלה‬
‫רחובות‬
An electroacoustic underwater antenna, particularly a lateral antenna which can be
fixed to the outer hull of an underwater craft, comprising a series of hydrophones (13)
successively arranged in at least one elongate, closed, oil-filled cavity at a distance
from each other. The aim of the invention is to achieve a high degree of reception sensitivity in the low frequency range with a sufficiently small, vertical aperture angle.
May 31, 2011-‫כ"ז באייר התשע"א‬
The inventive device is easy to produce and mount and is characterized by several cavities (14) which are fitted with hydrophones (13) at a parallel distance from each other,
arranged in front of a rigid plate (12) at a distance therefrom, and the plate (12) and
cavities (14) are embedded in a panel-type, acoustically transparent plastic element
(11). Several of said plastic elements (11) are arranged close to each other or behind
each other. .
__________________
]11[]21[
‫חומר יריעה ושיטה‬
]54[
SHEET MATERIAL AND
METHOD
]22[
]31[
]51[
]71[
22.06.2005
0414029.9
]32[ 23.06.2004
]33[ GB
Int. Cl.(2010.01) B31B 01//84, B65D 05//74
ELOPAK SYSTEMS AG,
SWITZERLAND
WOLFGANG KIESER
WO/2006/000881
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A top closure obturating panel (2) of a carton is formed with a partial depth cut (4) in
the form of an open loop of which one end (4a) is at a greater distance from a central
zone of the loop (4) than is the other end (4b). Following filling and top-sealing of the
carton, there is applied to the panel (2) a pour spout fitment consisting of a flanged
pour spout, a screw cap on the pour spout, and a plunger co-operating with the screw
cap and the pour spout in such manner that, upon unscrewing of the screw cap, the
plunger screws inwards. At its inner end, the plunger is formed with arcuate pushing
blades (6), which thereby cause the laminate material of the panel (2) to fracture along
the partial depth cut (4) such that an encircling portion (2a) of the panel (2) and an
encircled portion (2b) within the loop (4) separate from each other along the loop (4),
but remain interconnected by way of an intermediate portion (2c) extending through
between the ends (4a) and (4b) of the loop (4).
]72[
]87[
]74[
]57[
187
180141
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
‫שיטה ומערכות לניתוב מנות נתונים מנקודת‬
‫קצה לשער‬
]54[
METHOD AND SYSTEMS FOR
ROUTING PACKETS FROM AN
ENDPOINT TO A GATEWAY
]22[
]31[
22.07.2005
60/590837
]32[ 23.07.2004
]33[ US
60/601431
13.08.2004
US
60/607420
03.09.2004
US
60/634379
07.12.2004
US
Int. Cl.(2010.01) H04L 12//56, 29//06
CITRIX SYSTEMS, INC., U.S.A.
WO/2006/012612
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A method for securing remote access to private networks includes the step of intercepting from a data link layer a packet in a first plurality of packets destined for a first system on a private network. A packet in a second plurality of packets transmitted from a
second system on the private network destined for a system on a second network is
intercepted from the data link layer. A network address translation is performed on at
least one intercepted packet and the at least one intercepted packet is transmitted to a
destination, responsive to an application of a policy to the intercepted packet. An intercepted packet may be transmitted to a client application, responsive to a filtering table
or modified routing table, for transmission to a destination system, responsive to an
application of a policy. The client application may reside on a gateway computing device, on a client computing device, or on a peripheral device.
]51[
]71[
]87[
]74[
]57[
188
180404
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
180424
‫סינתזה של תרכובות הלומתיל פוליהלוגנטיות‬
‫ארומטיות‬
]54[
SYNTHESIS OF AROMATIC
POLYHALOGENATED
HALOMETHYL COMPOUNDS
]22[
]31[
]51[
]71[
]87[
]74[
19.07.2005
163101
]32[ 19.07.2004
]33[ IL
Int. Cl.(2010.01) C07C 17//14, C08K 05//00, 05//03
BROMINE COMPOUNDS LTD.
‫ באר שבע‬,‫תרכובות ברום בע"מ‬
WO/2006/008738
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention discloses a process for the preparation of highly pure Pentabromobenzyl bromide, PBB-Br, wherein the benzylic bromination reaction is carried out
in a suitable organic solvent in the presence of water and wherein the reaction temperature is such that it is sufficient to activate the initiator but not high enough to consume
a substantial amount thereof.
]57[
__________________
]11[]21[
]54[
189
ARYL-PYRIDINE DERIVATIVES,
PROCESS FOR THEIR
PREPARATION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
180481
,‫ תהליכין להכנתן‬,‫נגזרות של אריל–פירידין‬
‫תכשירים רפואיים המכילים אותן ושימושן‬
‫בהכנת תרופות‬
May 31, 2011-‫כ"ז באייר התשע"א‬
THEM AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS
]22[
]31[
]51[
]71[
]87[
]74[
]57[
20.07.2005
04103639.3
]32[ 28.07.2004
]33[ EP
Int. Cl.(2010.01) A61K 31//4418, 31//451, A61P 03//00, 09//12, C07D 21/3/76,
40/1/12
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2006/010546
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Compounds of formula (I) as well as pharmaceutically acceptable salts and esters
thereof, wherein R1 to R7, A, E and G have the significance given in claim 1 can be
used in the form of pharmaceutical compositions. The compounds of formula (I) are
useful as 11b-HSD1 inhibitors (T2D).
__________________
]11[]21[
‫צורה אננטיומרית של נגזרות חומצה‬
‫–דיאמינו ושיטה לייצורן‬3,2 ‫פרופיונית‬
]54[
ENANTIOMERIC FORM OF 2,3DIAMINOPROPIONIC ACID
DERIVATIVES AND PROCESS FOR
OBTAINING THEM
]22[
]31[
]51[
]71[
28.06.2005
102004033406.4 ]32[ 10.07.2004
]33[ DE
Int. Cl.(2010.01) C07C 27/1/22
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2006/005436
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to a method for producing enantiomeric form of 2, 3May 31, 2011-‫כ"ז באייר התשע"א‬
]87[
]74[
]57[
190
180571
diaminopropionic acid derivatives of formula (I) by asymmetric hydrogenation from
compounds of formula (II).
__________________
]11[]21[
180636
‫מפסק מתח גבוה והשימוש בו במחוללי‬
‫מיקרוגל‬
]54[
HIGH-VOLTAGE SWITCH AND USE
THEREOF IN A MICROWAVE
GENERATOR
]22[
]31[
]51[
]71[
08.07.2005
102004034895.2 ]32[ 19.07.2004
]33[ DE
Int. Cl.(2010.01) H03B 11//02
DIEHL BGT DEFENCE GMBH & CO.
KG, GERMANY
WO/2006/008000
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to a high-voltage switch, in particular for a microwave generator,
comprising an arc gap for switching on striking with a high voltage, characterised in
that several parallel wired arc gaps (12, 12a, 12b) are provided each with at least one
electrode (13, 13a, 13b) and a serially-wired fuse (14, 14a, 14b), which is irreversibly
destroyed on arcing across each arc gap (12, 12a, 12b).
]87[
]74[
]57[
__________________
]11[]21[
191
181175
May 31, 2011-‫כ"ז באייר התשע"א‬
‫ ושיטה עבור ייצור הנ"ל‬,‫בקבוקון מוגן‬
]54[
PROTECTED VIAL AND METHOD
FOR MANUFACTURING SAME
]22[
]31[
17.08.2005
1026870
]32[ 19.08.2004
]33[ NL
1027179
05.10.2004
NL
Int. Cl.(2010.01) A61J 01//00, B65B 53//02
PHARMACHEMIE B.V., THE
NETHERLANDS
WO/2006/019292
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
For the prevention of contamination of a vial (2) with traces of medicinal fluids, for
example cytostatics and antibiotics, which may be spilt on the outside of the vial (2)
while filling, the vial (2) is provided with a tight-fitting protective envelope (6) as a
last step in the production process. The envelope (6) comprises a bottom sticker (602)
which is attached to a bottom (202) of the vial (2) and a tight-fitting sleeve (601),
which is shrunk on a side wall (201) of the vial (2), while partly overlapping the bottom sticker (602) along a circumferential edge of the bottom (202) of the vial (2) As a
result of the arrangement of the envelope (6), a possible contamination which remains
on the outside of the vial (2) is encapsulated between the vial (2) and the envelope (6).
Consequently, a user is no longer exposed to toxic substances, because the user will
not touch the vial (2) itself, but will touch the envelope (6).
]51[
]71[
]87[
]74[
]57[
__________________
]11[]21[
]54[
192
METHOD AND SYSTEM FOR
DESIGNING A STRUCTURAL
LEVEL DESCRIPTION OF AN
ELECTRONIC CIRCUIT
181273
‫שיטה ומערכת לעיצוב תאור רמת מבנה של מעגל‬
‫חשמלי‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
01.09.2005
60/606425
]32[ 02.09.2004
Int. Cl.(2010.01) G06F 17//50
LOGICCON DESIGN AUTOMATION
LTD
WO/2006/025062
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
US
‫ תל אביב‬,‫לוג'יקון דייזין אוטומיישן בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A method and system for designing a structural level description of an electronic circuit with functional behavior described by a plurality of rules (fig 2 element 201), the
circuit being specified by data path (fig 2 element 203) and control path (fig 2 element
202) elements wherein at least one control path (fig 2 element 202) element is provided in a form of unresolved variable. The design comprises extracting (fig 2 element
204) a plurality of unresolved variables among the control path (fig 2 element 202)
elements and automatic processing of data path (fig 2 element 203) and control path
(fig 2 element 202) elements for accomplishing a state machine formulation (fig 2 element 206), wherein the states of the state machine include states representing at least
combinations of unresolved variables and corresponding transitions satisfying said
plurality of rules and predefined design criteria.
__________________
]11[]21[
‫תחליף פונקציונלי לסוכר‬
]54[
FUNCTIONAL SUGAR
REPLACEMENT
]22[
]31[
12.08.2005
04103889.4
]32[ 12.08.2004
]33[ EP
04447297.5
24.12.2004
EP
Int. Cl.(2010.01) A21D 13//06, 13//08, A23C 13//12, A23G 03//42, A23L 01//0528,
01//06, 01//308
SWEETWELL N.V., BELGIUM
WO/2006/015880
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]51[
]71[
]87[
]74[
193
181277
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The present invention is related to a functional food ingredient, which replaces sugar
on a 1/1 weight and/or volume basis in food recipes containing sucrose, with a substantial caloric reduction in view. More than an ingredient, it has to be seen as a functional ingredient, since it possesses some health promoting effects. The functional food
replacement for sucrose according to the present invention comprises prebiotic fibres
and sweeteners, and possibly other non selective fibres, minerals, vitamins and probiotic strains.
__________________
]11[]21[
]54[
METHOD FOR PLASMID DNA
FERMENTATION
]22[
]31[
]51[
]71[
16.08.2005
60/603000
]32[ 19.08.2004
Int. Cl.(2010.01) C12P 19//34
NATURE TECHNOLOGY CORP.,
U.S.A.
WO/2006/023546
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]87[
]74[
]57[
194
181410
DNA ‫שיטה לפרמנטציה של פלסמיד‬
]33[
US
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
Improvements in plasmid DNA production technology are needed to insure the economic feasibility of future DNA vaccines and DNA therapeutics. General methods are
described, by means of which it is possible to dramatically increase plasmid DNA
productivity in a fermentor. These processes feature Fed-batch fermentation strategies,
combined with novel growth and induction phase temperature shifts.
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
]54[
OBJECT PROCESS GRAPH
APPLICATION DEVELOPMENT
SYSTEM
]22[
]31[
]51[
]71[
]87[
]74[
09.09.2005
60/608563
]32[ 10.09.2004
Int. Cl.(2010.01) G06F 09//44
GRAPHLOGIC INC., U.S.A.
WO/2006/031640
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
195
181435
‫מערכת פיתוח לאפליקציה של גראפים לתהליכי‬
‫אובייקט‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
An object process graph (OPG) application development system. The system includes
an OPG application program interface (API), an OPG application editor, an OPG application window editor, and an OPG application notation. The OPG API provides
access to functions of an OPG system. The OPG application editor facilitates the creating and editing of the OPG applications via the OPG API. The OPG application window editor facilitates the editing of OPG application user interface windows while an
OPG application is running. The OPG application notation includes a plurality of key
words and associated definitions for describing and defining OPG applications.
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
]54[
METHOD FOR THE
DETERMINATION OF A
PROGRESSIVE OPHTHALMIC
LENS
]22[
]31[
]51[
]71[
21.02.2007
0601810
]32[ 01.03.2006
Int. Cl.(2010.01) G02C 07//02, 07//06
ESSILOR INTERNATIONAL
(COMPAGNIE GENERALE
D'OPTIQUE), FRANCE
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]74[
]57[
196
181479
‫שיטה לקבוע עדשה אופתלמית פרוגרסיבית‬
]33[
FR
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Method for the determination of a personalized progressive ophthalmic lens intended
to be inserted into a frame chosen by a given wearer for whom a power addition has
been prescribed in near-vision, the method comprising the stages of :
measuring parameters representing the frame chosen by the wearer ;
choosing an initial distribution of power and resulting astigmatism defect targets for
each direction of viewing under wearing conditions in an ordinary frame ;
calculating transformation coefficients using the measured parameters representing the
chosen frame and standard parameters ;
calculating a personalized distribution of the power and resulting astigmatism defect
May 31, 2011-‫כ"ז באייר התשע"א‬
targets on the lens by applying the calculated transformation coefficients to the initial
distribution;
calculating the power required on the lens for each direction of viewing by successive
iterations in order to obtain the target power defect and the target astigmatism defect.
__________________
]11[]21[
181519
‫שיטה ומערכת לגילוי ואיתור שגיאת כיוונון או‬
‫פגם במדחף של מסוק‬
]54[
METHOD AND SYSTEM FOR DETECTING AND
LOCATING AN ADJUSTMENT ERROR OR A
DEFECT OF A ROTORCRAFT ROTOR
]22[
]31[
]51[
]71[
]74[
22.02.2007
0609992
]32[
15.11.2006
]33[
FR
Int. Cl.(2010.01) B64C 27//00, G06F 19//00
EUROCOPTER, FRANCE
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The invention relates to a method of detecting and identifying a defect or an adjustment error of a rotorcraft
rotor using an artificial neural network (ANN), the rotor having a plurality of blades and a plurality of adjustment members associated with each blade; the network (ANN) is a supervised competitive learning
network (SSON, SCLN, SSOM) having an input to which vibration spectral data measured on the rotorcraft is applied, the network outputting data representative of which rotor blade presents a defect or an
adjustment error or data representative of no defect, and where appropriate data representative of the type
of defect that has been detected.
]57[
197
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
181525
‫מערך משאבה בעל מאפייני טעינה‬
‫מאובטחת‬
]54[
PUMP SET WITH SECURE LOADING
FEATURES
]22[
]31[
]51[
]71[
]74[
22.02.2007
11/366225
]32[
02.03.2006
]33[
US
Int. Cl.(2010.01) A61F 05//44, A61M 05//00, 05//142, 05//168, 31//00, F04B 43//00, 45//00
SHERWOOD SERVICES AG, SWITZERLAND
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]57[
198
A pump set for use with a pump to deliver a supply of liquid to a patient. The feeding set has a
conduit for the nutrient liquid and a safety interlock device associated with the conduit. The
pumping apparatus has a pumping device and a control system for controlling operation of the
pump. An electromagnetic radiation source is operatively connected to the control system of the
pump for emitting an electromagnetic radiation signal in a direction for striking the safety interlock device of the feeding set. The safety interlock device is adapted to affect the direction of the
electromagnetic radiation. An electromagnetic radiation detector is operatively connected to the
control system for receiving the electromagnetic radiation signal when the direction is affected by
the safety interlock device and providing an indication to the control system that the feeding set
conduit is properly positioned in the feeding pump.
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
‫מעטפת פולימרית הנתמכת על ידי ציפוי ושיטה‬
‫לייצורה‬
]54[
POLYMERIC SHELL
ADHERENTLY SUPPORTED BY A
LINER AND METHOD OF
MANUFACTURE
]22[
]31[
16.09.2005
60/614604
]32[ 30.09.2004
]33[ US
11/210515
24.08.2005
US
Int. Cl.(2010.01) A41D 19//00, A61B 19//04, B32B 25//10
ANSELL HEALTHCARE PRODUCTS
LLC, U.S.A.
WO/2006/039131
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
]57[
199
181535
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
An article comprising at least one cured, liquid-impervious polymeric shell substantially free from defects, at least one liner, and a non-tacky, thermoplastic adhesive layer
between the shell and the liner, wherein the adhesive layer is melted and solidified to
create a non-tacky bond between the shell and the liner, which can be moistureabsorbing or cut-resistant, whereby the liner supports and limits stretch ability of the
shell, thereby preventing adhesive delamination between the adhesive layer and either
May 31, 2011-‫כ"ז באייר התשע"א‬
of the shell and/or the liner; a method for the manufacture of an article comprising a
supported, polymeric shell, such as a glove, a gauntlet, an apron, or a boot, comprising
providing a cured, liquid-impervious, polymeric shell, providing a knitted/woven liner,
incorporating a non-tacky, thermoplastic adhesive layer between the shell and the liner, such as by hot-melt spraying, dry-powder spraying or fiber-coating, creating intimate contact between the shell, the adhesive layer, and the liner, subjecting the shell,
the adhesive layer, and the liner to infrared radiation to melt the adhesive layer and
create a bond between the shell and the liner, and cooling the shell; as well as other
methods.
__________________
]11[]21[
]54[
TRICYCLIC LACTAM
DERIVATIVES AS 11-BETA
HYDROXYSTEROID
DEHYDROGENASE INHIBITORS
]22[
]31[
]51[
26.08.2005
04104147.6
]32[ 30.08.2004
]33[ EP
Int. Cl.(2010.01) A61K 31//4035, 31//407, 31//437, A61P 03//00, C07D 20/9/64,
47/1/04, 49/5/04
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM
WO/2006/024628
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]71[
]87[
]74[
]57[
200
181581
ß–11 ‫תולדות לקטאם טריציקלי כמעכבות‬
‫הידרוקסיסטרואיד דהידרוגנאז‬
Compounds of formulae (I) and (I bis) are useful as 11BETA-HSD1 inhibitors for
treatment of obesity.
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
181687
]54[
APPARATUS FOR DELIVERING
ANTIGEN WHICH INDUCES
SPECIFIC CTL RESPONSE
]22[
]31[
10.07.1998
2209815
]32[ 10.07.1997
]33[ CA
08/988320
10.12.1997
US
Int. Cl.(2010.01) A61K 38//19, 39//12, A61M 01//00, 05//142, C07K 14//52
DIVISION FROM 133912
MANNKIND CORPORATION, U.S.A.
WO/1999/002183
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
An apparatus for delivering an antigen that includes an antigen specific CTL response
or sustains an induced antigen specific CTL response in an animal, wherein said apparatus comprises: a reservoir of a physiologically-acceptable, antigen-containing composition that is capable of inducing an antigen specific CTL response or sustaining an
induced antigen specific CTL response in an animal, a pump connected to the reservoir
to deliver the composition at a defined rate, a transmission line to discharge the composition from the reservoir, wherein the transmission line is capable of positioning in
the animal and can deliver the composition in a manner that reaches the lymphatic
system of the animal.
]51[
]62[
]71[
]87[
]74[
]57[
CTL ‫התקן להעברת אנטיגן אשר גורם לתגובת‬
‫ספציפית‬
__________________
]11[]21[
]54[
201
ROLL-UP HEATING FOR A
FLOOR OR WALL, ELECTRICAL
181756
‫ מחבר‬,‫חימום ניתן לגלילה עבור ריצפה או קיר‬
‫חשמלי עבור חימום ניתן לגלילה ושיטה לייצור‬
May 31, 2011-‫כ"ז באייר התשע"א‬
‫חימום ניתן לגלילה‬
CONNECTOR FOR A ROLL-UP
HEATING AND METHOD FOR
PRODUCING A ROLL-UP
HEATING
]22[
]31[
]51[
]71[
]87[
]74[
]57[
16.09.2005
1027053
]32[ 16.09.2004
60/616409
07.10.2004
Int. Cl.(2010.01) H05B 01//00
DEVI A/S, DENMARK
WO/2006/031114
BLUM, GADOR & CO.,
53 HASHALOM RD.,
GIVATAYIM 53454
]33[
NL
US
,'‫ גדור ושות‬,‫בלום‬
‫ מגדל הורד‬23 ‫ קומה‬,53 ‫דרך השלום‬
‫גבעתיים‬
The roll-up heating (1) for a floor, or wall, comprises an insulating layer (10) , a heating element (11) and a cladding (12) . The insulating layer (10) is intended for laying
on a floor (2) and the heating element (11) extends between the cladding (12) and the
insulating layer (10) . The cladding (12) is intended to support a floor covering- and
comprises a force distribution layer (13) for transmitting a force which is exerted on
the cladding (12) in a distributed manner to the insulating layer (10) . In as far as (a
part of) the heating element (11) is at the location or in the vicinity of the exerted
force, the load which will be exerted on it will be lower than the original load, due to
the force being transmitted in a distributed manner. This lowers the risk of the heating
element (11) being damaged.
__________________
]11[]21[
]54[
VEHICLE WITH CONTROLLED
RUNNING WHEELS
]22[
]51[
]71[
18.02.2007
Int. Cl.(2010.01) B62D 07//14
MICHAEL GRENADER
ALEXANDER ZOLDAN
]74[
MICHAEL GRENADER,
202
181772
‫כלי רכב בעל גלגלי תנועה מבוקרים‬
‫ חיפה‬,‫מיכאל גרנדר‬
‫ קריית מוצקין‬,‫אלכסנדר זולדן‬
,‫מיכאל גרנדר‬
May 31, 2011-‫כ"ז באייר התשע"א‬
50/15 ‫חטיבת כרמלי‬
‫חיפה‬
A vehicle with controlled running wheels (1…4) and steering device (5), which includes an
adjuster (13, 37, 38, 39, 42) linked to setters (15-18) of angles of wheel turn by means of
tracer pins (10) and guide slots (31-34), in which:
each setter is linked to its controlled wheel through a unit (6-9) that turns the wheel by an
angle that corresponds to the location of the center of turn of the vehicle;
at least two wheels, located along the diagonal of the vehicle, are drive wheels and are
linked to the engine;
one end of each tracer pin is kinematically connected to the adjuster by a common rotary
element (12), and the other end of the pin is connected to the guide slot of the corresponding setter;
the tracer pins are placed eccentrically with respect to the center of the rotary element, on
both sides of its axis;
the locations of the center of turn of the vehicle, that governs the direction of rectilinear motion and the radius of turn of the vehicle is determined by the shape and orientation of the
guide slots, the position of tracer pins relative to the guides, and the angle of turn and the
position of the rotary elements relative to its original position.
50/15 HATIVAT CARMELI ST.
HAIFA 32629
]57[
__________________
]11[]21[
203
]54[
DETONATION-PROOF GASTIGHT CONTAINER
]22[
]31[
]51[
02.09.2005
0402159-8
]32[ 09.09.2004
Int. Cl.(2010.01) F16J 13//12
181807
‫מיכל אטום לגז עמיד להצתה‬
]33[
SE
May 31, 2011-‫כ"ז באייר התשע"א‬
]71[
]72[
]87[
]74[
]57[
OLCON ENGINEERING AB,
SWEDEN
JOHNNY OHLSON
WO/2006/041351
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention relates to a, in the closed state, gas-tight detonation-proof container for the transport and storage of detonation-dangerous material, which container
can be opened and closed by remote control. The container (1, 2), which is of the type
which can be opened by separation, will also, if required, be able to be used for the
active detonation of dangerous material inside the same. The detonation-proof
transport container according to the invention is particularly characterized in that it is
opened and closed by means of a locking ring (3) , which is disposed between the two
parts (1, 2) of the container and is arranged such that it can be circumrotated in the
parting plane of the said parts and which, in the closed state, holds together the two
parts of the container and, for this purpose, has a double-sided multi-toothed bayonet
coupling (11, 12, 7, 8, 15, 16) which, upon a limited circumrotation, locks in the two
parts (1, 2) of the container.
__________________
]11[]21[
204
182463
‫שיטה והתקן לתמיכה ותפיסה של סובסטרט‬
‫במדפסת סובסטרט‬
]54[
METHOD AND APPARATUS FOR
SUPPORTING AND CLAMPING A
SUBSTRATE IN A SUBSTRATE
PRINTER
]22[
]31[
]51[
]71[
18.10.2005
10/967450
]32[ 18.10.2004
]33[ US
Int. Cl.(2010.01) B05C 17//08, B41F 15//26, H05K 03//12
SPEEDLINE TECHNOLOGIES, INC.,
U.S.A.
May 31, 2011-‫כ"ז באייר התשע"א‬
]87[
]74[
WO/2006/044767
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A stencil printer (10) for printing viscous material on a substrate (26) includes a frame
(12), a stencil (16) coupled to the frame (12), and a print head (18), coupled for the
frame (12), to deposit and print viscous material over the stenci (16). The stencil printer (10) further includes a substrate supporting and clamping assembly to support and
clamp a substrate in a print position. The substrate supporting and clamping assembly
(28) includes at least one support member to support the substrate in a print position, a
pair of rail members (22, 24), coupled to the frame (12), adapted to engage opposite
edges of the substrate (26), and a clamping mechanism (68), coupled to the frame, to
move at least one of the rail members (22, 24) against the substrate (26) to clamp the
substrate (26). The clamping mechanism (68) includes at least one piston to move the
at least one of the rail members (22, 24) between a first position in which the rail
member (22, 24) is spaced away from one of the opposite edges of the substrate (26)
and a second position in which the rail member (22, 24) engages one of the opposite
edges of the substrate (26) to clamp the substrate (26) between the rail members (22,
24) during a print operation. The clamping mechanism (68) further includes a pressure
regulator (70) to control a clamping force applied by the piston to the rail member (22,
24) against the edge of the substrate (26). A method for supporting and clamping a
substrate (26) in a print position is further disclosed.
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]11[]21[
205
]54[
PHARMACEUTICAL
COMPOSITIONS COMPRISING A
BENZOTHIAZOLE DERIVATIVE
AND THEIR USE
]22[
16.11.2005
182955
‫תכשירי רוקחות המכילים תולדת בנזותיאזול‬
‫ושימושם‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]31[
]51[
]71[
]72[
]87[
]74[
]57[
04105843.9
]32[ 17.11.2004
]33[ EP
60/628998
18.11.2004
US
Int. Cl.(2010.01) A61K 31//428, 31//506, 47//10, 47//14, 47//26
ARES TRADING S.A.,
SWITZERLAND
PASCALE GAILLARD, JEANPIERRE GOTTELAND, DANIELA
CHICCO, PIERANDREA ESPOSITO,
MARIO MAIO, LUCA DONATI,
ANDREA LEONARDI, STEFANIA
BERTERO, ISABELLE
JEANCLAUDE-ETTER, SIMONE
GRANDOLINI
WO/2006/053882
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD.,
18 ‫רחוב הקישון‬
18 HAKISHON ST.,
‫יבנה‬151 .‫ד‬.‫ ת‬,
P.O.B. 151,
YAVNE 81101
The present invention is related to macrogol glyceride pharmaceutical formulations
containing benzothiazole derivatives. In particular, the invention is related to benzothiazole stearoyl macrogol pharmaceutical formulations, method of preparation and use
thereof.
__________________
]11[]21[
]54[
APPARATUS FOR
CONTROLLING STANDBY
POWER
]22[
]31[
31.12.2004
10-2004]32[ 10.11.2004
0091564
Int. Cl.(2010.01) G06F 01//32
INCA SOLUTION CO. LTD,,
REPUBLIC OF KOREA
JEONG-SOO LEE, CHAN-DONG
KIM
WO/2006/052047
BEN-AMI & ASSOCIATES,
8 PLAUT ST.,
PARK TAMAR,
]51[
]71[
]72[
]87[
]74[
206
183019
‫מכשיר לבקרת חשמל במצב המתנה‬
]33[
KR
,'‫בן עמי ושות‬
8 ‫מנחם פלאוט‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]57[
P.O.B. 94,
‫רחובות‬94 .‫ד‬.‫ ת‬,
REHOVOT 76100
A standby power control apparatus includes: a power-supply unit for providing individual components with necessary power-supply voltages; an interface unit for interfacing a signal transmitted from a computer; an I/O terminal unit for transmitting input
signals received from a mouse and a keyboard to a microprocessor; a switching unit
for switching switches according to an external control signal; an individual load detector for detecting load of a peripheral device on the basis of the received powersupply state; a sensor for determining the presence or absence of a user; a microprocessor for switching the switching unit according to first to third input signals to control a power-supply voltage generated from the sockets; an individual drive signal generator for generating a drive signal to switch the switches of the switching unit; and a
monitoring/management unit for transmitting a power-supply control command signal
to the microprocessor, and providing the user with various administrator setup menus.
__________________
]11[]21[
]54[
METHOD FOR PREPARING NPHENYLPYRAZOLE-1CARBOXAMIDES
]22[
]31[
]51[
]71[
06.12.2005
60/633899
]32[ 07.12.2004
]33[ US
Int. Cl.(2010.01) C07C 25/5/58, C07D 23/1/14, 23/1/16, 23/1/20, 40/1/04
E.I. DU PONT DE NEMOURS AND
COMPANY, U.S.A.
WO/2006/062978
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method is disclosed for preparing compounds of Formula (I) by combining compounds of Formulae (II and III) and a sulfonyl chloride. Also disclosed are compounds
of Formula (III), which are useful as starting materials for this method.
]87[
]74[
]57[
207
183091
–1–‫–פנילפיראזול‬N ‫שיטה להכנת‬
‫קרבוקסאמידים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
183118
‫ זיהוים ושימוש‬,‫תאי גזע‬
]54[
STEM CELLS AND
IDENTIFICATION AND USE
THEREOF
]22[
]31[
]51[
]71[
14.11.2005
FI2004A000238 ]32[ 15.11.2004
]33[ IT
Int. Cl.(2010.01) G01N 33//569
AZIENDA OSPEDALIEROUNIVERSITARIA CAREGGI, ITALY
PAOLA ROMAGNANI, FRANCESCO
ANNUNZIATO, ENRICO MAGGI,
SERGIO ROMAGNANI
WO/2006/051112
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Herein is described a new population of circulating CD14+ cells, with a low density
surface expression of CD34 and endowed with stem capacity, a method for their purification and identification and their therapeutic use.
]72[
]87[
]74[
]57[
__________________
]11[]21[
]54[
208
HIGH TEMPERATURE SOLAR
183154
‫קולטן סולרי בטמפרטורות גבוהות‬
May 31, 2011-‫כ"ז באייר התשע"א‬
RECEIVER
]22[
]31[
]51[
]71[
]74[
]57[
13.05.2007
60/747087
]32[ 11.05.2006
Int. Cl.(2010.01) H01L 31//024
BRIGHTSOURCE ENERGY, INC.,
U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A solar receiver for concentrating collection system, comprising a receiver portion
having an array of tubes, at least some of which are at least partially transparent, the
receiver portion being disposed such that array of tubes receives concentrated solar
energy, each tube having a first inlet and first outlet so as to define a first flow channel
therebetween for conveying a working fluid the first outlet configured to evacuate the
working fluid from the first flow channel to an outlet pipe; and a second flow channel
for conveying a cooling fluid in thermal contact with the tubes, the second flow channel being defined between a second inlet and a second outlet, wherein the cooling fluid
conveyed by the second flow channel cools the working fluid conveyed by the first
flow channel further comprising a controller configured to detect temperatures of the
tubes and to control the flow of cooling fluid responsively thereto.
__________________
]11[]21[
‫מכשיר ושיטה לזיהוי וטיפול בתחושתיות‬
‫נרתיקית‬
]54[
DEVICE AND METHOD FOR
IDENTIFYING AND TREATING
VAGINAL AFFECTIONS
]22[
]51[
]71[
23.12.2004
Int. Cl.(2010.01) A61B 10//00, 19//04, G01N 33//52
ACTIAL FARMACEUTICA LDA,
PORTUGAL
WO/2006/080035
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to a pH test glove bearing a reporter substance indicating
the possible presence of vaginal affections, such as infections, in particular bacterial
vaginosis, or vaginitis. This glove is easy to use, accurate and safe for the woman usMay 31, 2011-‫כ"ז באייר התשע"א‬
]87[
]74[
]57[
209
183291
ing it. The present invention also provides packages comprising the glove and gynecological compositions for treating vaginal affections.
__________________
]11[]21[
‫מערכת ושיטה לפיזור חומר חיטוי לאסלה‬
]54[
TOILET DISINFECTANT
DISPENSING SYSTEM AND
METHOD THEREFOR
]22[
]51[
]71[
]74[
30.05.2007
Int. Cl.(2010.01) E03D 09//02
YOCHEVED SHASHO
‫ אביב‬-‫ תל‬,‫יוכבד שאשו‬
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A toilet-disinfectant dispensing system for a toilet bowl having a lid and a flush container, the system comprising: a dispenser for disinfectant substance, said dispenser
having an outlet leading to said toilet bowl; and a blower form of said dispenser, said
disinfectant substance comprises fluid disposed within said blower, and the blower
being installed between the lid and the flush container, thereby dispensing said disinfectant substance upon applying force by pressing said lid against said flush container.
]57[
This specification was examined in
210
183546
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
1968 – ‫ תשכ"ח‬,‫הפטנטים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
,212237
The applications for
division from this
application have not yet
been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
INFANT SEAT FOR MOTORCARS
]22[
]31[
]51[
]71[
]74[
11.06.2007
200601557U
]32[
30.06.2006
Int. Cl.(2010.01) B60N 02//28
JANE, S.A., SPAIN
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]57[
211
183837
‫מושב לפעוטות עבור מכוניות‬
]33[
ES
,‫ד"ר יצחק הס ושותפיו‬
279 ‫רחוב הירקון‬
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
The seat (1) includes a backrest (3) with lateral protections (4), and a liftable headrest (5). This
infant seat backrest is inferiorly provided with a complementary member (7) being linked to the
headrest by a mechanism (8) that when lifting (F) the headrest brings about a downwardly shifting motion (F') of the complementary member of the backrest. The mechanism is arranged between a rear plate (9) and a front plate (10) making up the backrest, the headrest and the complementary member of the backrest having guiding elements (11) for their shifting between the
two plates. The mechanism has an element (12) being rotatably secured at its center (13) and
having a respective link (14 and 15) fitted to each of its ends, the links being respectively linked
to the headrest and to the complementary member of the backrest.
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
‫הקצאת צרורות מידע ותמיכה בבקשה לשידור‬
‫נישנה אוטומטי כילאיים במערכת גישת רדיו‬
‫לגישת ריבוב חלוקת תדר אורתוגונלית‬
]54[
ALLOCATING DATA BURSTS
AND SUPPORTING HYBRID
AUTO RETRANSMISSION
REQUEST IN ORTHOGONAL
FREQUENCY DIVISION
MULTIPLEXING ACCESS RADIO
ACCESS SYSTEM
]22[
]31[
27.12.2005
10-2004]32[ 27.12.2004
]33[ KR
0112926
10-200427.12.2004
KR
0112929
Int. Cl.(2010.01) H04B 07//204, H04J 11//00, H04L 01//18
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2006/083077
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention relates to allocating data regions in an orthogonal frequency
division multiplexing access system. The present invention comprises receiving a mes-
]51[
]71[
]87[
]74[
]57[
212
183915
May 31, 2011-‫כ"ז באייר התשע"א‬
sage comprising information for locating a data region of a data map allocated to a
mobile station identified in the message for transmitting and receiving information,
and identifying the data region of the data map allocated to the identified mobile station by reading the received message, wherein the data region is identified independent
of identifying data regions of another data map.
__________________
]11[]21[
‫שימוש בקלאדריבין להכנת תכשיר לטיפול‬
‫בטרשת נפוצה‬
]54[
USE OF CLADRIBINE FOR
PREPARATION OF A
FORMULATION FOR TREATING
MULTIPLE SCLEROSIS
]22[
]31[
20.12.2005
60/638669
]32[ 22.12.2004
]33[ US
04106909.7
22.12.2004
EP
Int. Cl.(2010.01) A61K 09//20, 31//7076, A61P 25//00
MERCK SERONO S.A.,
SWITZERLAND
GIAMPIERO DE LUCA, ARNAUD
YTHIER, ALAIN MUNAFO, MARIA
LOPEZ-BRESNAHAN
WO/2006/067141
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD.,
18 ‫רחוב הקישון‬
18 HAKISHON ST.,
‫יבנה‬151 .‫ד‬.‫ ת‬,
P.O.B. 151,
YAVNE 81101
The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsingremitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein
the preparation is to be the orally administered and wherein re-treatments are possible.
]51[
]71[
]72[
]87[
]74[
]57[
213
183930
May 31, 2011-‫כ"ז באייר התשע"א‬
,212421
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
BASE FOR FITTING INFANT
SEATS TO MOTORCARS
]22[
]31[
]51[
]71[
]74[
24.06.2007
200601679 U ]32[ 14.07.2006
Int. Cl.(2010.01) B60N 02//28
JANE, S.A., SPAIN
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]57[
184160
‫בסיס עבור התאמת מושבי תינוקות למכוניות‬
]33[
ES
,‫ד"ר יצחק הס ושותפיו‬
279 ‫רחוב הירקון‬
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
A base includes an anchor being operable to engage a receiving element provided in a
motorcar. The anchor is actuated by a pneumatic device being in its turn actuated by a
control provided at the base. The pneumatic device and a control, made up by an articulated lever, are fitted to a framework. A piston of the pneumatic device is fitted to a
transversal carrier of the anchor by the head in a freely rotatable manner housing the
transversal carrier. The framework at each of its sides has a respective guide along
which the transversal carrier is shiftable, and supports for the fitting of the infant seat,
the framework being mounted on a platform.
__________________
214
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
184616
‫מערכת משאבה עם חיבור בטיחותי‬
]54[
PUMP SET WITH SAFETY INTERLOCK
]22[
]31[
]51[
]71[
]74[
15.07.2007
11/620353
]32[
05.01.2007
]33[
Int. Cl.(2010.01) A61M 05//142, 05//168, 25//085, F04B 01//00
COVIDIEN AG, SWITZERLAND
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A pump set (23) for use in a pumping apparatus (1) having a control system (17) for controlling operation of the pumping apparatus to supply fluid to a patient through the pump set loaded in the pumping
apparatus, a source of electromagnetic radiation operatively connected to the control system of the
pumping apparatus for emitting electromagnetic radiation, an electromagnetic radiation detector (109)
operatively connected to the control system for providing an indication that the pump set is properly
loaded on the pumping apparatus, the pump set comprising: a conduit (55) for carrying fluid to a patient;
an electromagnetic radiation propagation affecting member associated with the conduit and adapted for
mounting in the pumping apparatus in the path of the electromagnetic radiation from the source of electromagnetic radiation, the propagation affecting member comprising a body defining a fluid passage in
communication with the conduit for passing fluid through the body, the fluid passage having an axis, the
body including a light transmitting portion projecting generally radially from the fluid passage, the light
transmitting portion being formed of a material that transmits electromagnetic radiation, the light transmitting portion including at least one interposing surface and at least on channel located closer to the
axis of the fluid passage than the interposing surface, the channel defining a reflection surface generally
disposed on a radially outward side of the channel.
215
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
]54[
ACTUATING DEVICE
COMPRISING BIMETAL DISKS
]22[
]31[
]51[
]71[
09.02.2006
0501474
]32[ 14.02.2005
Int. Cl.(2010.01) G02B 07//02
SAGEM DEFENSE SECURITE,
FRANCE
WO/2006/085002
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
185178
‫התקן תפעול המכיל שתי דיסקיות מתכת‬
]33[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to an actuating device (15) comprising at least two coaxial bimetal disks (17, 18) and at least one axial strut (19) arranged between the disks (17,
18), the bimetal disks being mounted opposite each other and being deformable in opposite directions according to the thermal variations. The invention can be especially
applied to the thermal compensation of an optical system.
__________________
]11[]21[
216
]54[
HIGH THROUGHPUT ENDOILLUMINATOR PROBE
]22[
15.02.2006
185247
‫בודק מאיר פנימי בעל תפוקה גבוהה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]31[
]51[
]71[
]87[
]74[
]57[
60/653265
]32[ 15.02.2005
]33[ US
Int. Cl.(2010.01) A61B 01//07, 19//00, A61F 09//007
ALCON, INC., SWITZERLAND
WO/2006/088938
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A high throughput endo-illuminator and illumination surgical system are disclosed.
One embodiment of the high throughput endo-illumination surgical system comprises:
a light source for providing a light beam; a proximal optical fiber, optically coupled to
the light source for receiving and transmitting the light beam; a distal optical fiber,
optically coupled to a distal end of the proximal optical fiber, for receiving the light
beam and emitting the light beam to illuminate a surgical site, wherein the distal optical fiber comprises a tapered section having a proximal-end diameter larger than a distal-end diameter; a handpiece, operably coupled to the distal optical fiber; and a cannula, operably coupled to the handpiece, for housing and directing the distal optical fiber.
The tapered section's proximal end diameter can be the same as the diameter of the
proximal optical fiber, and can be, for example, a 20 gauge diameter. The tapered section's distal end diameter can be, for example, a 25 gauge compatible diameter. The
cannula can be a 25 gauge inner-diameter cannula. The proximal optical fiber can
preferably have an NA equal to or greater than the NA of the light source beam and the
distal optical fiber preferably can have an NA greater than that of the proximal optical
fiber and greater than that of the light source beam at any point in the distal optical
fiber (since the light beam NA can increase as it travels through the tapered section).
__________________
]11[]21[
]54[
CONTROL OF FLUID
CONDITIONS IN BULK FLUID
DELIVERY SYSTEMS
]22[
]31[
06.03.2006
60/659047
]32[ 04.03.2005
11/367140
03.03.2006
Int. Cl.(2010.01) B67D 07//08
AIR LIQUIDE ELECTRONICS U.S.
LP, U.S.A.
WO/2006/096646
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
217
185291
‫בקרת תנאי נוזלים במערכות להעברת נוזלים‬
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]57[
‫רמת החייל‬
An improved bulk fluid distribution for supplying process fluids to semiconductor process tools. The improved system having an alternating pressure vessel engine substantially eliminates pressure fluctuations in the bulk fluid supply line due to head losses
from the changing weight of the fluid in the dispensing vessels. The system also enables flexible control of the flow conditions of the fluid in the fluid supply line.
__________________
]11[]21[
‫מפענח רב ערוצי כמעט שקוף או‬/‫תכנית למקדד‬
‫שקוף‬
]54[
NEAR-TRANSPARENT OR
TRANSPARENT MULTICHANNEL ENCODER/DECODER
SCHEME
]22[
]31[
04.10.2005
60/655216
]32[ 22.02.2005
]33[ US
11/080775
14.03.2005
US
Int. Cl.(2010.01) G10L 19//00, H04H 20//28, H04S 03//00
FRAUNHOFER-GESELLSCHAFT
ZUR FORDERUNG DER
ANGEWANDTEN FORSCHUNG
E.V., GERMANY
WO/2006/089570
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
31 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
TEL AVIV 61013
Near-transparent or transparent multi-channel encoder/decoder scheme Abstract A
multi-channel encoder/decoder scheme additionally preferably generates a waveformtype residual signal (16). This residual signal is transmitted (18) together with one or
more multi-channel parameters (14) to a decoder. In contrast to a purely parametric
multi-channel decoder, the enhanced decoder generates a multi-channel output signal
having an improved output quality because of the additional residual signal.
]51[
]71[
]87[
]74[
]57[
218
185304
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
219
186197
‫התקן למינון ולעירפול יבש‬
]54[
DEVICE FOR DOSING AND DRY
NEBULIZATION
]22[
]31[
]51[
]61[
]71[
]87[
]74[
07.04.2006
102005016102.2 ]32[ 08.04.2005
]33[ DE
Int. Cl.(2010.01) A61M 11//06, 15//00, 16//20, B05B 11//06
186196
NYCOMED GMBH, GERMANY
WO/2006/105980
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The invention relates to a device (1) for dosing and dry nebulization of nebulizable
material (12) chosen from the group comprising anti- infective agents and immunomodulators, comprising a nebulization channel (3), which has a first attachment piece
and a second attachment piece, and a source of compressed carrier gas connected to the
first attachment piece via a valve (16) for the purpose of sending a carrier gas pressure
pulse into the nebulization channel. The device is characterized in that between the
first attachment piece and second attachment piece, and above the nebulization channel, a reservoir (10) open only towards the nebulization channel, which contains the
nebulizable material (12), is connected to the nebulizaton channel such that it is gastight with respect to the environment, and that, when the valve is closed, a pressure
compensation (22) takes place in the nebulization channel and in the reservoir. The
invention also relates to a method for dosing and dry nebulization of such a nebulizable
material by means of such a device.
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
186356
‫תכשיר ג'ל הידרואלכוהולי טרנסדרמלי לשימוש‬
2 ‫בטיפול בסוכרת מסוג‬
]54[
TRANSDERMAL
HYDROALCOHOLIC GEL
COMPOSITION FOR USE IN THE
TREATMENT OF TYPE-2
DIABETES
]22[
]31[
]51[
]71[
07.04.2006
60/669606
]32[ 08.04.2005
]33[
Int. Cl.(2010.01) A61K 47//10, A61P 03//10
UNIMED PHARMACEUTICALS,
LLC, U.S.A.
LABORATOIRES BESINS
INTERNATIONAL, FRANCE
WO/2006/108719
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention is generally related to a method of treating, preventing, or reducing the risk of developing type-2 diabetes, and, more particularly, is related to a method of administering a transdermal hydroalcoholic gel composition to treat or prevent
type-2 diabetes and a method of administering a transdermal hydroalcoholic gel composition to increase glycemic control in a subject in need thereof.
__________________
]11[]21[
220
186653
May 31, 2011-‫כ"ז באייר התשע"א‬
]54[
PASSIVE RADAR UTILIZING SPACE
BORNE DIGITAL
ELECTROMAGNETIC
ILLUMINATORS
]22[
]31[
25.05.2006
60/685797
]32[ 01.06.2005
PCT/IL2006/000618
25.05.2006
Int. Cl.(2010.01) G01S 13//90
DAN SHAKLARSKY
WO/2006/129306
DAN SHAKLARSKY,
9 DR. YONA ANGEL ST.
HAIFA 34952
]51[
]71[
]87[
]74[
]57[
‫מכ"מ פסיבי המנצל מקורות הארה‬
‫אלקטרומגנטיים ספרתיים נישאי חלל‬
]33[
US
WO
‫ חיפה‬,‫דן שקלרסקי‬
,‫דן שקלרסקי‬
9 ‫דר' יונה אנגל‬
‫חיפה‬
In a passive radar system a space-borne transmitter broadcasts wide-band digitally
modulated signals over a region and illuminates the region. A receiver antenna is oriented to receive radiation from at least one portion of the region. The portion is an area
viewed by the receiver antenna. A reference antenna is oriented toward the transmitter,
the reference antenna receives a portion of the wide-band digitally modulated signal. A
coherent processing time duration is selected based on: a radar cross-section of a target
within the viewed area, a bandwidth of the wide-band digitally modulated signal, and
the viewing angle of the receiver antenna. The received signal from the receiver antenna is coherently processed with a reference signal from the reference antenna, over a
time interval greater than the coherent processing time duration.
__________________
]11[]21[
221
]54[
METHOD AND SYSTEM FOR
CALIBRATION OF A RADIO
DIRECTION FINDER
]22[
20.04.2006
186834
‫מערכת ושיטה לכיול של מוצא כיוון רדיו‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]31[
]51[
]71[
]87[
]74[
11/113129
]32[ 25.04.2005
Int. Cl.(2010.01) G01S 01//08, 03//02
ELTA SYSTEMS LTD.
WO/2006/114784
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
]57[
A calibration method and a system for providing calibration data for use with a direction finder are provided. The method comprises providing a relative motion of a calibration receiver in a circle manner with respect to calibration transmitter at a predetermined distance from each other. The method also includes preparing and transmitting a communication frequency signal employed for transmitting a certain frequency
from a list of predetermined frequencies. The preparing comprises: (a) setting a value
of the dwell time ranges of the communication frequency signal to a predetermined
value; (b) synchronizing in time the dwell time ranges between the calibration transmitter and the calibration receiver by using clock signals of a common synchronization
source; (c) providing a hop duration time interval within the dwell time range for
transmitting the frequency; and (d) generating the communication frequency signal
corresponding to the frequency during the hop duration interval. At the calibration
receiver end, the method includes scanning the list of predetermined frequencies; intercepting a frequency signal transmitted during the hop duration time interval within
the dwell time ranges; and rejecting all other frequency signals received within the
dwell time ranges having duration different than the hop duration time interval by the
receiver.
US
‫ אשדוד‬,‫אלתא מערכות בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]11[]21[
222
]54[
TRANSFER OF KINETIC ENERGY
TO AND FROM FLUIDS
]22[
]31[
01.06.2006
60/685891
]32[
01.06.2005
187743
‫העברת אנרגיה קינטית לניגרים ומניגרים‬
]33[
US
May 31, 2011-‫כ"ז באייר התשע"א‬
]51[
]71[
]87[
]74[
]57[
Int. Cl.(2010.01) F03D 05//06
ARNOLD SYSTEMS LLC, U.S.A.
WO/2006/130719
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Method and apparatus for converting the kinetic energy of a moving fluid stream into
useful work by using a parallel cascade of aerofoils or hydrofoils positioned therein.
The foils may be provided with at least two degrees of freedom and adjacent foils
move in antiphase. The foils are subjected to resonant oscillations, known as flutter,
induced by the fluid flow. Profiled inflow and outflow ducts may be positioned upstream and downstream, and the apparatus may be enclosed in a profiled duct, to increase efficiency by altering the fluid velocity and pressure. The foils are cantilevered,
supported by vertical rods but are otherwise unattached. A cascade comprised of independent foil modules, each including a foil, a power conversion module and a motion
control module, may be programmed to (1) receive energy from a fluid stream to generate power, or (2) transfer energy into a fluid stream to create propulsion or pumping.
__________________
]11[]21[
223
]54[
USE OF A PHOTOACTIVE
COMPOUND FOR THE
MANUFACTURE OF A
MEDICAMENT FOR
ENHANCEMENT OF VISUAL
ACTIVITY, COMBINED WITH
IRRADIATING THEREAFTER
TARGET OCULAR TISSUE WITH
LIGHT ABSORBED BY A
PHOTOACTIVE COMPOUND
]22[
]31[
25.02.1997
08/613420
]32[
11.03.1996
187758
‫שימוש בתרכובת פעילה באור ליצור תרופה‬
‫לשיפור פעילות ראיה בצירוף הקרנת הרקמה‬
‫העינית עם אור הנבלע על ידי התרכובת הפעילה‬
‫באור‬
]33[
US
May 31, 2011-‫כ"ז באייר התשע"א‬
]51[
]62[
]71[
Int. Cl.(2010.01) A61K 09//127, 31//409, 41//00, 45//00, A61P 27//02
DIVISION FROM 126099
NOVARTIS AG, SWITZERLAND
QLT INC., CANADA
]87[
]74[
WO/1997/033619
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
Use of a green porphyrin, a hematoporphyrin derivative, a chlorin, a phlorin or a purpurin as a photoactive compound for the manufacture of a medicament for improving,
by repeated photodynamic therapy, visual activity in a human subject.
The parent application from which
this application has been divided has
not yet been published
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
126099
‫בקשת הורה לבקשה זו שטרם פורסמה‬
__________________
]11[]21[
‫שיטה והתקן ליצור אריג טווי–הדבקה מחוטים‬
‫תאיים‬
]54[
METHOD AND DEVICE FOR THE
MANUFACTURE OF A
SPUNBONDED FABRIC OF
CELLULOSIC FILAMENTS
]22[
]31[
]51[
]71[
12.12.2007
06026730.9
]32[ 22.12.2006
]33[ EP
Int. Cl.(2010.01) B05C 01//00, D01F 02//24
REIFENHAUSER GMBH & CO. KG
MASCHINENFABRIK, GERMANY
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A method for the manufacture of a spun-bonded fabric of cellulosic filaments, wherein
the filaments are spun from a cellulose solution by means of a spinneret wherein the
cellulosic filaments are subsequently introduced into a cooling chamber of at least two
cooling sections wherein the filaments in both cooling sections are supplied with process of cooling air of different rate and/or different temperature and/or different humidity wherein the cooled filaments are aerodynamically stretched downstream of the
cooling chamber wherein the aerodynamically stretched filaments are passed through a
diffuser and wherein the aerodynamically stretched filaments are deposited on a support after the filaments leave the diffuser.
]74[
]57[
224
188097
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
]54[
COLLISION AVOIDANCE
SYSTEM AND A METHOD
THEREFOR
]22[
]51[
]62[
]71[
29.06.2004
Int. Cl.(2010.01) G08G 01//0969, 01//16
DIVISION FROM 162767
ISRAEL AEROSPACE
INDUSTRIES LTD.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
225
188139
‫שיטה ומערכת למניעת התנגשות‬
‫ לוד‬,‫התעשייה האוירית לישראל בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A communication system mounted onboard a rotary winged host vehicle having a
rotor causing a respective communication interruption, for sharing data between participants of a radio link communication network, comprising:
a central processing unit for producing a data item,
a data link radio system for transmitting data items in the form of pulses during a
unique time slot assigned with the host,
and a radio controlling utility for receiving a pulse width depending upon at least a
duration of said communication
interruption and a duration of said time slot, giving rise to a modulated pulse and for
May 31, 2011-‫כ"ז באייר התשע"א‬
generating and transmitting a repetition of substantially identical modulated pulses ,
each of which indicating said data item,
thereby substantially reducing data discrepancies due to rotor interruptions.
__________________
]11[]21[
188253
‫הרכב רוקחות של תולדות ניטרואוקסי של‬
NSAIDS
]54[
PHARMACEUTICAL
FORMULATION OF NITROOXY
DERIVATIVES OF NSAIDS
]22[
]31[
]51[
]71[
]87[
]74[
29.06.2006
05106854.2
]32[ 26.07.2005
Int. Cl.(2010.01) A61K 09//48, 31//216
NICOX S.A., FRANCE
WO/2007/012539
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The present invention relates to a pharmaceutical formulation comprising: (a) one or
more NO-releasing NSAID(s) of formula (I); (b) one or more surfactants; (c) a carbonyl scavenger compound selected from free acid forms, salts, carboxylic acid esters
derivatives of a compound of the formula: H 2N-(CH2)m-(C6H4)-COOH wherein m = 010; and (d) optionally an oil or semi-solid fat and/ or a short-chain alcohol.
]33[
EP
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]11[]21[
]54[
226
REINFORCING FIBROUS
STRUCTURE FOR A COMPOSITE
MATERIAL AND A PART
CONTAINING SAID STRUCTURE
188304
‫מבנה סיבי מחזק לחומר מרוכב וחלק הכולל‬
‫מבנה זה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
21.06.2006
0506441
]32[ 24.06.2005
]33[ FR
Int. Cl.(2010.01) B29C 70//16, 70//24, B64C 11//20, D03D 25//00
SNECMA, FRANCE
SNECMA PROPULSION SOLIDE,
FRANCE
WO/2006/136755
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
A woven fibrous structure embodied in one piece, used for producing a composite material part and comprising an internal part or a core (72) and a part adjacent to the external surface thereof or a skin (74, 76), is formed by three-dimensional core weaving
with at least one weave selected from interlock and multilayer weaves and by skin
weaving with a weave which differs from the core weave and selected from a multilayer weave and a two-dimensional weave. It can be also formed by three-dimensional
weaving with at least one core interlock weave (72) and weaving with a fabric-, satin
or skin twill-type weave, wherein skin weaving is of a multilayer or two-dimensional
type. .
__________________
]11[]21[
227
]54[
SYSTEM AND METHOD FOR
JOINING NON-TRANSPARENT
PARTS BY MEANS OF A
RADIATION CURABLE
ADHESIVE
]22[
]31[
]51[
20.12.2007
00088/07
]32[ 22.01.2007
Int. Cl.(2010.01) B29C 65//14
188311
‫מערכת ושיטה לחיבור חלקים לא שקופים‬
‫באמצעי קרינת ריפוי מדביקה‬
]33[
SE
May 31, 2011-‫כ"ז באייר התשע"א‬
]71[
]74[
]57[
EROWA AG, SWITZERLAND
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A system for joining non-transparent parts by means of an electromagnetic radiation
curable adhesive, characterized in that the system comprises at least one at least partly
transparent element for inserting between the parts to be joined together such that
electromagnetic radiation beamed into the element initiates curing of a film of adhesive applied to the element and or to a non transparent part.
__________________
]11[]21[
]54[
FEET-EXERCISING DEVICE
]22[
]51[
]71[
]72[
]74[
24.12.2007
Int. Cl.(2010.01) A63B 21//00, 22//08
SHLOMO WEISBERGER
SHLOMO WEISBERGER
SHLOMO WEISBERGER,
60 HA'ALONIM ST,
KIRYAT TIVON 36041
]57[
A feet exercise device comprising:
188387
‫מתקן לתרגול רגליים‬
‫ קריית טבעון‬,‫שלמה וייסברגר‬
‫שלמה וייסברגר‬
,‫שלמה וייסברגר‬
60 ‫האלונים‬
‫קריית טבעון‬
two containers having wheels with a common predetermined rotational direction;
a harnessing device for securing individually the feet of an exerciser to said containers;
a medium comprising fluidic material to be placed in each of said containers for stepping on.
228
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
188803
]54[
LOW PH AERATED PRODUCTS
]22[
]31[
]51[
]71[
13.09.2006
05255943.2
]32[ 23.09.2005
]33[ EP
Int. Cl.(2010.01) A23G 01//52, 09//20, C07K 14//37
UNILEVER PLC, UNITED
KINGDOM
WO/2007/039065
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
‫ נמוך‬pH ‫מוצרים מאווררים בעלי‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
An aerated composition having a pH of less than 5.5 is provided, which composition
comprises hydrophobin.
__________________
229
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
189129
‫הרכבים מאווררים המכילים הידרופובין‬
]54[
AERATED COMPOSITIONS
COMPRISING HYDROPHOBIN
]22[
]31[
]51[
]71[
05.01.2007
06250524.3
]32[ 31.01.2006
]33[ EP
Int. Cl.(2010.01) A23G 09//32, 09//38, A23J 03//20, A23L 01//00, 01//19
UNILEVER PLC, UNITED
KINGDOM
WO/2007/087968
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]87[
]74[
]57[
An aerated composition having an overrun of at least 10% and comprising water and
an emulsified fat phase wherein at least 50% of the fat is liquid at 5°C is provided,
characterized in that the composition comprises hydrophobin. An aeratable composition is also provided.
__________________
]11[]21[
‫מסלול מקובע לכלי רכב מסילתיים‬
]54[
FIXED CARRIAGEWAY FOR RAIL
VEHICLES
]22[
]31[
]51[
]71[
]87[
]74[
12.10.2006
102005054820.2 ]32[ 15.11.2005
]33[ DE
Int. Cl.(2010.01) E01B 01//00
RAIL. ONE GMBH, GERMANY
WO/2007/056968
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Fixed track bed for rail vehicles which is mounted on elastic elements, with the concrete support plate (3) being composed of prefabricated plate elements (6) and a layer
of local concrete located thereon, with the prefabricated plate elements resting on the
elastic elements and forming a monolithic composite with the local concrete.
]57[
230
189167
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
‫התקן למדידת מיקום בוכנה בגליל‬
]54[
DEVICE FOR MEASURING THE
POSITION OF A PISTON IN A
CYLINDER
]22[
]31[
]51[
]71[
]74[
28.01.2008
0700596
]32[ 29.01.2007
]33[ FR
Int. Cl.(2010.01) F15B 15//14, F16H 21//04
HISPANO-SUIZA, FRANCE
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A device for measuring the position of a piston in a cylinder, extending along an axis,
the device comprising at least two position sensors, respectively comprising:
a first sensor member integral with a supporting pallet linked to the piston,
a second sensor member integral with the cylinder,
the first and second members of each sensor being arranged for being mobile in translation one relative to the other, along an axis parallel to the axis of the cylinder, the
device being characterized in that the first sensor members are integral with the same
supporting pallet being connected to the piston through a ball joint link.
]57[
231
189214
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
‫גלאי סמיכות עבור סגר למשקפות לראיית לילה‬
]54[
PROXIMITY DETECTOR FOR
NIGHT VISION GOGGLES SHUTOFF
]22[
]31[
]51[
]71[
14.09.2006
11/235930
]32[ 27.09.2005
]33[
Int. Cl.(2010.01) G01S 17//02, G08B 13//18
ITT MANUFACTURING
ENTERPRISES, INC., U.S.A.
WO/2007/120178
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
232
189378
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A night vision device is disclosed. The device includes a housing that houses an intensifier tube and a proximity sensor mounted on the housing. An ON/OFF switch is operatively coupled to the intensifier tube and to the proximity sensor such that operation
of the ON/OFF switch to the 'ON' position automatically activates the proximity sensor. A method of operating the night vision device with the proximity sensor is also
disclosed.
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
189658
]54[
PROCESSES FOR THE
PREPARATION OF N-PHENYL-2PYRIMIDINE-AMINE
DERIVATIVES
]22[
]31[
]51[
]62[
]71[
]87[
]74[
06.02.2003
0202873.6
]32[ 07.02.2002
]33[ GB
Int. Cl.(2010.01) C07D 21/3/46
DIVISION FROM 163158
NOVARTIS AG, SWITZERLAND
WO/2003/066613
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to novel amides and a process for preparing these amides.
]57[
–2–‫–פניל‬N ‫תהליכים להכנת תולדות של‬
‫פירימידין–אמין‬
__________________
]11[]21[
233
]54[
DEVICE AND METHOD FOR
CONTROLLING AN ANGULAR
COVERAGE OF A LIGHT BEAM
]22[
]31[
16.08.2006
60/711428
]32[
26.08.2005
189711
‫התקן ושיטה לשליטה בכיסוי זוויתי של קרן אור‬
]33[
US
May 31, 2011-‫כ"ז באייר התשע"א‬
]51[
]71[
]72[
]87[
]74[
]57[
Int. Cl.(2010.01) G02B 05//08
CAMTEK LTD.
DIANA SHAPIROV
WO/2007/023487
RECHES PATENTS,
P.O.B. 2148, HERZLIYA PITUACH
‫ מגדל העמק‬,‫קמטק בע"מ‬
‫דיאנה שפירוב‬
,‫רכס פטנטים‬
11 ‫מגדלי אקרשטיין המנופים‬
‫הרצליה פיתוח‬2148 .‫ד‬.‫ ת‬,
A system (8) and method for controlling an angular coverage of a light beam includes
defining a non-uniform angular coverage of a first light beam; altering a first spatial
relationship between a first movable transmissive deflector (20) and a first light source
(11) in response to the definition; directing a first light beam from the first light source
(11) through the first movable transmissive deflector (20) such as to provide a first
deflected light beam; and focusing the first deflected light beam, by a first optical focusing element (16), to provide a first focused light beam that is focused onto a first
area (17) that is characterized by a location that is substantially indifferent to changes
in the first spatial relationship.
__________________
]11[]21[
]54[
CONVERTIBLE CYCLING
APPARATUS
]22[
]31[
]51[
]71[
29.08.2006
11/224114
]32[ 13.09.2005
]33[
Int. Cl.(2010.01) B62J 01//16, B62K 13//00
TAGA DESIGN & DEVELOPMENT
LTD.
SHLOMO BARAK
WO/2007/031987
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.,
REHOVOT 76209
]72[
]87[
]74[
]57[
234
190019
‫מתקן אופניים הפיך‬
US
‫ תל אביב‬,‫תגא תכנון ופיתוח בע"מ‬
‫שלמה ברק‬
,‫דקל פטנט בע"מ‬
27 ‫חדר‬, 18 ‫מנוחה ונחלה‬
‫רחובות‬
Cycling apparatus including at least one front wheel and at least one rear wheel rotatably mounted on axles on a frame, a riding seat attached to the frame, a drive mechanism coupled to at least one of the wheels for driving the cycling apparatus, at least
one handlebar post attached to a portion of the frame, and a carrier member attachable
to the frame for carrying at least one of a child and an object therein and movable between first and second attachment orientations, wherein in the first attachment orientation the cycling apparatus is in a rider-powered orientation drivable by a rider sitting
on the seat and powering the drive mechanism, and wherein in the second attachment
orientation the cycling apparatus is in a stroller orientation wherein the at least one
May 31, 2011-‫כ"ז באייר התשע"א‬
handlebar post is arranged with respect to the carrier member to form a pushable
stroller,; wherein a center of gravity of the carrier member with respect to the axle of
the at least one front wheel at the first attachment orientation is different than at the
second attachment orientation.
__________________
]11[]21[
‫מחבר ניקוז עבור התקן קיבול מעבד חומר‬
]54[
DRAIN CONNECTOR FOR
SUBSTANCE PROCESSING
RECEPTACLE
]22[
]31[
]51[
]71[
18.09.2006
60/718466
]32[ 19.09.2005
]33[ US
Int. Cl.(2010.01) E03D 09//00, F16K 31//00
ADVANCED TECHNOLOGY
MATERIALS, INC., U.S.A.
WO/2007/035592
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A selectively closeable drain connector (100, 100A, 800) includes a hollow plunger
(110, 210, 810) moveable relative to an aperture-defining drain flange (150, 150A,
250, 850). The connector (100, 100A, 300, 400, 500, 500A, 800) includes two circumferential seals (133, 134, 235, 236) between the plunger (110, 210, 810) and the flange
(150, 150A, 250, 850), and includes at least one passage (126A-126C, 226A-226D,
826A-826C) disposed between the seals (133, 134, 235, 236) leading to a hollow interior (125, 225, 825). The drain connector (100, 100A, 300, 400, 500, 500A, 800) may
be joined to a processing bag (491, 591, 591A, 601, 701) and/or tank (301, 501, 501A,
601, 701) to form a substance processing receptacle 300, 400, 500, 500A).
]87[
]74[
]57[
235
190195
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
190511
‫פורמולציה משהה לפראלנקאזן‬
]54[
RETARD FORMULATION FOR
PRALNACASAN
]22[
]31[
]51[
]71[
29.09.2006
102005048293.7 ]32[ 08.10.2005
]33[ DE
Int. Cl.(2010.01) A61K 09//20, 09//24, 31//551
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2007/042160
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The inventive retard tablets comprising at least two layers, wherein at least one layer
rapidly releases a drug 1S 9S (RS, 3S) N-(2-Ethoxy-5-oxo- tetrafuran-3-yl)-6, 10dioxo-9-(isochinolin-1-oyl-amino)-1, 2, 3, 4, 7, 8, 9, 10-octahydro- 6-H-pyridazino [1 ,
2-a] [1, 2] diazepin-1-carboxamide and/or the salts or derivatives thereof and/or acids
released therefrom and at least one layer releases a drug 1S, 9S (RS, 3S) N-(2-Ethoxy5-oxo-tetrafuran-3-yl)-6,10- dioxo-9-(isochinolin-1-oyl-amino)-1, 2, 3, 4, 7, 8, 9, 10octahydro-6-H-pyridazino [1, 2-a] [1, 2] diazepin-1-carboxamide and/or the salts or
derivatives thereof and/or acids released therefrom in a delayed manner for treating
autoimmune diseases, type I and type II diabetes, rheumatoid arthritis, osteoarthritis
and/or psoriasis
]87[
]74[
]57[
__________________
236
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
190513
‫ בפרט‬,‫מתקן לאריזה וחלוקה של גופים מוצקים‬
‫או קפסולות‬/‫טבליות למתן דרך הפה ו‬
]54[
DEVICE FOR THE PACKAGING
AND DISPENSING OF SOLID
SHAPED BODIES, ESPECIALLY
ORAL TABLETS AND/OR
CAPSULES
]22[
]31[
]51[
]71[
26.09.2006
P0500919
]32[ 05.10.2005
]33[ HU
Int. Cl.(2010.01) A47F 01//10, B65D 83//04
CHINOIN GYOGYSZER ES
VEGYESZETI TERMEKEK GYARA
ZRT., HUNGARY
WO/2007/039779
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to a device for the packaging and dispensing of solid shaped bodies, especially oral tablets or/and capsules, which device has a container sealed with a
cap suitable for storing shaped bodies, a dispensing opening, and tools forwarding the
shaped bodies from the inside of the container to the dispensing opening. The container (5) is constructed in a house (1) in a way that it can be moved like a piston against
elastic returning force. The dispensing opening (35) is situated in the bottom (2a) of
the house (1) ; when the device is in a position when it is not used for dispensing, the
end-part of the container (5) , with an opening (20) for releasing one shaped body at a
time situated opposite the end of the container (5) sealed with a cap, fits into the dispensing opening (35) by sealing it, and it is constructed in a way that in the course of
the dispensing operations it makes it possible to dispense favourably one shaped body
at a time outside of the house (1) .
]87[
]74[
]57[
__________________
237
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
191825
‫מבנה מתאם‬
]54[
FITTING STRUCTURE
]22[
]31[
17.11.2006
2005-344460 ]32[ 29.11.2005
]33[ JP
2006-110828
13.04.2006
JP
Int. Cl.(2010.01) F16L 23//00, 23//04
IHARA SCIENCE CORPORATION,
JAPAN
WO/2007/063717
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
31 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
TEL AVIV 61013
An engagement section (7a) of a holder (7) is engaged with a metal gasket (6), the
gasket (6) is received in a tubular section (7b), and the tubular section (7b) is fitted in a
step section (5a) of a connection pipe (1a). Then, another connection pipe (1b) is
placed close to and facing the connection pipe (1a) that holds the gasket (6) through
the holder (7), and a center ring (9) is installed surrounding the outer peripheries of
flanges (2a, 2b). Subsequently, while a trapezoidal section having slopes (3a, 3b) as
opposite sides is inserted into a groove (14), segments (10a-10c) are closed to form a
ring shape. A bolt (11) penetrated through a cutout (12) of the segment (10a) is
screwed into a threaded hole (13) of the segment (10c). The screwing of the bolt causes the amount of insertion of the trapezoidal section, which has the slopes (3a, 3b) as
opposite sides, into the groove (14) to be increased. As a result the distance between
the flanges (2a, 2b) is reduced and contact pressure of projections (4a, 4b) against both
sides of the gasket (6) is increased.
]51[
]71[
]87[
]74[
]57[
__________________
]11[]21[
]54[
238
SUBSTITUTED PYRIDINES AND
193368
‫פירידינים ופירידאזינים בעלי פעילות מעכבת‬
May 31, 2011-‫כ"ז באייר התשע"א‬
PYRIDAZINES WITH
ANGIOGENESIS INHIBITING
ACTIVITY, USES THEREOF IN
THE PREPARATION OF
PHARMACEUTICAL
COMPOSITIONS AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]22[
]31[
]51[
]62[
]71[
]87[
]74[
]57[
‫ שימוש בהם להכנת תכשיר‬,‫היווצרות כלי דם‬
‫רוקחי ותכשירים רוקחיים המכילים אותם‬
26.09.2000
09/407600
]32[ 28.09.1999
]33[ US
Int. Cl.(2010.01) A61K 31//395, A61P 43//00, C07D 40/1/06, 40/1/12, 40/1/14,
40/3/12, 40/3/14, 40/5/14, 41/7/14, 48/7/04, 49/1/048, 49/5/02, 51/3/04
DIVISION FROM 148880
BAYER CORPORATION, U.S.A.
WO/2001/023375
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
Substituted pyridines and pyridazines having angiogenesis inhibiting activity and generalized structural formula (I) wherein the ring containing A, B, D, E, and L is phenyl
or a nitrogen-containing heterocycle; groups X and Y may be any of a variety of defined linking units; R1 and R2 may be defined independent substituents or together
may be a ring-defining bridge; ring J may be an aryl, pyridyl, or cycloalkyl group; and
G groups may be any of a variety of defined substituents. Pharmaceutical compositions containing these materials, and methods of treating a mammal having a condition characterized by abnormal angiogenesis or hyperpermeability processes using
these materials are also disclosed.
__________________
]11[]21[
]54[
239
METHOD AND SYSTEM FOR
194654
‫שיטה ומערכת לשליטה על חלוקת משאבי‬
‫מחשוב‬
May 31, 2011-‫כ"ז באייר התשע"א‬
TRANSACTION RESOURCE
CONTROL
]22[
]31[
]51[
]71[
]87[
]74[
]57[
27.12.2007
60/871994
]32[ 27.12.2006
]33[ US
Int. Cl.(2010.01) G06F 09//46
MORE IT RESOURCES LTD.
‫ בני ברק‬,‫ בע"מ‬.‫טי‬.‫מור משאבי אי‬
WO/2008/078329
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A method of controlling resource consumption of running processes, sub processes
and/or treads (such as a database or an application transaction) in a computerized system, in which resources consumed by less important processes are freed by periodically suspending (by causing them to demand less resources) and resuming these processes transparently to other entities of the computerized system and externally to the OS
without intervention in its inherent resource allocation mechanism and allowing the
OS of the computerized system to allocate the free resources to other running processes.
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
1968 – ‫ תשכ"ח‬,‫הפטנטים‬
This specification was examined in accordance
with regulation 35 of the Patent Regulations,
5728 - 1968
__________________
]11[]21[
]54[
CONTAINERS FROM OXYGENSCAVENGING RESIN
COMPOSITIONS HAVING LOW
HAZE
]22[
]31[
25.07.2002
09/916671
]32[ 26.07.2001
]33[
10/195385
16.07.2002
Int. Cl.(2010.01) B65D 81//24, C08J 03//22
DIVISION FROM 160021
M & G POLIMERI ITALIA S.P.A.,
ITALY
WO/2003/010225
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
]51[
]62[
]71[
]87[
]74[
240
195082
‫מיכלים מתכשירי שרפים סופחי חמצן בעלי‬
‫אביכות נמוכה‬
US
US
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]57[
BEER-SHEVA 84152
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
A resin composition provides good optical properties when stretched and efficient oxygen-scavenging, the resin composition comprising a film-forming polyester and an
effective amount of oxygen-scavenging particles, wherein the particles have a particle
size distribution such that particles of less than about 25 microns in size do not exceed
a concentration defined by a formula that includes the apparent density of the particles.
A container provides effective oxygen-scavenging functionality, while having low
haze. A method is also provided for incorporating high levels of oxygen-scavenging
particles into a film-forming polyester resin composition with low haze when
stretched.
__________________
]11[]21[
‫התקן לריפוי הקרנה מתנייע‬
]54[
MOBILE RADIATION THERAPY
APPARATUS
]22[
]31[
18.05.2007
60/747734
]32[ 19.05.2006
]33[ US
11/687225
16.03.2007
US
Int. Cl.(2010.01) A61G 03//00, A61N 05//10
BREYA, LLC, U.S.A.
WO/2007/136733
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention provide techniques for diagnosing medical conditions and providing
appropriate treatment at a patient's home residence. A mobile x-ray team can be dispatched to the patient's home residence. A technical team reviews patient data to determine a proper therapy plan. A mobile radiation therapy apparatus is dispatched to
the patient's home as required by the therapy plan. The mobile radiation therapy apparatus includes a radiation source and shielding, and is capable of superficial radiation
therapy and/or High Dose Rate (HDR) implant therapy. For HDR therapy, the mobile
radiation therapy apparatus itself is a specialized radiation vault which the patient will
enter. The technical team adjusts the therapy plan based on the additional analysis, and
the mobile radiation therapy apparatus is dispatched in accordance with adjusted therapy plan.
]51[
]71[
]87[
]74[
]57[
241
195371
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
195446
‫תכשירים נוגדי דלקת המכילים רצפי גלקטין‬
]54[
ANTI-INFLAMMATORY
COMPOSITIONS COMPRISING
GALECTIN SEQUENCES
]22[
]31[
13.11.2003
60/426041
]32[ 14.11.2002
]33[ US
60/428691
25.11.2002
US
Int. Cl.(2010.01) A61K 38//17, A61P 29//00, C07K 14//435, C12N 15//12
DIVISION FROM 168519
TEL-AVIV MEDICAL CENTER
-‫ תל‬,‫קרן מחקרים רפואיים ופיתוח תשתית‬
RESEARCH AND DEVELOPMENT
‫אביב‬
FUND
‫יישום חברה לפיתוח המחקר של‬
YISSUM RESEARCH
‫ירושלים‬
,‫בירושלים‬
‫האוניברסיטה העברית‬
DEVELOPMENT COMPANY OF
]51[
]62[
]71[
]72[
]87[
]74[
]57[
THE HEBREW UNIVERSITY OF
JERUSALEM
ITSHAK GOLAN, LORA MELNIK,
‫ דן כספי‬,‫ לורה מלניק‬,‫יצחק גולן‬
DAN CASPI
WO/2004/043332
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
A pharmaceutical composition, comprising, as active ingredients, a galectin-8 or a
derivative thereof which maintains the anti-inflammatory activity of said galectin-8
and at least one type of a non-steroidal anti-inflammatory drug (NSAID) and a pharmaceutically acceptable carrier.
__________________
242
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
195447
‫פוליפפטיד גלקטין בעל תכונות נוגדות דלקות‬
]54[
GALECTIN POLYPEPTIDE
HAVING ANTI-INFLAMMATORY
PROPERTIES
]22[
]31[
13.11.2003
60/426041
]32[ 14.11.2002
]33[ US
60/428691
25.11.2002
US
Int. Cl.(2010.01) A61K 38//17, A61P 29//00, C07K 14//435, 14//705, C12N 15//12,
15//74
DIVISION FROM 168519
TEL-AVIV MEDICAL CENTER
-‫ תל‬,‫קרן מחקרים רפואיים ופיתוח תשתית‬
RESEARCH AND DEVELOPMENT
‫אביב‬
FUND
‫יישום חברה לפיתוח המחקר של‬
YISSUM RESEARCH
‫ירושלים‬
,‫בירושלים‬
‫האוניברסיטה העברית‬
DEVELOPMENT COMPANY OF
]51[
]62[
]71[
]72[
]87[
]74[
]57[
THE HEBREW UNIVERSITY OF
JERUSALEM
ITSHAK GOLAN, LORA MELNIK,
‫ דן כספי‬,‫ לורה מלניק‬,‫יצחק גולן‬
DAN CASPI
WO/2004/043332
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
An isolated polypeptide comprising a galectin-8 amino acid sequence devoid of amino
acids 115-150 of SEQ ID NO: 4 and being at least 95% identical to the amino acid
sequence set forth in SEQ ID NO: 6, 8, or 16, wherein said polypeptide reduces proinflammatory cytokines and increases anti-inflammatory cytokines in synovial fluid
cells.
__________________
]11[]21[
243
]54[
ANTI-GALECTIN ANTIBODIES
AND DIAGNOSTIC USES
THEREOF
]22[
]31[
13.11.2003
60/426041
60/428691
]32[
14.11.2002
25.11.2002
195448
‫נוגדנים נגד גלקטין והשימוש בהם לאבחון‬
]33[
US
US
May 31, 2011-‫כ"ז באייר התשע"א‬
]51[
]62[
]71[
]72[
]87[
]74[
]57[
Int. Cl.(2010.01) A61K 39//395, A61P 29//00, C07K 16//18, 16//28, C12N 15//13
DIVISION FROM 168519
TEL-AVIV MEDICAL CENTER
-‫ תל‬,‫קרן מחקרים רפואיים ופיתוח תשתית‬
RESEARCH AND DEVELOPMENT
‫אביב‬
FUND
‫יישום חברה לפיתוח המחקר של‬
YISSUM RESEARCH
‫ירושלים‬
,‫בירושלים‬
‫האוניברסיטה העברית‬
DEVELOPMENT COMPANY OF
THE HEBREW UNIVERSITY OF
JERUSALEM
ITSHAK GOLAN, LORA MELNIK,
‫ דן כספי‬,‫ לורה מלניק‬,‫יצחק גולן‬
DAN CASPI
WO/2004/043332
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
Isolated polynucleotides encoding novel galectin-8 variants polypeptides are provided.
Also provided are methods and kits using same for diagnosing, prognosing and treating rheumatoid arthritis (RA) and other joint / chronic inflammatory diseases.
__________________
]11[]21[
]54[
NUCLEIC ACID ENCODING
TRUNCATED TRYPTOPHANYL
TRNA SYNTHETASE
]22[
]31[
]51[
]62[
]71[
21.03.2001
60/193471
]32[ 31.03.2000
]33[ US
Int. Cl.(2010.01) A61K 31//7088, 38//02, C07K 02//00, 14//435, C12N 09//00, 15//54
DIVISION FROM 151940
THE SCRIPPS RESEARCH
INSTITUTE, U.S.A.
WO/2001/075078
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Compositions comprising truncated tryptophanyl-tRNA synthetase polypeptides useful
for regulating angiogenesis, as well as nucleic acids encoding such tRNA synthetase
polypeptides are described. Methods of making and using such compositions are also
disclosed.
]87[
]74[
]57[
244
195677
tRNA–‫חומצת גרעין המקודת טריפטופניל‬
‫סינטטז מקוצר‬
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
195973
‫שיטות וחומרים לבחינת אפופטוזיס‬
]54[
METHODS AND MATERIALS FOR
OBSERVING APOPTOSIS
]22[
]31[
]51[
]71[
]87[
]74[
20.06.2007
60/814955
]32[ 20.06.2006
Int. Cl.(2010.01) G01N 33//50
GENENTECH, INC., U.S.A.
WO/2007/149486
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
The invention provides methods and materials for observing protein fragments generated during apoptosis in order to observe this process in mammalian cells. Embodiments of the invention can be used for example to observe apoptosis in order to examine the sensitivity of a mammalian cancer cell to apoptosis inducing agents.
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]11[]21[
245
]54[
METHOD FOR ACCELERATING
UNLOADING OF DATA FROM A
PERIPHERAL DEVICE
]22[
]51[
]62[
]71[
11.01.1999
Int. Cl.(2010.01) G06F 13//12
DIVISION FROM 152212
SANDISK IL LTD.
196372
‫שיטה להאצת הורדת נתונים מהתקן היקפי‬
‫ כפא סבא‬,‫סאנדיסק אייאל בע"מ‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]74[
]57[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method for accelerated unloading of data from a peripheral device to a plurality of
memory addresses associated with a CPU, which has a data bus and an accumulator
having a connection to said data bus, the method comprising:
disabling said connection between said data bus and said accumulator; and
unloading data from said peripheral device onto said data bus.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
__________________
]11[]21[
196444
‫טיהור רנ"א על–ידי היווצרות סליל משולש עם‬
‫אוליגונוקלאוטיד מקובע‬
]54[
PURIFICATION OF RNA BY A
TRIPLE HELIX FORMATION
WITH AN IMMOBILIZED
OLIGONUCLEOTIDE
]22[
]31[
]51[
]62[
]71[
]87[
]74[
25.05.2001
09/580923
]32[ 26.05.2000
]33[ US
Int. Cl.(2010.01) B01D 15//38, C12N 15//10, C12Q 01//68
DIVISION FROM 152860
CENTELION, FRANCE
WO/2001/092511
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A method for purifying double-stranded RNA from a solution containing the doublestranded RNA mixed with other components, comprising passing the solution through
a support comprising a covalently coupled oligonucleotide capable of forming a triple
helix with the double-stranded RNA by hybridization with a specific sequence present
in the double-stranded RNA without formation of any non-canonical triad, wherein the
covalently coupled oligonucleotide comprises the sequence TCTTTTTTTCCT (SEQ
ID NO:28) or TTCTTTTTTTTCTT (SEQ ID NO:30).
]57[
__________________
]11[]21[
]54[
246
METHOD OF TREATMENT OF A
WORKPIECE FOR IMPROVED
197164
‫שיטת טיפול במוצר לשיפור עמידות נגד קורוזיה‬
‫של משטח מגנזיום‬
May 31, 2011-‫כ"ז באייר התשע"א‬
MAGNESIUM SURFACE
CORROSION-RESISTANCE
]22[
]31[
]51[
]62[
]71[
]72[
]87[
]74[
]57[
25.06.2002
60/301147
]32[ 28.06.2001
]33[ US
Int. Cl.(2010.01) C23C 22//57
DIVISION FROM 159221
ALONIM HOLDINGS
‫ קיבוץ‬,‫אלונים אחזקות אגש"ח בע"מ‬
AGRICULTURAL COOPERATIVE
‫אלונים‬
SOCIETY LTD.
ILYA OSTROVSKY
‫איליה אוסטרובסקי‬
WO/2003/002773
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A method, a composition and a method for making the composition for increasing the
corrosion resistance of a magnesium or magnesium al1oy surface is disclosed. The
composition is a water/organic solution of one or more hydrolyzed silanes. By binding
silane moieties to the magnesium surface, an anti-corrosion coating on a magnesium
workpiece is produced. A complementary method, composition and method for preparing the composition for treating a metal surface to increase corrosion resistance is disclosed. The composition is an aqueous hydrogen fluoride solution with a non-ionic
surfactant.
__________________
]11[]21[
‫שיטה והתקן לבקרת שידורים במערכת‬
‫תקשורות‬
]54[
METHOD AND APPARATUS FOR
CONTROLLING TRANSMISSIONS
OF A COMMUNICATIONS
SYSTEM
]22[
]31[
]51[
]62[
]71[
20.03.2001
09/539157
]32[ 30.03.2000
]33[ US
Int. Cl.(2010.01) H04W 52//00, 52//24, 52//26, 52//34
DIVISION FROM 151705
QUALCOMM INCORPORATED,
U.S.A.
WO/2001/076098
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
May 31, 2011-‫כ"ז באייר התשע"א‬
]87[
]74[
247
197980
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method for processing a signal to be transmitted from a transmitting entity to a receiving entity, the method comprising:
selecting a transmit channel from at least two transmit channels associated with the
transmitting entity, wherein each of the at least two transmit channels has an associated
back-off factor and transmit power, and wherein the transmit power for each of the at
least two transmit channels is based on the back-off factor for the transmit channel,
and wherein the selecting is based on the back-off factor of the selected transmit channel and on at least one attribute associated with the receiving entity; and
assigning the selected transmit channel to the receiving entity.
REHOVOT 76122
]57[
__________________
]11[]21[
198131
]54[
NUCLEAR FACTOR KAPPA B
INDUCING FACTOR
]22[
]31[
02.04.2001
60/193905
]32[ 31.03.2000
]33[ US
0018307.9
26.07.2000
GB
Int. Cl.(2010.01) A61K 39//395, C07K 16//18
DIVISION FROM 151987
AVENTIS PHARMACEUTICALS
INC., U.S.A.
WO/2001/074900
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
An isolated antibody that specifically binds to a Nuclear Factor κB Including Factor
(NFIF) protein.
]51[
]62[
]71[
]87[
]74[
]57[
KB ‫פקטור משרה פקטור גרעין‬
__________________
]11[]21[
]54[
248
BOEHMITE PARTICLES
198456
‫חלקיקי בוהמייט‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]22[
]31[
]51[
]62[
]71[
]87[
]74[
]57[
16.04.2003
60/374,014
]32[ 19.04.2002
]33[ US
Int. Cl.(2010.01) C01F 07//44, C08K 03//00
DIVISION FROM 164534
SAINT-GOBAIN CERAMICS &
PLASTICS, INC., U.S.A.
WO/2003/089508
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
7 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A modified polymer material is disclosed, including a polymer base and boehmite particles provided in the polymer base. The boehmite particles are made up of mainly
anisotropically shaped particles.
__________________
]11[]21[
‫מבנה שובר גלים מטיפוס מדרוני מאבן עם‬
‫ליבה מבנית‬
]54[
RUBBLE MOUND
BREAKWATER STRUCTURE
WITH CONSTRUCTIVE CORE
]22[
]51[
]71[
14.07.2009
Int. Cl.(2010.01) C04B 11/1/74, E02B 03//06, E02D 29//09
DAVID SHVARTSMAN
‫לציון‬-‫ ראשון‬,‫דוד שוורצמן‬
ALEXANDER SHVARTZ, U.S.A.
‫אלקסנדר שוורץ‬
]74[
,‫דוד שוורצמן‬
10/3 ‫ראובן ובת שבע‬
‫לציון‬-‫ראשון‬
Rubble mound structure, comprising a stone core, rock armour or armour from concrete units, which in order to increase its stability under complex engineeringgeological conditions and under action of seismic loads of high intensity, is provided
with a constructive core, guaranteeing overall stability; and in order to ensure local
stability of the slopes of said structure, plates are laid down on the inner lateral surface
of berms at the base of the rock armour or armour from concrete units to the level of
the base of said structure and said rubble mound structure can comprise the disposition
of constructive core and said plates with intervals along the whole construction.
]57[
DAVID SHVARTSMAN,
3/10 REUVEN AND BAT SHEVA,
RISHON-LEZION
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
249
199843
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
1968 – ‫ תשכ"ח‬,‫הפטנטים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
__________________
]11[]21[
]54[
RETAINING WALL WITH
UNLOADING STRUCTURE OF
GRAVITY TYPE
]22[
]51[
]71[
14.07.2009
Int. Cl.(2010.01) E02D 29//02
DAVID SHVARTSMAN
ALEXANDER SHVARTZ, U.S.A.
]74[
]57[
199845
‫קיר תומך עם מבנה פורק עומס גרביטציוני‬
‫לציון‬-‫ ראשון‬,‫דוד שוורצמן‬
‫אלקסנדר שוורץ‬
DAVID SHVARTSMAN,
,‫דוד שוורצמן‬
3/10 REUVEN AND BAT SHEVA,
10/3 ‫ראובן ובת שבע‬
RISHON-LEZION
‫לציון‬-‫ראשון‬
A retaining wall , containing a guarding structure, including sheet pile or gravity main
wall, anchor system and unloading structure, distinguished in that the unloading structure is executed in a form mutually-anchored face and rear panels on the main wall in
order to increase stability and strength of the retaining wall and essentially decrease
the quantity of materials.
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
1968 – ‫ תשכ"ח‬,‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
__________________
]11[]21[
]54[
MULTIHUED LABELS
]22[
]31[
30.08.1999
09/146984
]32[ 03.09.1998
]33[
09/332613
14.06.1999
Int. Cl.(2010.01) G01N 01//00, 21//64, 33//58
DIVISION FROM 141759
TRELLIS BIOINFORMATICS, INC.,
U.S.A.
WO/2000/014545
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]62[
]71[
]87[
]74[
250
199919
‫תוויות מרובות גוונים‬
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]57[
A spatially defined arrangement of particulate different labels wherein each different
label comprises a particulate support to which is coupled at least two signal generating
fluorophores wherein each of said fluorophores emits a detectable signal different
from that emitted by the other(s) and wherein the magnitude of each of said emitted
signals is varied among said different labels whereby each different label is thereby
characterized by a different hue, which hue is detected and distinguished from the other hues in the multiplicity of labels whereby each different label is identifiable in situ,
and wherein said arrangement of particulate labels is displayed on a surface to permit
determination of the spatial position of said labels by means of fluorescence microscopy; and wherein each different label is associated with a different reagent .
__________________
]11[]21[
201146
‫תהליך להכנת תכשיר מתרומבין שהנגיפים‬
‫הוצאו מכלל פעולה‬
]54[
PROCESS FOR PRODUCING A
VIRUS-INACTIVATED
THROMBIN PREPARATION
]22[
]31[
]51[
]62[
]71[
07.07.2003
0216002.6
]32[ 10.07.2002
]33[ GB
Int. Cl.(2010.01) A61K 38//00, A61L 02//00, A61P 07//04, C12N 09//74
DIVISION FROM 165989
NHS BLOOD AND TRANSPLANT,
UNITED KINGDOM
WO/2004/007707
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method for the preparation of virus-inactivated thrombin comprising solventdetergent virus inactivation of a solution comprising prothrombin and factor X, loading
the virus inactivated prothrombin and factor X onto an anion exchange medium, washing the medium to remove the reagents used for the solvent-detergent virus inactivation, and activating the prothrombin on the medium to form thrombin by the addition
of metal ions, preferably calcium ions. The thrombin is then preferably selectively
eluted from the anion exchange medium.
]87[
]74[
]57[
__________________
251
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
202330
‫אוכלוסיות מבודדות המכילות תאים מולידיים‬
‫מקריש ווארטון של הטבורי בני–אדם ושיטות‬
‫המשמשות בהם‬
]54[
ISOLATED CELL POPULATIONS
COMPRISING PROGENITOR
CELLS FROM WHARTON'S
JELLY OF HUMAN UMBILICAL
CORDS AND METHODS
UTILIZING SAME
]22[
]31[
]51[
]62[
]71[
10.02.2004
60/446275
]32[ 11.02.2003
]33[ US
Int. Cl.(2010.01) C12N 05//00
DIVISION FROM 170221
JOHN E. DAVIES, CANADA
DOLORES BAKSH, CANADA
RAHUL SARUGASER, CANADA
MORRIS HOSSEINI, GERMANY
ANTONY DAVID SUTTON
LICKORISH, CANADA
WO/2004/072273
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
Human progenitor cells are extracted from Wharton's jelly that lies within a perivasculature zone of human umbilical cord. The progenitor cell population proliferates rapidly, and harbours both osteoprogenitor cells and MHC-/- cells, and is useful to grow and
repair human tissues including bone.
]87[
]74[
]57[
__________________
252
May 31, 2011-‫כ"ז באייר התשע"א‬
]11[]21[
203708
‫שיטה ומתקן לספור מקבלי תוכן שידור בטלפון‬
‫אלחוטי‬
]54[
METHOD AND APPARATUS TO
COUNT BROADCAST CONTENT
RECIPIENTS IN A WIRELESS
TELEPHONE NETWORK
]22[
]31[
]51[
]62[
]71[
18.02.2004
10/368876
]32[ 18.02.2003
]33[
Int. Cl.(2010.01) H04L 12//18, H04W 04//06
DIVISION FROM 170231
QUALCOMM INCORPORATED,
U.S.A.
WO/2004/075516
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method of operating a wireless mobile station, comprising:
receiving wireless transmission of a broadcast parameters message from a base station, the message including an identity of at least one broadcast content stream and, in
association with each broadcast content stream, an indicator having one of the following values: REGISTER, DO NOT REGISTER;
examining contents of the broadcast parameters message;
responsive to conditions including the examination revealing that the indicator is set
to REGISTER in association with a given broadcast content stream for which a user
of the mobile station has elected to receive, commencing a registration process including transmitting to the base station a prescribed format of a registration message in
association with the given broadcast content stream;
responsive to conditions including the examination revealing that the indicator is set
to DO NOT REGISTER in association with a given broadcast content stream, refraining from transmitting any registration messages to the base station in association with
the given broadcast content stream.
__________________
]11[]21[
]54[
253
BINDING MOLECULES OF
AMYLOID-BETA PEPTIDE AND
METHODS FOR PRODUCING
SAME
203790
‫מולקולות קישור של פפטיד עמילואיד– ביתא‬
‫ושיטות ליצורן‬
May 31, 2011-‫כ"ז באייר התשע"א‬
]22[
]31[
]51[
]62[
]71[
]87[
]74[
]57[
03.11.2005
0424563.5
]32[ 05.11.2004
]33[ GB
Int. Cl.(2010.01) A61K 39//00, 39//385, 47//48, A61P 25//00, 25//28, C07K 16//00
DIVISION FROM 182692
NOVARTIS AG, SWITZERLAND
WO/2006/048295
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A binding molecule which is a monoclonal human antibody against Aβ-1-42 generated
by the immune system of a human in response to the administration of a VLP structure
chemically coupled to a fragment of the Aβ-1-42 peptide or its pharmaceutically acceptable salts, which is capable of binding to Aβ-1-42 with a dissociation constant <
1000nM.
__________________
]11[]21[
– ‫ – נאפתירידין‬1 ,8 – ‫ – כלורו‬7( – 2 –‫שימוש ב‬
– )‫ – אוקסו – הקסיל‬2 – ‫ – מתיל‬5( – 3 – )‫ – יל‬2
– 1 ,8 – ‫ – כלורו‬7( – 2 – ‫ – איזואינדולינון ו‬1
– 5 – ‫ – מתיל‬5( – 3 –)‫ – יל‬2 – ‫נאפתירידין‬
– 1 – )‫ – אוקסו – הקסיל‬2 – ‫הידרוקסי‬
‫איזואינדולינון להכנת תכשיר תרופתי לטיפול‬
‫בהפרעה טורדנית – כפייתית‬
]54[
USE OF 2-(7-CHLORO-1, 8 NAPHTHYRIDINE-2-YL)-3-(5METHYL-2-OXO-HEXYL)-1ISOINDOLINONE AND 2-(7CHLORO-1, 8 - NAPHTHYRIDINE2-YL) -3-(5-METHYL-5-HYDROXY2-OXOHEXYL)-1ISOINDOLINONE IN THE
PREPARATION OF A
PHARMACEUTICAL
COMPOSITION FOR TREATING A
SOCIAL ANXIETY DISORDER
]22[
]31[
]51[
]62[
]71[
22.04.2002
60/287545
]32[ 30.04.2001
]33[ US
Int. Cl.(2009.01) A61K 31/4035, A61P 25/00, C07D 471/04
DIVISION FROM 149280
ENDO PHARMACEUTICALS
SOLUTIONS INC., U.S.A.
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The use of a compound which is 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2May 31, 2011-‫כ"ז באייר התשע"א‬
]74[
]57[
254
204665
oxo-hexyl)-1-isoindolinone or 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-5hydroxy-2-oxohexyl)-1-isoindolinone, or a pharmaceutically acceptable salt or optical
isomer thereof in the preparation of a medicament for the curative, palliative or
prophylactic treatment of obsessive-compulsive disorder.
__________________
255
May 31, 2011-‫כ"ז באייר התשע"א‬
‫פטנטים‬
PATENTS
‫פטנטים שחודשו‬
PATENTS RENEWED
105553
124935
126944
142269
147712
150346
152320
152576
155465
159519
162560
165858
170492
175171
181183
185930
105611
126345
127017
142581
148464
150837
152321
152591
155470
159707
163518
165935
170659
175527
181468
188593
105613
126504
127160
142952
149046
151099
152333
152603
156171
160484
163635
166152
171384
176785
182290
188706
105661
126509
127943
142989
149144
151446
152351
152629
157333
160633
163831
166492
172321
177094
182362
193149
105662
126682
131979
143029
149147
151987
152408
152716
157483
161356
164695
166573
172904
177493
182570
193219
105678
126796
132676
143353
149175
152151
152462
152788
158003
161383
164943
167066
174435
178382
182716
196081
120736
126835
134267
147386
150266
152297
152556
153639
158385
161842
164945
167324
174583
178700
182994
199409
124551
126864
142194
147610
150315
152319
152567
154775
158516
162025
165218
170168
175022
178917
182995
200255
‫פטנטים שחודשו לעשרים שנה‬
PATENTS RENEWED FOR 20 YEARS
143641
‫צווי הארכה שחודשו‬
EXTENSION ORDERS RENEWED
84497
256
92208
96268
May 31, 2011-‫כ"ז באייר התשע"א‬
‫פטנטים שלגביהם הוגשו‬
‫בקשות להארכת תקופת‬
‫ההגנה על פי פרק ד' סימן‬
‫ לחוק הפטנטים‬1'‫ב‬
Patents for which applications have been filed for
extension of the patent term
under chapter 4, part B1 of
the Patens Law
No. of basic patent:
117636
:‫מס' פטנט בסיסי‬
:‫שם המבקש‬
Proprietors:
AVENTIS PHARMA S.A.
Date of application:
257
26.04.2011
:‫תאריך הגשת הבקשה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
‫פטנטים שלגביהם הוגשו‬
‫בקשות להארכת תקופת‬
‫ההגנה על פי פרק ד' סימן‬
‫ לחוק הפטנטים‬1'‫ב‬
Patents for which applications have been filed for
extension of the patent term
under chapter 4, part B1 of
the Patens Law
No. of basic patent:
156306
:‫מס' פטנט בסיסי‬
:‫שם המבקש‬
Proprietors:
GLAXOSmithKLINE LLC
Date of application:
258
10.04.2011
:‫תאריך הגשת הבקשה‬
May 31, 2011-‫כ"ז באייר התשע"א‬
‫הודעה‬
NOTICE
‫ לחוק‬60 ‫לפי סעיף‬
1967-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
141089
5/2006
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
‫ישקר בע"מ‬
ISCAR LTD.
:‫שם האמצאה‬
Title of invention:
‫שימת שיבוב‬
CUTTING INSERT
Any person may oppose the
said application within three
months from the date of this
Patents Journal, as prescribed by section 61 of the
law and by regulation 92 of
the Patent Regulations,
5728-1968
259
‫כל אדם רשאי להתנגד‬
‫לבקשה האמורה תוך‬
‫שלושה חודשים מתאריך‬
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
92 ‫ לחוק ובתקנה‬61 ‫בסעיף‬
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
1968
May 31, 2011-‫כ"ז באייר התשע"א‬
NOTICE
Notice under section 172 of tha law
concerning patent application No.
Delete the notice
The notice was published by mistake
260
‫הודעה‬
‫ לחוק‬172 ‫לפי סעיף‬
179285 '‫בענין בקשת פטנט מס‬
179285
.‫מחק את ההודעה‬
‫ההודעה פורסמה בטעות‬
May 31, 2011-‫כ"ז באייר התשע"א‬
‫שינויים בפרטים רשומים בפנקס‬
CHANGES IN PARTICULARS ENTERED IN REGISTER
261
May 31, 2011-‫כ"ז באייר התשע"א‬
‫מדגמים‬
DESIGNS
‫מדגמים שנרשמו‬
DESIGNS REGISTERED
Class
49860 ,49856 ,49850
49861
11)01(
25.07.2010
‫סוג פרסום‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
48771
9)01(
20.12.2009
‫סוג פרסום‬
RECKITT & COLMAN (OVERSEAS) LIMITID
Aerosol containers
Convention date (OHIM)
Class
30.06.2009
49492
9)01(
23.05.2010
‫מיכל אירוסול‬
)‫תאריך האמנה (איחוד אירופי‬
‫סוג פרסום‬
CILAG GMBH INTERNATIONAL
Bottle
Convention date (OHIM)
Class
262
27.11.2009
49366
24)04(
20.07.2009
‫בקבוק‬
)‫תאריך האמנה (איחוד אירופי‬
‫סוג פרסום‬
May 31, 2011-‫כ"ז באייר התשע"א‬
MCKEON PRODUCTS, INC.
Earplug
Convention date (U.S.A.)
263
22.01.2009
‫אוטם אוזניים‬
)‫תאריך האמנה (ארצות הברית‬
May 31, 2011-‫כ"ז באייר התשע"א‬
Class
49884
9)01(
27.07.2010
‫סוג פרסום‬
FLAMAGAS S.A.
Lighter fluid bottle
Convention date (Spain)
Class
17.02.2010
44701
13)03(
29.08.2007
‫בקבוק מצית נוזלי‬
)‫תאריך האמנה (ספרד‬
‫סוג פרסום‬
‫ פתיה בע"מ‬.‫א‬
‫תקע חשמלי‬
E. FETAYA LTD.
Plug
Class
48300
8)06(
09.09.2009
‫סוג פרסום‬
‫) בע"מ‬1980( ‫עמישי חברה לשיווק‬
AMISHAY MARKETING
COMPANY (1980) LTD.
‫מערכת ידיות לדלת‬
Door handles set
Class
48526
4)02(
12.11.2009
‫סוג פרסום‬
COLGATE-PALMOLIVE COMPANY
Toothbrush
Convention date (U.S.A.)
Class
14.05.2009
48563
4)02(
18.11.2009
.GLAXOSMITHKLINE
264
‫מברשת שיניים‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
BIOLOGICALS S.A
May 31, 2011-‫כ"ז באייר התשע"א‬
‫מברשת שיניים‬
‫תאריך האמנה (הממלכה‬
‫המאוחדת)‬
‫כ"ז באייר התשע"א‪May 31, 2011-‬‬
‫‪20.05.2009‬‬
‫‪Toothbrush‬‬
‫)‪Convention date (Great Britain‬‬
‫‪265‬‬
Class
48937
9)07(
25.01.2010
‫סוג פרסום‬
COLGATE-PALMOLIVE COMPANY
Nozzle for a container cap
Convention date (U.S.A.)
Class
31.07.2009
49959
9)01(
17.08.2010
SANO BRUNOS ENTERPRISES
LTD.
‫זרבובית עבור מכסה של מיכל‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
‫סנו מפעלי ברונוס בע"מ‬
‫בקבוק‬
Bottle
48448 ,48447 ,48446
48451 ,48450 ,48449
Class
25)01(
21.10.2009
‫סוג פרסום‬
‫יוסף מרדלר‬
‫פרופיל‬
YOSEF MERDLER
Profile
Class
49956
11)02(
16.08.2010
‫סוג פרסום‬
‫שי אילון‬
‫פסל קינטי‬
SHAI EILON
Kinetic statue
Class
266
48672
9)07(
10.12.2009
‫סוג פרסום‬
May 31, 2011-‫כ"ז באייר התשע"א‬
RECKITT & COLMAN (OVERSEAS) LIMITID
Aerosol cap
Convention date (OHIM)
267
11.06.2009
‫מכסה למיכל אירוסול‬
)‫תאריך האמנה (אוהיים‬
May 31, 2011-‫כ"ז באייר התשע"א‬
Class
49078
23)01(
25.02.2010
‫סוג פרסום‬
VICTAULIC COMPANY
Pipe coupling
Convention date (U.S.A.)
Class
28.08.2009
49153
26)04(
21.03.2010
HAGIM NEHALIM MARKETING
LTD.
‫מחבר לצינור‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
‫חגים נחלים שיווק בע"מ‬
‫נר שמן‬
Oil candle
Class
49278
9)01(
14.04.2010
‫סוג פרסום‬
YEREVAN BRANDY COMPANY CJSC
Bottle
Convention date (OHIM)
Class
23.11.2009
49435 ,49434 ,49433
23)02(
11.05.2010
Device for toilet paper
Class
LIOR JORNO
‫סוג פרסום‬
‫זאב רז‬
‫התקן לנייר בית שימוש‬
ZEEV RAZ
268
‫בקבוק‬
)‫תאריך האמנה (איחוד אירופי‬
49450
7)06(
13.05.2010
‫סוג פרסום‬
‫ליאור ג'ורנו‬
May 31, 2011-‫כ"ז באייר התשע"א‬
‫כלי קיבול קיסמים‬
Toothpick receptacle
Class
49462 ,49461 ,49460
49465 ,49464 ,49463
49468 ,49467 ,49466
49469
25)01(
17.05.2010
‫סוג פרסום‬
‫קליל תעשיות בע"מ‬
‫פרופיל‬
KLIL INDUSTRIES LTD.
Profile
Class
49686
12)08(
27.06.2010
‫סוג פרסום‬
BYD COMPANY LIMITED
Automoblie
Convention date (CHINA)
Class
‫כלי תחבורה‬
)‫תאריך האמנה (סין‬
26.12.2009
49774
13)03(
07.07.2010
‫סוג פרסום‬
‫תמח"ש תעשיית מתכת וחשמל בע"מ‬
TAMHASH METAL &
ELECTRICITY LTD.
‫פס צבירה‬
Busbar
Class
49786
12)08(
11.07.2010
‫סוג פרסום‬
SUZUKI MOTOR CORPORATION
Automoblie
Convention date (JAPAN)
269
19.01.2010
‫מכונית‬
)‫תאריך האמנה (יפן‬
May 31, 2011-‫כ"ז באייר התשע"א‬
Class
49885
27)05(
27.07.2010
‫סוג פרסום‬
FLAMAGAS S.A.
Lighter
Convention date (Spain)
270
10.03.2010
‫מצית‬
)‫תאריך האמנה (ספרד‬
May 31, 2011-‫כ"ז באייר התשע"א‬
Class
49903
3)01(
01.08.2010
‫סוג פרסום‬
TOYMONSTER INTELLECTUAL PROPERTY LIMITED
‫מזוודה‬
Suitcase
Class
49992 ,49989 ,49984
49994 ,49993
11)01(
19.08.2010
‫סוג פרסום‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
50031
14)02(
29.08.2010
‫סוג פרסום‬
APPLE INC.
Electronic device
Convention date (U.S.A.)
Class
19.04.2010
50084
6)01(
16.09.2010
‫מכשיר אלקטרוני‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
‫זאב כץ‬
‫כסא‬
ZEEV KATZ
Chair
Class
50114
11)01(
03.10.2010
‫סוג פרסום‬
H. STERN COMERCIO E INDUSTRIA S.A.
Jewel
271
‫תכשיט‬
May 31, 2011-‫כ"ז באייר התשע"א‬
Class
50170
7)01(
18.10.2010
‫סוג פרסום‬
‫צבי‬-‫שונית בן‬
‫קערה‬
SHUNIT BEN-TZVI
Bowl
Class
50209 ,50208 ,50207
50211
11)02(
26.10.2010
‫סוג פרסום‬
‫דימיטרי צחנסקי‬
‫פסל‬
DIMITRI TSEHANSKI
Statue
Class
50266
21)01(
07.11.2010
‫סוג פרסום‬
TOYMONSTER INTELLECTUAL PROPERTY LIMITED
‫צעצועי רכיבה‬
Ride on toys
Class
49631
3)01(
17.06.2010
‫סוג פרסום‬
IMAGINARIUM, S.A
Bag
Convention date (Spain)
Class
PHOTAX MOLDS LTD.
272
22.12.2009
49902
13)03(
01.08.2010
‫תיק‬
)‫תאריך האמנה (ספרד‬
‫סוג פרסום‬
‫פוטקס תבניות בע"מ‬
May 31, 2011-‫כ"ז באייר התשע"א‬
‫קופסא לשקע קיר‬
‫כ"ז באייר התשע"א‪May 31, 2011-‬‬
‫‪Box for wall socket‬‬
‫‪273‬‬
Class
48203
6)03(
18.08.2009
‫סוג פרסום‬
‫כתר פלסטיק בע"מ‬
‫שולחן‬
KETER PLASTIC LTD.
Table
Class
49038
15)05(
18.02.2010
‫סוג פרסום‬
SHOP VAC CORPORATION
Vacuum cleaner
Convention date (U.S.A.)
Class
31.08.2009
49591
20)03(
15.06.2010
‫סוג פרסום‬
‫ רוט תעשיות בע"מ‬.‫צ‬
‫שלט פרסום‬
Z. ROTH INDUSTRIES LTD.
Bill board
Class
‫שואב אבק‬
)‫תאריך האמנה (ארצות הברית‬
49409
24)04(
04.05.2010
‫סוג פרסום‬
TEVA PHARMACEUTICALS IRELAND
Inhaler
Convention date (OHIM)
Class
ANDREA NETA COREN
SCARF
274
20.11.2009
49519
2 )05(
30.05.2010
‫משאף‬
)‫תאריך האמנה (איחוד אירופי‬
‫סוג פרסום‬
‫אנדראה נטע קורן‬
‫צעיף‬
May 31, 2011-‫כ"ז באייר התשע"א‬
Class
49721
24)04(
30.06.2010
‫סוג פרסום‬
TEVA PHARMACEUTICALS IRELAND
Inhaler
Convention date (OHIM)
275
08.01.2010
‫משאף‬
)‫תאריך האמנה (איחוד אירופי‬
May 31, 2011-‫כ"ז באייר התשע"א‬
‫מדגמים שבוטלו‬
DESIGNS VOID
26192
34332
26230
26197
34335
26231
34307
34338
26232
34308
34339
26233
34309
34375
34311
34374
34312
34372
34313
26227
42243
42592
42460
42662
42462
42806
‫מדגמים שחודשו‬
DESIGNS RENEWED
35010
42463
35127
42469
35316
42497
35458
42556
‫ רשם‬Asa Kling
‫וסימני‬Commissioner of Patents,
Designs and Trade Marks
276
41644
42591
‫אסא קלינג‬
‫ המדגמים‬,‫הפטנטים‬
‫מסחר‬
May 31, 2011-‫כ"ז באייר התשע"א‬
‫מפתחות לבקשות שקובלו‬
‫‪INDICES OF APPLICATIONS ACCEPTED‬‬
‫מפתח שמי‬
‫‪NAME INDEX‬‬
‫מיכאל גרנדר ‪181772 -‬‬
‫אביאם מערכות בע"מ ‪170118 -‬‬
‫אוניברסיטת בן‪-‬גוריון בנגב‪ ,‬הרשות למחקר‬
‫ופיתוח ‪163216 -‬‬
‫אלגת שרותי גימור תעופתי ‪197164 -‬‬
‫אלווריון בע"מ ‪170924 , 169417 -‬‬
‫אלונים אחזקות אגש"ח בע"מ ‪197164 -‬‬
‫אלכסנדר זולדן ‪181772 -‬‬
‫אלקסנדר שוורץ ‪199845 , 199843 -‬‬
‫אלתא מערכות בע"מ ‪186834 -‬‬
‫אנקוטון בע"מ ‪176262 -‬‬
‫דוד שוורצמן ‪199845 , 199843 -‬‬
‫דורון אורבך ‪175460 -‬‬
‫דן שקלרסקי ‪186653 -‬‬
‫התעשייה האוירית לישראל בע"מ ‪188139 -‬‬
‫טבע תעשיות פרמצבטיות בע"מ ‪156280 -‬‬
‫יוכבד שאשו ‪183546 -‬‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים ‪, 195446 -‬‬
‫‪195448 , 195447‬‬
‫יצחק לבטון ‪176262 -‬‬
‫סאנדיסק אייאל בע"מ ‪196372 -‬‬
‫סטדימד בע"מ ‪175460 -‬‬
‫עודי רחמני ‪179002 -‬‬
‫קמטק בע"מ ‪189711 -‬‬
‫קפטק בע"מ ‪175925 -‬‬
‫קרן מחקרים רפואיים ופיתוח תשתית ‪-‬‬
‫‪195448 , 195447 , 195446‬‬
‫רסדבקו חברה למחקר ולפתוח בע"מ ‪-‬‬
‫‪168603‬‬
‫שגיב אגודה שיתופית חקלאית בע"מ ‪-‬‬
‫‪177036‬‬
‫שלמה וייסברגר ‪188387 -‬‬
‫שלמה חיימי ‪175925 -‬‬
‫שמואל קוסולאפוב ‪162063 -‬‬
‫תגא תכנון ופיתוח בע"מ ‪190019 -‬‬
‫תרכובות ברום בע"מ ‪180424 -‬‬
‫לוג'יקון דייזין אוטומיישן בע"מ ‪181273 -‬‬
‫לקסטרן בע"מ ‪159305 -‬‬
‫מולטילוק טכנולוגיות בע"מ ‪173378 -‬‬
‫מור משאבי אי‪.‬טי‪ .‬בע"מ ‪194654 -‬‬
‫‪- 145907‬‬
‫ ‪ACTIAL FARMACEUTICA LDA‬‬‫כ"ז באייר התשע"א‪May 31, 2011-‬‬
‫ ‪ABBOTT BIOTHERAPEUTICS CORP.‬‬‫‪168744178042 ,‬‬
‫‪ACTELION PHARMACEUTICALS LTD.‬‬
‫‪277‬‬
183291
ADVANCED TECHNOLOGY MATERIALS, INC. - 190195
AIR LIQUIDE ELECTRONICS U.S. LP 185291
ALBEMARLE CORPORATION - 179584
ALCON, INC. - 185247
ALERE SWITZERLAND GMBH - 175626
, 175627 , 175628
ALEXANDER SHVARTZ - 199843 ,
199845
ALEXANDER ZOLDAN - 181772
ALGAT SHERUTEY GIMUR TEUFATI 197164
ALONIM HOLDINGS AGRICULTURAL
COOPERATIVE SOCIETY LTD. - 197164
ALVARION LTD. - 169417 , 170924
ANSELL HEALTHCARE PRODUCTS
LLC - 172468 , 181535
ANTONY DAVID SUTTON LICKORISH
- 202330
ARES TRADING S.A. - 177375 , 182955
ARNOLD SYSTEMS LLC - 187743
ASAHI KASEI CHEMICALS CORPORATION - 174177
ASK S.A. - 170967
ASTRAZENECA AB - 169370
ATLAS ELEKTRONIK GMBH - 179948
ATLAS ELEKTRONIK GMBH - 179948 ,
179950
AVENTIS PHARMACEUTICALS INC. 198131
AVIEM SYSTEMS LTD. - 170118
AZIENDA OSPEDALIEROUNIVERSITARIA CAREGGI - 183118
BASF PLANT SCIENCE GMBH - 170560
BAYER CORPORATION - 193368
BAYER CROPSCIENCE AG - 155265 ,
175024
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT - 164733
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND DEVELOPMENT AUTHORITY - 163216
BILLY T. FOWLER - 177500
BIOCON LIMITED - 149056 , 149256
278
BIOGEN IDEC MA INC. - 141877
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - 145720
BREYA, LLC - 195371
BRIGHTSOURCE ENERGY, INC. 183154
BRISTOL-MYERS SQUIBB COMPANY 178965
BROMINE COMPOUNDS LTD. - 180424
CAMTEK LTD. - 189711
CAPTECH LTD. - 175925
CENTELION - 196444
CERATIZIT AUSTRIA GESELLSCHAFT
M.B.H - 167867
CHINOIN GYOGYSZER ES
VEGYESZETI TERMEKEK GYARA
ZRT. - 190513
CIDWAY TECHNOLOGIES LTD. 176262
CILAG GMBH INTERNATIONAL 179653
CITRIX SYSTEMS, INC. - 180404
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS - 172831
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS - 172831
CORDIS CORPORATION - 173064
COVIDIEN AG - 184616
CRUCELL HOLLAND B.V. - 164802
DAN SHAKLARSKY - 186653
DAVID J. ARLTON - 178592
DAVID K.R. KARAOLIS - 173065
DAVID SHVARTSMAN - 199843 ,
199845
DCA DESIGN INTERNATIONAL LIMITED - 170619
DEERE & COMPANY - 177732
DEVI A/S - 181756
DIEHL BGT DEFENCE GMBH & CO. KG
- 180636
DOLORES BAKSH - 202330
DORON AURBACH - 175460
DYADIC INTERNATIONAL (USA),
INC. - 152272
May 31, 2011-‫כ"ז באייר התשע"א‬
E.I. DU PONT DE NEMOURS AND
COMPANY - 176420 , 183091
EDWARDS VACUUM, INC. - 185291
ELENA MARKEVICH - 175460
ELLEN AB - 160937
ELOPAK SYSTEMS AG - 180141
ELTA SYSTEMS LTD. - 186834
ENCOTONE LTD. - 176262
ENDO PHARMACEUTICALS SOLUTIONS INC. - 204665
EROWA AG - 188311
ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) 181479
EUROCOPTER - 181519
F. HOFFMANN-LA ROCHE AG - 150548
, 165055 , 173905 , 180481
FIRMENICH SA - 175728
FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. - 145638
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V. - 185304
GENENTECH, INC. - 155279 , 157705 ,
195973
GLAXO GROUP LIMITED - 178152
GOOD SPACE LTD. - 169559
GRAPHLOGIC INC. - 181435
GRIGORY SALITRA - 175460
HAMAMATSU PHOTONICS K.K. 169586
HANA BIOSCIENCES INC. - 145720
HARRIS CORPORATION - 166676
HISPANO-SUIZA - 189214
ID BIOMEDICAL CORPORATION 143905
IHARA SCIENCE CORPORATION 191825
IMMUNEX CORPORATION - 137037
INCA SOLUTION CO. LTD, - 183019
INEX PHARMACEUTICALS CORPORATION - 145720
INTERDIGITAL TECHNOLOGY COR279
PORATION - 171717
INVENTIO AG - 178466
ISAAC J. LABATON - 176262
ISRAEL AEROSPACE INDUSTRIES
LTD. - 188139
ITT MANUFACTURING ENTERPRISES,
INC. - 189378
JANE, S.A. - 183837 , 184160
JANSSEN PHARMACEUTICA, N.V. 179630 , 181581
JOHN E. DAVIES - 202330
LABOPHARM (BARBADOS) LIMITED 168114
LABOPHARM EUROPE LIMITED 168114
LABOPHARM INC - 168114
LABORATOIRES BESINS INTERNATIONAL - 186356
LEXTRAN LTD. - 159305
LG ELECTRONICS INC. - 183915
LOGICCON DESIGN AUTOMATION
LTD - 181273
LONZA AG - 170253
LORD CORPORATION - 179395
M & G POLIMERI ITALIA S.P.A. 195082
MANNKIND CORPORATION - 181687
MARK AARON EMALFARB - 152272
MEDION DIAGNOSTICS AG - 177144
MERCK SERONO S.A. - 183930
MICHAEL GRENADER - 181772
MICROSOFT CORPORATION - 174085
MIKHAIL LEVI - 175460
MORE IT RESOURCES LTD. - 194654
MORPHOCHEM AG - 175409
MORRIS HOSSEINI - 202330
MUL-T-LOCK TECHNOLOGIES LTD. 173378
N.V. ORGANON - 178562
NATIONAL BLOOD AUTHORITY 201146
NATURE TECHNOLOGY CORP. 181410
May 31, 2011-‫כ"ז באייר התשע"א‬
NETWORK APPLIANCE, INC. - 178576
NEW YORK MEDICAL COLLEGE 150979
NHS BLOOD AND TRANSPLANT 201146
NICOX S.A. - 188253
NIPPON SODA - 155265
NOBEX CORPORATION - 149056 ,
149256
NOVARTIS AG - 149498 , 177183 ,
187758 , 189658 , 203790
NOVO NORDISK A/S - 161358
NYCOMED DANMARK A/S - 154041
NYCOMED GMBH - 186197
OLCON ENGINEERING AB - 181807
ONERA (OFFICE NATIONAL D'ETUDES
ET DE RECHERCHES AEROSPATIALES) - 175196
ORDA KOREA CO, LTD. - 169424
ORGANES, TISSUS: REGENERATION,
REPARATION, REMPLACEMENT-OTR3
- 162192
OXFORD GLYCOSCIENCES (UK) LTD.
- 145907
PAUL E. ARLTON - 178592
PDL BIOPHARMA, INC. - 168744 ,
178042
PDM CO. LTD. - 169559
PEAT INTERNATIONAL, INC. - 178044
PHARMACHEMIE B.V. - 181175
POMPER, Mark, Elliot - 195371
QLT INC. - 187758
QUALCOMM INCORPORATED - 176768
QUALCOMM INCORPORATED - 197980
, 203708
QUEENS UNIVERSITY AT KINGSTON 169971
R. OOSTERLING BEHEER B.V. - 181756
RAHUL SARUGASER - 202330
RAIL. ONE GMBH - 189167
RAYTHEON COMPANY - 169563
REIFENHAUSER GMBH & CO. KG
MASCHINENFABRIK - 188097
280
RESDEVCO RESEARCH AND DEVELOPMENT CO. - 168603
ROAMWARE, INC. - 177986
SAGEM DEFENSE SECURITE - 185178
SAGIV AGUDAH SHITUFIT CHAKLAIT
BE'AM - 177036
SAINT-GOBAIN CERAMICS & PLASTICS, INC. - 198456
SAMUEL KOSOLAPOV - 162063
SANDISK IL LTD. - 196372
SANOFI-AVENTIS - 168516 , 171694
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 165788 , 168340 , 180571
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 174807 , 190511
SCHERING CORPORATION - 177033
SHERWOOD SERVICES AG - 181525
SHIRE CANADA, INC. - 143905
SHLOMO HAIMI - 175925
SHLOMO WEISBERGER - 188387
SKINMEDICA, INC. - 160131
SNECMA - 188304
SNECMA PROPULSION SOLIDE 188304
SPEEDLINE TECHNOLOGIES, INC. 182463
STEADYMED LTD. - 175460
SUMITOMO CHEMICAL COMPANY,
LIMITED. - 174781
SUN PHARMA ADVANCED RESEARCH
COMPANY (SPARC LTD.) - 164196
SUN PHARMACEUTICAL INDUSTRIES
LIMITED - 164196
SWEETWELL N.V. - 181277
TAGA DESIGN & DEVELOPMENT LTD.
- 190019
TARGET DISCOVERY - 168006
TECHNOLOGY LICENSING CORPORATION - 160747
TEIKOKU SEIYAKU CO., LTD. - 166668
TEL-AVIV MEDICAL CENTER RESEARCH AND DEVELOPMENT FUND 195446 , 195447 , 195448
TERASPAN NETWORKS INC. - 173172
TEVA PHARMACEUTICAL INDUSMay 31, 2011-‫כ"ז באייר התשע"א‬
TRIES LTD. - 156280
THE BOC GROUP,INC. - 185291
THE PROCTER & GAMBLE COMPANY
- 178706
THE SCRIPPS RESEARCH INSTITUTE 195677
THE UNIVERSITY OF ALABAMA 178281
THE UNIVERSITY OF BRISTOL 167780
THOMAS E. JOHNSON - 177500
TIBOTEC PHARMACEUTICALS LTD. 173891
TRELLIS BIOINFORMATICS, INC. 199919
DRID - 172831
UNIVERSITE DE LAUSANNE - 171158
UNIVERSITY OF VIRGINIA PATENT
FOUNDATION - 166796
WARNER-LAMBERT COMPANY LLC 204665
WOMEN FIRST HEALTHCARE, INC. 160131
WYETH LLC - 164806
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM - 195446 , 195447 ,
195448
YOCHEVED SHASHO - 183546
UCB S.A. - 145907
UDI RAHMANI - 179002
UNILEVER PLC - 188803 , 189129
UNIMED PHARMACEUTICALS, LLC 186356
UNIVERSIDAD AUTONOMA DE MA-
‫מפתח ענייני‬
SUBJECT MATTER INDEX
A01N - 155265
A21D - 181277
A23G - 189129
A47J - 160747
A61B - 181535, 183291, 185247
A61F - 181525
A61K - 141877, 145720, 145907,
149498, 150548, 160131,
160937, 165788, 168114,
168603, 168744, 173065,
174807, 178042, 182955,
183930, 186356, 187758,
188253, 190511, 195446,
195677, 203790
A61M - 170619, 175460, 177375,
179653, 186197
A61N - 195371
A63B - 188387
281
A63H - 169424
B01D - 159305,
B23B - 167867
B25B - 177036
B29C - 172468,
B31B - 180141
B60N - 183837,
B62D - 181772
B62J - 190019
B63G - 179950
B64C - 178592,
B65B - 175925,
B65D - 190513
B66B - 178466
B67D - 185291
174177
188311
184160
181519, 188304
181175
C01F - 198456
May 31, 2011-‫כ"ז באייר התשע"א‬
C04B - 199843
C07B - 177500
C07C - 149056, 149256,
165055, 166668,
174781, 175024,
180571
C07D - 145638, 150979,
156280, 164196,
168340, 168516,
171694, 173891,
175409, 176420,
177183, 178152,
178965, 179630,
181581, 183091,
193368
C07D - 204665
C07K - 137037, 143905,
161358, 164733,
171158, 181687,
195447, 198131
C08B - 162192
C08J - 178281, 195082
C08L - 179584
C09J - 179395
C12N - 152272, 155279,
170560, 172831,
195448, 196444,
202330
C12P - 181410
C23C - 197164
D01F - 188097
D01G - 177732
D04H - 178706
E01B - 189167
E02D - 199845
E03C - 179002
E03D - 183546
E05B - 173378
163216,
170253,
180424,
154041,
164806,
169370,
173905,
177033,
178562,
180481,
189658,
157705,
167780,
188803,
164802,
175728,
201146,
F15B - 189214
F16J - 181807
F16K - 190195
F16L - 191825
F23G - 178044
F24J - 169971
F42B - 169563
G01J - 168006
G01N - 175626,
177144,
199919
G01S - 186653,
G02B - 173172,
G02C - 181479
G02F - 175196
G06F - 166796,
181273,
194654,
G06K - 162063,
G06Q - 176262
G07B - 169559
G08B - 173064,
G08G - 188139
G10K - 179948
175627, 175628,
183118, 195973,
186834
185178, 189711
174085, 178576,
181435, 183019,
196372
170967
189378
H01L - 169586, 183154
H02J - 170118
H03B - 180636
H04B - 183915
H04L - 166676, 176768, 180404,
203708
H04S - 185304
H04W - 169417, 170924, 171717,
177986, 197980
H05B - 181756
H05K - 182463
F03D - 187743
F04B - 184616
282
May 31, 2011-‫כ"ז באייר התשע"א‬
‫קודים למדינת המופיעים ביומן‬
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
JP
KR
LK
LU
283
Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
Japan
Republic of Korea
Sri Lanka
Luxembourg
Code
MX
MY
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA
Country or Organization
Mexico
Malaysia
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property
Organization (W.I.P.O.)
South Africa
May 31, 2011-‫כ"ז באייר התשע"א‬
LV
Latvia
‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
284
May 31, 2011-‫כ"ז באייר התשע"א‬